[
  {
    "conditions": [
      {
        "key": "age",
        "value": 19,
        "operator": "<"
      }
    ],
    "action": "Conduct HEADSS assessment",
    "annotation": "Questions to consider include:\u2013 Who do you live with? Any recent changes at home?\n\u2013 How are your relationships with teachers, friends, employers, and colleagues??\n\u2013 Are\u00a0you\u00a0studying,\u00a0working,\u00a0or\u00a0both? How\u00a0are you doing at school/work?\u2013 Any\u00a0recent\u00a0changes\u00a0in\u00a0school\u00a0or\u00a0workplace?\n\u2013 How do\u00a0you feel about your home environment? \n\u2013 How many meals do you have daily? Is your diet adequate? Do you sleep enough?\n\u2013 What's your free time like? Do you socialise with\u00a0family or friends??\n\u2013 Do your friends smoke, drink, or recreational drug use? What about you?\n\u2013 Do you know about sexual and reproductive health? Any concerns or questions?\n\u2013 Have you experienced any menstrual changes? Have you missed your period? Do you\u00a0have any\u00a0concerns?\n\u2013 How do you define your\u00a0sexuality? Are you attracted to malee? \n\u2013 Have you taken any steps to prevent sexual and reproductive health\u00a0problems?\n\u2013 Have you or your friend's experienced sexual health issues such as unwanted pregnancy, STIs or sexual coercion? What about you? If yes, ask \u2013 did you seek and receive any treatment for these?",
    "action_key": 0
  },
  {
    "conditions": [
      {
        "key": "DAK, STI risk assessment conducted",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide Treatment Counsel on dual protection , Partner notification.  Offer routine HIV and STI testing",
    "annotation": "\u2013Provide testing, diagnosis and  immediate treatment of  STIs based on signs/symptoms.\u2013Offer HIV testing and counseling \u2013 Support Partner notification of diagnosis   symptoms \u2013 Promote condom/lubricant use, combination  of condoms with other FP methods,  mutually faithful relationships and engagement in non-penetrative sexual intimacy to prevent STIs.",
    "action_key": 1
  },
  {
    "conditions": [
      {
        "key": "DAK, Pelvic/genital examination conducted",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Prompt diagnosis and treatment based on syndromic diagnosis or perform STI testing.",
    "annotation": "\u2013Provide testing, diagnosis and  immediate treatment of  STIs based on signs/symptoms. \u2013Offer HIV testing and counseling \u2013 Support Partner notification of diagnosis   symptoms \u2013 Promote condom/lubricant use, combination  of condoms with other FP methods,  mutually faithful relationships and engagement in non-penetrative sexual intimacy to prevent STIs.",
    "action_key": 2
  },
  {
    "conditions": [
      {
        "key": "DAK, HIV risk assessment conducted",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Offer HIV testing and counseling Provide full information and counseling Treat STI and Promote condom use Offer PrEP or PEP Address mental health concerns related to violence Encourage seeking medical and legal assisitance",
    "annotation": "\u2013Provide HIV services: testing, counselling, and risk-reduction counselling.Promote dual protection - Condom demonstration and provision \n\u2013Consider access to PrEP or PEP screening and provision.\n\u2013Refer for harm reduction services, including clean needles.\n\u2013Provide resources and referrals for support services \u2013Provide treatment for STIs - Encourage her to discuss with peer groups about HIV transmission and prevention mechanisms",
    "action_key": 3
  },
  {
    "conditions": [
      {
        "key": "DAK, HIV test result",
        "value": "DAK, HIV-positive",
        "operator": "="
      }
    ],
    "action": "\u2013Refer for immediate HIV services, treatment, and support decisions.Counsel clients on:\u2013Test Result confidentiality \n\u2013HIV treatment effectiveness and viral load suppression. \n\u2013Partner disclosure and  testing .\u2013Condom use for STI prevention.",
    "annotation": "\u2013Refer for immediate HIV services, treatment, and support decisions. Counsel clients on:\u2013Test Result confidentiality \n\u2013HIV treatment effectiveness and viral load suppression. \n\u2013Partner disclosure and  testing .\u2013Condom use for STI prevention.",
    "action_key": 4
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Counsel client on self-injection of DMPA-SC, storage and disposal. Demonstrate and provide injection devices.",
    "annotation": "\u2013 Counsel clients on self-injection of DMPA-SC for convenience.\n\u2013 Counsel on safe storage, appropriate temperature conditions, and proper disposal of used devices.\n\u2013 Use visual aids and instruction sheets to explain and demonstrate the self-injection process. Observe the client practicing until proficient.\n\u2013 Supply clients with injection devices for future self-injections.\nand discuss any concerns or questions.",
    "action_key": 5
  },
  {
    "conditions": [
      {
        "key": "DAK, Cervical Cancer risk assessment conducted",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel on safer sexual practices, smoking cessation, and the importance of regular screening and Conduct STI screening, treatment, and provide counseling on regular cancer  screening.",
    "annotation": "\u00e2\u20ac\u201cIncreased risk of HPV infection and cervical cancer.\n  \u00e2\u20ac\u201cProvide safe sex counselling \n\u00e2\u20ac\u201cRecommended regular screening \n\u00e2\u20ac\u201cProvide counseling on smoking cessation and regular screening.\n\u00e2\u20ac\u201cScreen for STIs and provide appropriate treatment. \n\u00e2\u20ac\u201cProvide Partner counselling and access to  Voluntary medical male circumsision (VMMC )services ",
    "action_key": 6
  },
  {
    "conditions": [
      {
        "key": "DAK, Clients wishes and future plans for childbearing",
        "value": "DAK, Client decides not to use contraception at this time",
        "operator": "="
      }
    ],
    "action": "Counsel on early fertility return  8-10 days postabortion ,contraceptive methods, failure rates and provide backup methods",
    "annotation": "",
    "action_key": 7
  },
  {
    "conditions": [
      {
        "key": "DAK, Clients wishes and future plans for childbearing",
        "value": "DAK, Client decides to wait before choosing a contraceptive method",
        "operator": "="
      }
    ],
    "action": "Counsel on early fertility return  8-11 days post abortion ,contraceptive methods, failure rates and provide back up methods",
    "annotation": "",
    "action_key": 8
  },
  {
    "conditions": [
      {
        "key": "DAK, Clients wishes and future plans for childbearing",
        "value": "DAK, Client wants to become pregnant again soon after a miscarriage",
        "operator": "="
      }
    ],
    "action": "Counsel on early fertility return  8-12 days postabortion ,contraceptive methods, failure rates and provide back up methods",
    "annotation": "",
    "action_key": 9
  },
  {
    "conditions": [
      {
        "key": "DAK, Clients wishes and future plans for childbearing",
        "value": "DAK, Woman is being treated for infection or vaginal/cervical injury",
        "operator": "="
      }
    ],
    "action": "Discuss completion of treatment/management before resuming sexual activity.",
    "annotation": "",
    "action_key": 10
  },
  {
    "conditions": [
      {
        "key": "DAK, Clients wishes and future plans for childbearing",
        "value": "DAK, Woman may have been exposed to STI  or experienced sexual violence",
        "operator": "="
      }
    ],
    "action": "Offer STI screening and refer survivors of sexual violence for support and care",
    "annotation": "",
    "action_key": 11
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Cu-IUD use may cause 3-6 months of spotting or light bleeding, which decreases over time.  \u2013 Consider short-course NSAIDs during bleeding days for treatment.                                                                                                                                                        \u2013 Exclude gynecologic causes.  If a gynaecologic problem is identified, treat or refer the woman for care.                                                                                                                                                               \u2013 If bleeding is unacceptable with no gynecologic problem, consider IUD removal and alternative method.                                                                                                                                  \u2013 STI/PID treatment and condom use can be continued with Cu-IUD. If PID symptoms persist, remove IUD while continuing antibiotics.",
    "action_key": 12
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Emergency contraceptive ( pills, IUCD...) use may cause  spotting or light bleeding, which decreases over time.  \u2013 Consider short-course NSAIDs during bleeding days for treatment.                                                                                                                                                        \u2013 Exclude gynecologic causes.  If a gynaecologic problem is identified, treat or refer the woman for care.                                                                                                                                                               \u2013 If bleeding is unacceptable with no gynecologic problem, consider IUCD removal and alternative method.",
    "action_key": 13
  },
  {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Etonogestrel (ETG)or Levonorgestrel(LNG)  implant use may cause spotting or light bleeding, which is not harmful  and decreases over time.\n\u2013 Exclude gynecologic issues for persistent spotting and bleeding. If a gynaecologic problem is identified, treat or refer if necessary .\n\u2013 If bleeding is unacceptable and no gynecologic problems exist, discuss implant removal and alternative method.",
    "action_key": 14
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Reassure clients that heavy or prolonged bleeding with IUD use is common and generally not harmful but improves over time.                                                                                                   \u2013 Initial Cu-IUD use may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 Offer treatment options like NSAIDs or tranexamic acid for menstrual bleeding.Aspirin should NOT be used. Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                   \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss IUD removal and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 15
  },
  {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Heavy or prolonged  bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial Implant use may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                   \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                     \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss implant removal and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 16
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial injection may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                                                                                            \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                        \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss injection discontinuation  and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 17
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged  bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Assure her that heavy or prolonged bleeding with POPs is common but not harmful. It usually improves over time. For short-term relief, suggest NSAIDs try  the same treatment as for irregular bleeding.Provide iron tablets or encourage iron-rich foods to prevent anemia.",
    "action_key": 18
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Irregular vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client  that irregular bleeding is common with IUD use and usually improves over time. NSAIDs can provide short-term relief. If irregular bleeding persists or occurs after several months of normal bleeding, evaluate for other unrelated underlying conditions unrelated to method use..",
    "action_key": 19
  },
   {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular  bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that irregular bleeding is common with implants and usually improves over the first year. NSAIDs can provide short-term relief, and if needed, COCs or 50 \u03bcg ethinyl estradiol can be tried when irregular bleeding starts. If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, evaluate for unrelated underlying conditions.",
    "action_key": 21
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Irregular vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reasure client that irregular bleeding is common with progestogen-only injectables , is not harmful and usually improves over the first few months. NSAIDs can provide short-term relief. If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, evaluate for unrelated underlying conditions.",
    "action_key": 22
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Irregular blleding at unexpected times that bothers the client",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Reassure client  that irregular bleeding is common with POPs, whether breastfeeding or not, and is y not harmful. It may improve or stop after the first few months, but some women may experience ongoing irregular bleeding.\nTo reduce irregular bleeding:\n    \u2013 Emphasize proper pill intake, especially after vomiting or diarrhea.\n    \u2013 Suggest NSAIDs for short-term relief when irregular bleeding occurs.\n    \u2013 If NSAIDs are ineffective after a few months, consider trying a different POP formulation for at least 3 months.\n    \u2013 If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, consider evaluating for unrelated underlying conditions.",
    "action_key": 23
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Irregular blleding at unexpected times that bothers the client",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that irregular bleeding is common with COCs and is generally not harmful. It often improves or stops after the first few months of use. To reduce irregular bleeding:\n\u2013 Emphasize consistent daily pill intake at the same time each day.\n\u2013 Educate her on proper missed pill management, including after vomiting or diarrhea.\n\u2013 Suggest NSAIDs for short-term relief when irregular bleeding occurs.\n\u2013 If NSAIDs do not help , try a different COC formulation for at least 3 months. If irregular bleeding persists or occurs after several months, evaluate for underlying conditions.",
    "action_key": 24
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "The exact mechanism by which Cu-IUCD causes amenorrhea is not fully understood, but it is believed to be related to the copper ions released by the device.It is thought that these effects of copper ions on the uterus can also affect the menstrual cycle. Specifically, copper ions can cause inflammation in the uterus, which can disrupt the normal hormonal signals that regulate the menstrual cycle. This disruption can lead to changes in the timing and duration of menstrual periods, and in some cases, to amenorrhea.  No treatment needed for amenorrhea. If client finds situation unacceptable, remove CU-IUD and discuss alternative methods. Assess for pregnancy or underlying conditions if bleeding stops soon after insertion.",
    "action_key": 25
  },
  {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Test for rule out pregnancy  if no monthly bleeding soon after implant insertion. Remove the implant if client is confirmed pregnant.                                                                                                                                   \u2013  Reassure her that no monthly bleeding is normal with implants and not harmful.Similar to not having periods during pregnancy due to effect of hormones. \u2013 Amenorrhea does not need medical treatment. If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 26
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Ammenorhea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Amenorrhea does not need medical treatment.                               \u2013  Reassure her that no monthly bleeding is normal with injectable contraceptives and not harmful.Similar to not having periods during pregnancy due to effect of hormones.                                                                                                      \u2013  If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 27
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client  that this is normal during breastfeeding. It is not harmful.Reassure her that no monthly bleeding is normal with POPs and not harmful.Similar to not having periods during pregnancy due to effect of hormones.                                                                                                                        \u2013  If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 28
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that some women using POPs may stop monthly bleeding. This is is not harmful, indicative of pregnancy, or infertility. No blood buildup occurs inside client.",
    "action_key": 29
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess and reassure if bleeding is confirmed.\n\u2013 Assure client she may stop monthly bleeding. Not harmful, pregnancy or infertility related.  \n\u2013  Ask if she takes pills daily. If so, reassure her she is unlikely to be pregnant. She can resume COCs. \n\u2013 Assess skipped break (21-day pack) or nonhormonal pills (28-day pack). Assure no pregnancy risk,  and can continue COC use.\n\u2013 For missed hormonal pills or late pack start:, client can continue COC use.\n\u2013 Return if signs/symptoms of early pregnancy (missed 3+  pills or started pack 3+ days late).",
    "action_key": 30
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "For unexplained vaginal bleeding (not related to the method):\n\u2013 Refer or evaluate by history/pelvic exam.Diagnose and treat as appropriate.\n\u2013 Client can continue using the IUD during evaluation.\n\u2013 If bleeding is due to STI or PID, client can continue using the IUD during treatment",
    "action_key": 31
  },
  {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Unexplained vaginal bleeding: Refer or evaluate for diagnosis and treatment. Consider stopping implants for easier diagnosis. Offer alternative method (excluding certain options) until evaluation and treatment complete. Continued use of implants allowed for STI or PID treatment.",
    "action_key": 32
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "Orvalues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Consider switching methods for abnormal bleeding unrelated to the method.\n\u2013 Refer for evaluation and treatment based on history and pelvic examination.\n\u2013 Discontinue progestogen-only injectables if the cause of bleeding is unknown, providing an alternative method.(NOT implants or a copper-bearing or LNG-IUD)\n\u2013 Progestogen-only injectables can be continued during treatment for bleeding caused by STI or PID.",
    "action_key": 33
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Unexplained vaginal bleeding (that suggests a medical condition not related to the method).\n\u2013 Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.\n\u2013 She can continue using POPs while her condition is being evaluated.\n\u2013 If bleeding is caused by STI or PID, she can continue using POPs during treatment.",
    "action_key": 34
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.\n\u2013 She can continue using COCs while her condition is being evaluated.\n\u2013 If bleeding is caused by STI or PID, she can continue using COCs during treatment.",
    "action_key": 35
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Menstrual pain",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Cramping is normal after IUD insertion and during the first 3-6 months of use, especially during monthly bleeding. It decreases over time and is not harmful.\n\u2013 Recommend NSAIDs, aspirin (325-650 mg), paracetamol (325-1000 mg), or other pain relievers. Avoid aspirin if heavy or prolonged bleeding.\n\u2013 If severe cramping persists beyond the first 2 days after insertion, assess for possible partial expulsion or perforation.",
    "action_key": 36
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Change in timing of monthly bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "- Emergency contraceptive pills (ECPs), also known as morning-after pills, can cause changes in monthly menstrual bleeding patterns.When synthetic hormones like Levonorgestrel,taken in high doses, as is the case with ECPs, they can disrupt the normal hormonal balance in the body and cause changes in the menstrual cycle.                                                                                                                                                                                                                      -  Reasure the client that this is normal following emergency contraceptive pills.",
    "action_key": 37
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues and concerns",
        "value": "DAK, Bleeding or blood clots",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Address complications of vasectomy to ensure men's satisfaction.\n\u2013 Listen to client's concerns and provide advice, support, and appropriate treatment.\n\u2013 Minor bleeding and small uninfected blood clots typically resolve without treatment.\n\u2013 Large blood clots may require surgical drainage.\n\u2013 Infected blood clots necessitate antibiotics and hospitalization",
    "action_key": 38
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Menstrual pain",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "Orvalues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Abdominal bloating and discomfort\n\u2013 Consider locally available remedies.",
    "action_key": 39
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Possible anaemia",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Monitor Cu-IUD users for signs of anaemia due to increased bleeding.\n\u2013 Look for symptoms of pale appearance, fatigue, dizziness, irritability, headache, ringing in the ears, sore tongue, and brittle nails.\n\u2013 Consider blood testing for low haemoglobin (less than 9 g/dL) or haematocrit (less than 30) \n\u2013 Provide iron tablets and encourage consumption of iron-rich foods such as meat, poultry (especially beef and chicken liver), fish, green leafy vegetables, and legume",
    "action_key": 40
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Partner can feel IUD strings during intercourse",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Inform the client that short strings can sometimes cause discomfort.\n\u2013 Discuss the option of cutting the strings even shorter so they do not extend out of the cervical canal.This can alleviate partner discomfort, but may complicate removal (requires specialized provider).",
    "action_key": 41
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Suspected perforation",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Suspected uterine puncturing (perforation):\nIf suspected during insertion or sounding, stop the procedure immediately and remove the IUD if inserted.\nObserve the client carefully in the clinic:\n   \u2013 Keep the woman at bed rest for the first hour and monitor vital signs every 5 to 10 minutes.\n   \u2013 If stable after one hour, assess for signs of intra-abdominal bleeding(such as low hemoglobin) and continue observation.If no symptoms, she can be sent home but should avoid sex for 2 weeks. Help her choose another method.\n   \u2013 If rapid pulse, falling blood pressure, or increasing pain around the uterus, refer to higher level of care.\n   \u2013 If suspected uterine perforation within 6 weeks or more after insertion, refer to an experienced clinician for evaluation and possible IUD removal.",
    "action_key": 42
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Expulsion",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Rare. Usually occurs within a few months of insertion or with infection\u2013 If no infection, replace the expelled rod or capsule through a new incision or refer for replacement.\n\u2013 For single-rod implant, reinsert near the old insertion if desired to continue use",
    "action_key": 43
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, IUD partial expulsion",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "IUD partially comes out (partial expulsion)\n\u2013 Remove the IUD. Discuss options: another IUD or different method. For another IUD, immediate insertion if not pregnant. If not continuing with IUD, assist in choosing another method",
    "action_key": 44
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Missing strings",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Missing strings (suggesting possible pregnancy, uterine perforation or expulsion)\n\u2013 Ask client about IUD expulsion, last period, pregnancy symptoms, and backup method use.                                                                                                                                                                                           \u2013 Perform minor, safe procedures  using forceps to check for the strings in the cervical canal. If the strings cannot be located, it suggests they may have moved into the uterus or that the IUD has been expelled unnoticed.                                                                                                                         \u2013  Refer the client for an ultrasound or X-ray (if pregnancy can be ruled out). Meanwhile, provide her with a backup method to use in case the IUD has come out",
    "action_key": 45
  },
  {
    "conditions": [
      {
        "key": "DAK, Other Issues related with using oral contraceptive pills",
        "value": "DAK, Acne",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns, discuss how to manage side-effects, and determine whether or not the client would like to keep using the method, switch methods or stop using the method.",
    "annotation": "\u2013 Consider switch to COCs for acne improvement if client wants to stop using method.  \u2013 Consider  local acne remedies",
    "action_key": 46
  },
  {
    "conditions": [
      {
        "key": "DAK, Other Issues related with using oral contraceptive pills",
        "value": "DAK, Acne",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns, discuss how to manage side-effects, and determine whether or not the client would like to keep using the method, switch methods or stop using the method.",
    "annotation": "\u2013COCs can improve acne, although it may worsen for some. If acne persists after a few months of pill use, try a different COC formulation for at least 3 months.                                                                                                 \u2013Consider  locally available acne remedies.",
    "action_key": 47
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraine",
        "value": "DAK, Ordinary headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Nonmigrainous headaches\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Any headaches that get worse or occur more often during use of implants should be evaluated.",
    "action_key": 48
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with injectable contraceptives- Headache related issues",
        "value": "DAK, Non-migrainous (mild or severe)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Nonmigrainous headaches\n\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Any headaches that get worse or occur more often during use of injectables should be evaluated.",
    "action_key": 49
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraines - Oral contraceptive",
        "value": "DAK, Non-migrainous (mild or severe)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Nonmigrainous headaches\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Any headaches that get worse or occur more often during POP use should be evaluated.",
    "action_key": 50
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraines - Oral contraceptive",
        "value": "DAK, Non-migrainous (mild or severe)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Nonmigrainous headaches can be addressed with the following options:\n\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg), or other pain relievers.\n\u2013 Consider extended use of hormonal pills, where the client takes a hormonal pill daily for 84 days, skips the non-hormonal pills in 28-day packs for 7 days, then resumes the cycle.\n\u2013 Evaluate headaches that worsen or occur more frequently during COC use.",
    "action_key": 51
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraine",
        "value": "DAK, Migraine headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Consider switching methods\n   \u2013 If she has migraine headaches without aura, she can continue to use implants if she wishes\n   \u2013 If she has migraine with aura, remove the implants. Help her choose a method without hormones.",
    "action_key": 52
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with injectable contraceptives- Headache related issues",
        "value": "DAK, Migraine headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Consider switching methods\n   \u2013 If she has migraine headaches without aura, she can continue to use the method if she wishes\n   \u2013 If she has migraine with aura, do not give the injection. Help her choose a method without hormones.",
    "action_key": 53
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraines - Oral contraceptive",
        "value": "DAK, Migraine headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 A woman who has migraine headaches with or without aura can safely start POPs.\n\u2013 If she develops migraine headaches without aura while taking POPs, she can continue to use POPs if she wishes.\n\u2013 If she develops migraine with aura while using POPs, stop POPs. Help her choose a method without hormones.",
    "action_key": 54
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraines - Oral contraceptive",
        "value": "DAK, Migraine headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Regardless of her age, a woman who develops migraine headaches, with or without aura, or whose migraine headaches become worse while using COCs should stop using COCs.\n\u2013 Help her choose a method without estrogen.",
    "action_key": 55
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Breast tenderness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Address engorged breasts and blocked ducts promptly to prevent progression to infected breasts. Treat breast infection with antibiotics as directed by clinic guidelines. Aid healing by breastfeeding frequently, massaging the breasts, applying heat or warm compresses, trying different breastfeeding positions, ensuring proper attachment, and expressing milk before breastfeeding.",
    "action_key": 56
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Breast tenderness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Address engorged breasts and blocked ducts promptly to prevent progression to infected breasts. Treat breast infection with antibiotics as directed by clinic guidelines. Aid healing by breastfeeding frequently, massaging the breasts, applying heat or warm compresses, trying different breastfeeding positions, ensuring proper attachment, and expressing milk before breastfeeding.",
    "action_key": 57
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Breast tenderness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Recommend that she wear a supportive bra (including during strenuous activity and sleep).\n\u2013 Try hot or cold compresses.\n\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n- Consider locally available remedies.",
    "action_key": 58
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Breast tenderness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Recommend that she wear a supportive bra (including during strenuous activity and sleep).\n\u2013 Try hot or cold compresses.\n\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Consider locally available remedies.",
    "action_key": 59
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Breast tenderness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Recommend that she wear a supportive bra (including during strenuous activity and sleep).\n\u2013 Try hot or cold compresses.\n\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Consider locally available remedies.",
    "action_key": 60
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Weight change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Review diet and counsel as needed.",
    "action_key": 61
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Weight change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Review diet and counsel as needed.",
    "action_key": 62
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Weight change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Review diet and counsel as needed.",
    "action_key": 63
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Nausea or dizziness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Consider locally available remedies.",
    "action_key": 64
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Nausea or dizziness",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Consider locally available remedies.",
    "action_key": 65
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "orValues": [
          "DAK, Nausea",
          "DAK, Dizziness"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 For nausea, suggest taking POPs at bedtime or with food.\n\u2013 If symptoms continue, consider locally available remedies.",
    "action_key": 66
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "orValues": [
          "DAK, Nausea",
          "DAK, Dizziness"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 For nausea, suggest taking COCs at bedtime or with food.\n\u2013 If symptoms continue\n   \u2013 Consider locally available remedies\n   \u2013 Consider extended use if her nausea comes after she starts a new pill pack.",
    "action_key": 67
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "value": "DAK, Vomiting",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "If she vomits within 2 hours after taking an active (hormonal) pill, she should take another pill from her pack as soon as possible, then keep taking pills as usual",
    "action_key": 68
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "value": "DAK, Vomiting",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Vomiting within 2 hours after taking an active pill:\n\u2013 Client should take another active pill immediately and continue taking pills as usual.\nSevere vomiting for more than 24 hours:\n\u2013 Continue taking pills if possible, despite discomfort.\n\u2013 If severe vomiting persists for 2 or more days, follow instructions for 3 or more missed pills",
    "action_key": 69
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "value": "DAK, Severe diarrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Severe diarrhoea for more than 24 hours:\n\u2013 The woman should continue taking pills (if she can) despite her discomfort.\n\u2013 If severe diarrhoea continues for 2 or more days, she should follow the procedures for missed pills.",
    "action_key": 70
  },
  {
    "conditions": [
      {
        "key": "DAK, Nausea, vomiting, dizziness, and diarrhoea - Oral contraceptive",
        "value": "DAK, Severe diarrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Severe diarrhoea for more than 24 hours:\n\u2013 The woman should continue taking pills (if she can) despite her discomfort.\n\u2013 If severe diarrhoea continues for 2 or more days, she should follow the procedures for 3 or more missed pills.",
    "action_key": 71
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "A woman who has one of these conditions can safely start implants. If, however, the condition develops while she is using implants:\n\u2013 Remove the implants or refer for removal\n\u2013 Help her choose a method without hormones\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 72
  },
  {
    "conditions": [
      {
        "key": "DAK, Heart attack - Oral contraceptive",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 A woman who has one of these conditions can safely start POPs. If, however, the condition develops after she starts using POPs, she should stop. Help her choose a method without hormones.\n\u2013 Refer for diagnosis and care If not already under care.",
    "action_key": 73
  },
  {
    "conditions": [
      {
        "key": "DAK, Heart attack - Oral contraceptive",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking COCs.\n\u2013 Give her a backup method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 74
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Do not start or give the next injection. Tell her to stop taking using injectable contraceptives.\n\u2013 Give her a backup method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 75
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "A woman who has heart disease due to blocked or narrowed arteries, or stroke can safely start implants. If, however, the condition develops while she is using implants:\n\u2013 Remove the implants or refer for removal.\n\u2013 Help her choose a method without hormones.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 76
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 A woman who has heart disease due to blocked or narrowed arteries, or stroke can safely start POPs. However, if the condition develops after she starts using POPs, she should stop. Help her choose a method without hormones.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 77
  },
  {
    "conditions": [
      {
        "key": "DAK, Other conditions",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking COCs.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 78
  },
  {
    "conditions": [
      {
        "key": "DAK, Pregnancy related concerns",
        "value": "DAK, Missed Pills",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Note that client may forget or be late in taking a pill. Adolescents may need extra support.  If client is 3 or more hours late or misses a POP pill(12 or more hours late taking a POP containing desogestrel 75 mg), she should take it as soon as possible and continue taking pills daily. If client has regular monthly bleeding, use a backup method for the next 2 days. Consider ECP if client had sex in the past 5 days.",
    "action_key": 79
  },
  {
    "conditions": [
      {
        "key": "DAK, Pregnancy related concerns",
        "value": "DAK, Missed Pills",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Note that client may forget or be late in taking a pill. Adolescents may need extra support. Provide the following guidance if client misses a hormonal pill:\nTake the missed pill as soon as possible. Continue taking pills as usual, one each day.\nMissed 1 or 2 pills? Started new pack 1 or 2 days late?                                                                                     \u2013 Take the pill ASAP and there's little or no risk of pregnancy.\nMissed 3 or more pills in the first or second week or started a new pack 3 or more days late, \u2013 Take the pill ASAP . Use a backup method for the next 7 days. Consider ECP if client had sex in the past 5 days.\nMissed 3 or more pills in the third week                                                                                              \u2013 Take the pill ASAP . Use a backup method for the next 7 days. Consider ECP if client had sex in the past 5 days. Finish all hormonal pills in the pack, throwing away the 7 nonhormonal pills in a 28-pill pack. \nMissed any nonhormonal pills? (last 7 pills in 28-pill pack)\n \u2013 Discard missed nonhormonal pill(s) and continue taking COCs as usual, starting the new pack as scheduled.",
    "action_key": 80
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with injectable contraceptives",
        "value": "DAK, Late injections",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Clients less than 4 weeks late for DMPA or less than 2 weeks late for NET-EN can receive their next injection without tests or a backup method.\n\u2013 Clients more than 4 weeks late for DMPA or more than 2 weeks late for NET-EN can still receive their next injection if they meet specific criteria, such as not having had sex, using a backup method or, taken ECPs after any unprotected sex or is fully or nearly fully breastfeeding and gave birth less than 6 months ago.                                                                                                \u2013 Client will need a backup method for the first 7 days after the injection.\n\u2013 Discuss reasons for lateness and possible solutions, emphasizing the importance of returning on time for future injections.For clients consistently late, consider using a backup method, taking ECPs, choosing another method, or considering DMPA-SC-SI.\n\u2013 For clients more than 4 weeks late for DMPA or more than 2 weeks late for NET-EN, additional steps can be taken to confirm non-pregnancy.",
    "action_key": 81
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Support for self-injection",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess client's experience and satisfaction with self-injection.\n\u2013 Observe self-injection proces and provide guidance ehere neccesary\n\u2013 Administer injection if client is still unable to inject herself and provide injection devices for future use.\n\u2013 Invite client to seek assistance if needed.",
    "action_key": 82
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Mood changes or changes in sex drive",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess life changes impacting mood, sex drive, and relationship dynamicsand provide support                                                                                                                                                                                \u2013 Refer clients with serious mood changes, such as major depression, for professional care.                                                                                                                                                            \u2013 Consider locally available remedies.",
    "action_key": 83
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Mood changes or changes in sex drive",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess life changes impacting mood, sex drive, and relationship dynamicsand provide support                                                                                                                                                                                \u2013 Refer clients with serious mood changes, such as major depression, for professional care.                                                                                                                                                            \u2013 Consider locally available remedies.",
    "action_key": 84
  },
  {
    "conditions": [
      {
        "key": "DAK, Heart attack - Oral contraceptive",
        "value": "DAK, Mood changes or changes in sex drive",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess life changes impacting mood, sex drive, and relationship dynamics. Provide appropriate support.\n\u2013 Note that postpartum depression is unrelated to POPs. Refer clients with significant mood changes or major depression for professional care.\n\u2013 Stress the importance of adherence to minimize side effects and pregnancy risk.\n\u2013 Most side-effects improve within a few months, but if persistant , consider trying a different POP formulation for at least 3 months or assistance in choosing another method.                                                                                                                                                                                   \u2013 Consider local remedies.",
    "action_key": 85
  },
  {
    "conditions": [
      {
        "key": "DAK, Heart attack - Oral contraceptive",
        "value": "DAK, Mood changes or changes in sex drive",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Discuss extended use of COCs to address mood changes during the hormone-free week.\n\u2013 Ask about life changes that may impact mood or sex drive and provide appropriate support.\n\u2013 Refer clients with serious mood changes, such as major depression.\n\u2013 Stress the importance of adherence to minimize side effects and pregnancy risk.\n\u2013 Most side-effects improve within a few months, but if persistant , consider trying a different COC formulation for at least 3 months or assistance in choosing another method. \n\u2013 Consider local remedies.",
    "action_key": 86
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Pain after insertion or removal",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Check the tightness of the bandage or gauze on her arm for pain relief after insertion.\n\u2013 Apply a new bandage and advise her to avoid pressing on the site for a few days.\n\u2013 Provide over-the-counter pain relievers such as  aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg).",
    "action_key": 87
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Infection at the insertion site",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Implants to remain in place. Clean infected area with soap and water or antiseptic.              \u2013 Prescribe oral antibiotics for 7-10 days.                                                                                                                                                                                   \u2013 Instruct client to return if infection persists or if  expulsion/partial expulsion post-infection occurs . If infection has not cleared, remove the implants or refer for removal.",
    "action_key": 88
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Infection at the insertion site",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male sterilization",
          "DAK, Female sterilization"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Infection at the puncture or incision site (redness, heat, pain, pus)                                                                            \u2013 Clean the area with soap and water or antiseptic.\n\u2013 Prescribe oral antibiotics for 7 to 10 days and ask the client to return if experiencing persistent symptoms after completing the antibiotics.",
    "action_key": 89
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Abscess",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Management of abscess with implants:\n\u2013 Clean and drain the abscess while keeping the implants in place.\n\u2013 Provide proper wound care. and administer oral antibiotics for 7 to 10 days.\n\u2013 Instruct the client to monitor the wound and seek further evaluation if there are signs of persistent infection.\n\u2013 Consider removal of the implants or referral for removal if the infection persis",
    "action_key": 90
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Male or Female sterilization",
        "value": "DAK, Abscess",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Treatment for abscess                                                                                                                                            \u2013 Clean the area with antiseptic, incise and drain the abscess, and provide wound care.\n\u2013 Prescribe a course of oral antibiotics for 7 to 10 days and ask the client to return if experiencing persistent symptoms after completing the antibiotics.",
    "action_key": 91
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Male or Female sterilization",
        "value": "DAK, Abscess",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Treatment for abscess                                                                                                                                            \u2013 Clean the area with antiseptic, incise and drain the abscess, and provide wound care.\n\u2013 Prescribe  oral antibiotics for 7 to 10 days and ask the client to return if experiencing persistent symptoms after completing the antibiotics.",
    "action_key": 92
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Difficulties in using condom",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Difficulty putting on the condom\n\u2013 Ask clients to show how they put the condom on, using a model or other item. Correct any errors.",
    "action_key": 93
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Difficulties in using condom",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Difficulty inserting female condom:\n\u2013 Ask client to demostate insertion . Assess client's insertion technique and provide guidance for any errors.\n\u2013 Uncomfortable or painful inner ring: Advise readjusting the condom by tucking the inner ring behind the pubic bone",
    "action_key": 94
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Mild irritation in or around the vagina or penis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Mild genital irritation or allergic reaction to condoms:\n\u2013 Suggest using another brand of condoms as sensitivity can vary.\n\u2013 Suggest lubricant or water on the condom to reduce friction and irritation.\n\u2013 If symptoms persist, assess or refer for possible infection or STI.\n\u2013 If no infection is present and irritation continues, consider latex allergy.\n\u2013 If not at risk for STIs, choose another method.\n\u2013 If at risk for STIs, suggest female condoms or plastic male condoms.If unavailable, urge continued  latex condoms usage and discontinue if symptoms worsen.\n\u2013 If neither partner has an infection, a mutually faithful relationship provides STI protection but not pregnancy prevention.",
    "action_key": 95
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Mild irritation in or around the vagina or penis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Mild irritation in the genital area (itching, redness, rash) usually resolves on its own.\n\u2013 Suggest lubricant use with condoms to reduce friction and irritation.\n\u2013 If symptoms persist, assess and treat for possible infection or STI.\nConsider alternative methods if no infection is present, unless at risk for STIs.\n\u2013 For STI prevention, recommend male condoms or continued use of female condoms despite discomfort.\n\u2013 If neither partner has an infection, a mutually faithful relationship provides STI protection but not pregnancy prevention.",
    "action_key": 96
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Condom breaks, slips off the penis or is not used",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Condom issues (breaks, slips off, or not used) can be addressed with emergency contraceptive pills (ECPs) to prevent pregnancy. Partners should communicate about such incidents to consider ECPs.\n \u2013 Refer for post-exposure prophylaxis against HIV and presumptive treatment for other STIs if condom issues occur. Assess or refer if signs or symptoms of STIs are present.\n \u2013 Assess condom usage technique, including opening and proper application, providing guidance and correcting any errors.\n \u2013 Inquire about lubricant usage to ensure appropriate amount and type are used.\n \u2013 Emphasize the importance of timely penis withdrawal to minimize the risk of slip.",
    "action_key": 97
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Condom breaks, slips off the penis or is not used",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Emergency contraceptive pills can prevent pregnancy in case of condom slips, non-use, or incorrect use.\n\u2013 Refer for post-exposure prophylaxis against HIV and presumptive treatment for other STIs if necessary.\n\u2013 Provide education on correct insertion of the female condom if slips are reported",
    "action_key": 98
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Difficulty persuading partner to use method",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Discuss importance of condom use and dual protection strategies with the partner.\n\u2013 Consider combining condoms with another effective contraceptive method or using condoms during the fertile period for better pregnancy protection.\n\u2013 Encourage continued condom use for STI prevention if there is a risk.\n\u2013 Highlight that a mutually faithful relationship provides STI protection but not pregnancy prevention.",
    "action_key": 99
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Difficulty persuading partner to use method",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Discuss ways to talk with her partner about the importance of condom use for protection from pregnancy and STIs.",
    "action_key": 100
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Condom squeaks or makes noise during sex",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Suggest adding more lubricant to the inside of the condom or onto the penis.",
    "action_key": 101
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Severe allergic reaction to latex",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Advise distontinuation g latex condoms.\n\u2013 Refer for necessary care in case of severe allergic reaction to latex, as it can lead to life-threatening anaphylactic shock. Help the client choose another method.\nHelp the client choose another method.                                                                                                     \u2013 If STI risk cannot be avoided, consider using female condoms or non-latex male condoms. Monogamy provides STI protection without condoms, but not against pregnancy.",
    "action_key": 102
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Deep vein thrombosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Remove the implants or refer for removal.\n\u2013 Suggest to use condoms as back-up method until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 103
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Deep vein thrombosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Do not give next injection.\n\u2013 Suggest to use condoms as back-up method until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 104
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Deep vein thrombosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking POPs.\n\u2013 Suggest to use condoms as back-up method until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 105
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Deep vein thrombosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking COCs.\n\u2013 Suggest to use condoms as back-up method until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 106
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Pulmonary embolism",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Remove the implants or refer for removal.\n\u2013 Give her a back-up method to use until her condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 107
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Pulmonary embolism",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Do not give next injection.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 108
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Pulmonary embolism",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking POPs.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 109
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Pulmonary embolism",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Tell her to stop taking COCs.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 110
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Implant",
        "value": "DAK, Pulmonary embolism",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Remove the implants or refer for removal.\n\u2013 Suggest to use condoms as back-up method until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 111
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Liver disorders",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Do not give next injection.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 112
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Liver disorders",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Tell her to stop taking POPs.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 113
  },
  {
    "conditions": [
      {
        "key": "DAK, Venous thromboembolism - Oral contraceptive",
        "value": "DAK, Liver disorders",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Tell her to stop taking COCs.\n\u2013 Give her a back-up method to use until the condition is evaluated.\n\u2013 Refer for diagnosis and care if not already under care.",
    "action_key": 114
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Pelvic inflammatory disease (PID)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Treat suspected PID promptly with appropriate antibiotics or refer for treatment to prevent complications.\n\u2013 Target gonorrhea, chlamydia, and anaerobic infections with treatment.\n\u2013 Counsel on STI prevention, treatment, and condom use, providing condoms if possible.\n\u2013 IUD removal is optional; consider it after starting antibiotics and discuss alternative contraception.\n\u2013 If infection persists, consider IUD removal and contibue Anitiotics . If IUD not removed,  continuing antibiotics and closely monitor the woman's health.\n\u2013 Provide comprehensive STI management, including condom counseling.",
    "action_key": 115
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns, discuss how to manage side-effects, and determine whether or not the client would like to keep using the method, switch methods or stop using the method.",
    "annotation": "\u2013 Assess for pregnancy, including ectopic pregnancy, and perform pelvic examination if immediate surgical facilities are available; otherwise, refer for definitive diagnosis/care.                                                                                                                                                       \u2013 Explain risks of IUD use during pregnancy, including preterm delivery, miscarriage (including septic miscarriage), and absence of birth defects with LNG-IUD.                                                             \u2013 Provide counseling based on program guidelines for pregnancy continuation or termination.                                                                                                                                           \u2013 Advise IUD removal if pregnancy is continued, emphasizing associated risks and close monitoring. Ensure close follow-up and prompt care-seeking for signs of septic miscarriage if client keeps the IUD.                                                                                                                                        \u2013 Refer for ultrasound if IUD strings are not visible or retrievable to determine IUD location, and if it is still in the uterus or if ultrasound is not available, closely monitor the pregnancy and advise prompt care-seeking for signs of septic miscarriage",
    "action_key": 116
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues at insertion site (implant insertion)",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Assess for pregnancy, including ectopic pregnancy.\n\u2013 Remove the implants or refer for removal if she will carry the pregnancy to term.\n\u2013 There are no known risks to a fetus conceived while a woman has implants in place.",
    "action_key": 117
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues related with injectable contraceptives",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns, stop or switch methods.",
    "annotation": "\u2013 Assess for pregnancy.\n\u2013 Stop injections if pregnancy is confirmed.\n\u2013 There are no known risks to a fetus conceived while a woman is using injectables or to a woman who receives an injection while pregnant.",
    "action_key": 118
  },
  {
    "conditions": [
      {
        "key": "DAK, Pregnancy related concerns",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess for pregnancy, including ectopic pregnancy.\n\u2013 Tell her to stop taking POPs if pregnancy is confirmed.\n\u2013 There are no known risks to a fetus conceived while a woman is taking POPs.",
    "action_key": 119
  },
  {
    "conditions": [
      {
        "key": "DAK, Pregnancy related concerns",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess for pregnancy.\n\u2013 Tell her to stop taking COCs if pregnancy is confirmed.\n\u2013 There are no known risks to a fetus conceived while a woman is taking COCs.",
    "action_key": 120
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Female condom",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Assess for pregnancy. A woman can safely use female condoms during pregnancy for continued STI protection.",
    "action_key": 121
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Female sterilization",
        "value": "DAK, Suspected pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Assess for pregnancy, including ectopic pregnancy which is alife-threatening emergency requiring immediate surgical intervention.                                                                                            \u2013 Perform pelvic examination only if immediate surgical facilities are available refer for definitive diagnosis and care.",
    "action_key": 122
  },
  {
    "conditions": [
      {
        "key": "DAK, Returning client with problem in IUD",
        "value": "DAK, Severe pain in lower abdomen",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Suspected PID - Assess for PID if ectopic pregnancy is ruled out. Perform examinations if possible. Look for signs/symptoms: unusual discharge, fever/chill, pain during sex/urination, bleeding between periods, nausea/vomiting, tender pelvic mass, and abdominal tenderness.(direct or rebound abdominal tendernesss ) on gentle or sudden release\n\u2013 Suspected ectopic pregnancy - Ectopic pregnancy is a life-threatening emergency. Perform pelvic examination if immediate surgery available. Refer for definitive diagnosis and surgical care.",
    "action_key": 123
  },
  {
    "conditions": [
   {
        "key": "DAK, Returning client with problem in IUD",
        "orValues": [
          "DAK, Severe pain in lower abdomen",
          "DAK, Suspected pregnancy",
          "DAK, Ectopic pregnancy"
         ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Severe abdominal pain - Be alert for signs of ectopic pregnancy: unusual abdominal pain or tenderness, abnormal vaginal bleeding or no bleeding, light-headedness, or fainting.                                                                                                                                                     \u2013 While the IUD reduces risk of ectopic pregnancy, it does not eliminate it. Immediate referral for suspected ectopic pregnancy.                                                                                                          \u2013 Perform pelvic examination only if immediate surgical facilities are available.                                                                              \u2013 Ectopic pregnancy is a life-threatening emergency requiring immediate surgery.\n\u2013 If no additional symptoms, assess for pelvic inflammatory disease (PID).",
    "action_key": 124
  },
  {
    "conditions": [
      {
        "key": "DAK, Abdominal pain",
        "value": "DAK, Severe pain in the lower abdomen",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Abdominal pain - Evaluate for enlarged ovarian follicles or cysts.                                            \u2013 A woman can continue to use implants during evaluation.                                                                                                                                                  \u2013 Assure the client that treatment is not needed unless complications arise. Reassure the client that they usually resolve on their own. Follow up in 6 weeks if possible.                          \u2013 Ectopic pregnancy is rare and not caused by implants, but it can be life-threatening                       \u2013 Be alert for signs of ectopic pregnancy:  unusual abdominal pain or tenderness, abnormal vaginal bleeding or no monthly bleeding(outside the usual), light-headedness, dizziness, or fainting).                                                                                                                                                          \u2013 Immediate referral required if ectopic pregnancy or serious condition suspected.",
    "action_key": 125
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Severe pain in lower abdomen",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Abdominal pain - Evaluate for enlarged ovarian follicles or cysts.                                                                                                                                                                    \u2013 Assure the client that treatment is not needed unless complications arise. Reassure the client that they usually resolve on their own. Follow up in 6 weeks if possible.                                 \u2013 Be alert for signs of ectopic pregnancy:  unusual abdominal pain or tenderness, abnormal vaginal bleeding or no monthly bleeding(outside the usual), light-headedness, dizziness, or fainting).                                                                                                                                                          \u2013 Immediate referral required if ectopic pregnancy or serious condition suspected.",
    "action_key": 126
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with Female sterilization",
        "value": "DAK, Severe pain in lower abdomen",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "If the surgical procedure was performed recently, assess for any other problem that may indicate that the condition is related to the surgery                                                                         \u2013 Assess for symptoms like bleeding, lack of appetite, bowel or urination problems, or fever. Refer to surgical capable facility if present.\n\u2013 For past surgeries, be alert for ectopic pregnancy.\n\u2013 A combination of signs or symptoms should increase suspicion of ectopic pregnancy: unusual abdominal pain or tenderness, abnormal vaginal bleeding or no monthly bleeding(outside the usual), light-headedness, dizziness, or fainting).                                                                                                                                                                                \u2013 Ectopic pregnancy is a life-threatening emergency requiring prompt surgery. Perform pelvic examination  only if immediate surgery is availableat facility.",
    "action_key": 127
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with using oral contraceptive pills",
        "value": "DAK, Other (specify)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "If the client will be unable to walk for one week or more due to circumstances such as major surgery, a leg cast, or other reasons:\n\n\u2013 Advise her to inform her doctors that she is using COCs.\n\u2013 Instruct her to discontinue COC use during this period and use a backup method.\n\u2013 Recommend restarting COCs 2 weeks after she is able to move about again.",
    "action_key": 128
  },
  {
    "conditions": [
      {
        "key": "DAK, Issues with condom use",
        "value": "DAK, Other",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Male condoms",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Regarding miconazole or econazole use for vaginal infections client should :\n\u2013 Avoid using latex condoms during treatment to prevent damage.(Oral treatment will not harm condoms.)\n\u2013 Use alternative methods such as female condoms, plastic male condoms, or abstain from sex until treatment is completed.",
    "action_key": 129
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, Highly effective",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Highly effective methods: combined oral contraceptives, progestogen-only pills, DMPA-IM, DMPA-SC,  DMPA-SI and , implants,  and copper-bearing IUD. Choice would need to be cross-checked with  medical eligibility.",
    "action_key": 130
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, No hormones",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "A method that does not contain hormones is the copper-bearing IUD. Choice would need to be cross-checked with  medical eligibility.",
    "action_key": 131
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, Regular bleeding",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Methods that result in regulary monthly bleedings, similar to a period: combined oral contraceptives and copper-bearing IUD. Choice would need to be cross-checked with medical eligibility.",
    "action_key": 132
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, Privacy",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Methods that are not able to be detected by your partner or other people when in use: any injectable, implant or IUD.  Choice would need to be cross-checked with medical eligibility.",
    "action_key": 133
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, Client controlled",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Methods that can be stopped or started without seeing a medical provider: combined oral contraceptives, progestogen-only pills and DMPA self-injectable. Choice would need to be cross-checked with medical eligibility.",
    "action_key": 134
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, Long lasting",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Methods that can last a number of years: implants, levonorgestrel IUD and copper-bearing IUD. Choice would need to be cross-checked with medical eligibility.",
    "action_key": 135
  },
  {
    "conditions": [
      {
        "key": "DAK, Client preferences",
        "value": "DAK, STI prevention",
        "operator": "="
      }
    ],
    "action": "Counsel client on possible methods based on their preferences and medical eligibility",
    "annotation": "Methods that prevent STIs along with pregnancy: male and female condoms.",
    "action_key": 136
  },
  {
    "conditions": [
      {
        "key": "DAK, Minimum requirements for IPV assessment FP",
        "orValues": [
          "DAK, Private setting: the woman must be alone",
          "DAK, There is a protocol/standard operating procedure for managing women subjected to violence",
          "DAK, There has been training on how to ask, minimum response or beyond.",
          "DAK, Confidentiality is ensured"
        ],
        "operator": "OR"
      },
      {
          "key": "DAK, Signs and symptoms for clinical inquiry of IPV",
          "value": true,
          "operator": "="
      }
    ],
    "action": "Conduct clinical enquiry and discuss concerns",
    "annotation": "To assess the impact of violence on reproductive and sexual life, ask:\n(1) Partner interference with contraception?\n(2)Forced or pressured pregnancy?\n(3) Partner refusal to use condoms?\n(4) Intentional unprotected sex for pregnancy?                                                                                                                                                 Discuss alternative methods less susceptible to partner interference:\n\u2013 Injectable contraceptives: No visible skin signs, may stop or regulate menstrual periods. Regular follow-up required.\n\u2013 Subcutaneous DMPA (DMPA-SC): Similar to injectables, self-administered option, regular follow-up needed.\n\u2013 Implants: Long-lasting, may be felt under the skin, changes in bleeding pattern. No regular follow-up required.\n\u2013 Copper and hormonal IUDs: Hidden in the uterus, partner may feel strings at the cervix, may require adjustment",
    "action_key": 137
  },
  {
    "conditions": [
      {
        "key": "DAK, Minimum requirements for IPV assessment FP",
        "orValues": [
          "DAK, Private setting: the woman must be alone",
          "DAK, There is a protocol/standard operating procedure for managing women subjected to violence",
          "DAK, There has been training on how to ask, minimum response or beyond.",
          "DAK, Confidentiality is ensured"
        ],
        "operator": "OR"
      },
      {
          "key": "DAK, Signs and symptoms for clinical inquiry of IPV",
          "value": true,
          "operator": "="
      }
    ],
    "action": "Provide first-line support using LIVES",
    "annotation": "\u2013 Listen empathetically and without judgement\n\u2013 Inquire about her needs and concerns and respect her choices\n\u2013 Validate \u2013 show her that you understand and believe her\n\u2013 Enhance safety \u2013  identify her risks and help her develop a plan to protect herself and her children\n\u2013 Support \u2013 connect her to information, services and social support as needed.",
    "action_key": 138
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method provided that she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, provided that she is not pregnant",
    "action_key": 139
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method provided that she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, provided that she is not pregnant",
    "action_key": 139
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, assuming menarche has occurred",
    "action_key": 140
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, assuming menarche has occurred",
    "action_key": 141
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 142
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Parity",
        "value": 1.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 143
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 144
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 145
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 146
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 147
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 148
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 149
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 150
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 151
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 152
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Client smokes < 15 cigarettes per day",
          "DAK, Client smokes >= 15 cigarettes per day"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 153
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 154
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": "<"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, assuming menarche has occurred",
    "action_key": 155
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nWhen multiple major risk factors exist, the risk of cardiovascular disease may increase substantially. Some progestogen-only contraceptives (POCs) may increase the risk of thrombosis, although this increase is substantially less than with combined oral contraceptives (COCs).",
    "action_key": 156
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nIt is desirable to have blood pressure measurements taken before initiation of progestogen-only contraceptive (POC) use. However, women should not be denied the use of POCs simply because their blood pressure cannot be measured.",
    "action_key": 157
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nWomen adequately treated for hypertension are at reduced risk of acute myocardial infarction (MI) and stroke as compared with untreated women. Although there are no data, progestogen-only contraceptive (POC) users with adequately controlled and monitored hypertension should be at reduced risk of acute MI and stroke compared with untreated hypertensive POC users.",
    "action_key": 158
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140,
        "maxValue": 159,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=,<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 159
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 160
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 161
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 162
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 163
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 164
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 165
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 166
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 167
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 168
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 169
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Major surgery without prolonged immobilization",
          "DAK, Minor surgery without immobilization"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 170
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the conditions and the high cost of screening.",
    "action_key": 171
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 172
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 173
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 174
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 175
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Levoplant)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 176
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 177
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 178
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "orValues": [
          "DAK, Uncomplicated valvular heart disease",
          "DAK, Complicated valvular heart disease"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 179
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 180
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 181
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 182
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 183
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 184
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 185
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 9for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 186
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nAsk if client is taking any medications for epilepsy. Certain anticonvulsants lower progestogen-only contraceptive (POC) effectiveness. Use of other contraceptives should be encouraged for women who are long-term users of any of these drugs.",
    "action_key": 187
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nThere is a potential for drug interactions between certain antidepressant medications and hormonal contraceptives.",
    "action_key": 188
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 189
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nUnusually heavy bleeding should raise the suspicion of a serious underlying condition.",
    "action_key": 190
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable \n\nSuspicion of a serious condition. If pregnancy or an underlying pathological condition (such as pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation.",
    "action_key": 191
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 192
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 193
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 194
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u03b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 195
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u03b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 196
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 197
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 198
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 199
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nEvaluation should be pursued as early as possible.",
    "action_key": 200
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 201
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 202
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 203
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 204
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 205
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 206
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Uterine fibroids",
        "orValues": [
          "DAK, Uterine fibroids without distortion of the uterine cavity",
          "DAK, Uterine fibroids with distortion of the uterine cavity"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 207
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "orValues": [
          "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
          "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 208
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 209
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 210
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 211
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 212
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 213
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain antiretroviral drugs may interact with hormonal contraceptives. Ask if client is taking any medication and check for contraindications.",
    "action_key": 214
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain antiretroviral drugs may interact with hormonal\ncontraceptives. Ask if client is taking any medication and check for contraindications.",
    "action_key": 215
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Schistosomiasis with liver fibrosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 216
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "orValues": [
          "DAK, Non-pelvic tuberculosis",
          "DAK, Known pelvic tuberculosis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain drugs that are used to treat tuberculosis may interact with POCs. Ask if the woman is taking drugs for treatment of tuberculosis and check for contraindications.",
    "action_key": 217
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 218
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 219
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Non-insulin dependent diabetes",
          "DAK, Insulin-dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 220
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 221
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 222
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 223
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Thyroid disorders",
        "orValues": [
          "DAK, Simple goitre",
          "DAK, Hyperthyroidism",
          "DAK, Hypothyroidism"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 224
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
          "DAK, Symptomatic gall bladder disease (medically treated)",
          "DAK, Asymptomatic gall bladder disease"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 225
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, History of pregnancy-related cholestasis",
          "DAK, Past combined oral contraceptives-related cholestasis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 226
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
          "DAK, Acute or flare viral hepatitis",
          "DAK, Carrier viral hepatitis",
          "DAK, Chronic viral hepatitis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 227
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 228
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 229
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 230
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
          "DAK, Benign hepatocellular adenoma",
          "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 231
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 232
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 233
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 234
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 235
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, EFV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nPharmacokinetic data suggest potential drug interactions between some antiretroviral drugs (particularly some non-nucleoside reverse transcriptase inhibitors [NNRTIs] and ritonavir-boosted protease inhibitors [PIs]) and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.",
    "action_key": 236
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, ETR",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nPharmacokinetic data suggest potential drug interactions between some antiretroviral drugs (particularly some non-nucleoside reverse transcriptase inhibitors [NNRTIs] and ritonavir-boosted protease inhibitors [PIs]) and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.",
    "action_key": 237
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NVP",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nPharmacokinetic data suggest potential drug interactions between some antiretroviral drugs (particularly some non-nucleoside reverse transcriptase inhibitors [NNRTIs] and ritonavir-boosted protease inhibitors [PIs]) and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.",
    "action_key": 238
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, RPV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nAntiretroviral drugs have the potential to either decrease or increase the levels of steroid hormones in women using hormonal contraceptives.",
    "action_key": 239
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nPharmacokinetic data suggest potential drug interactions between some antiretroviral drugs (particularly some non-nucleoside reverse transcriptase inhibitors [NNRTIs] and ritonavir-boosted PIs) and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.",
    "action_key": 240
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 241
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nAlthough the interaction of certain anticonvulsants with LNG/ETG implants is not harmful to women, it is likely to reduce the effectiveness. Use of other contraceptives should be encouraged for women who are long-term users of any of these drugs.",
    "action_key": 242
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 243
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 244
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nLong-term use of rifampicin or rifabutin may reduce the effectiveness of LNG/ETG implants. Women on these medications should be encouraged to consider alternative contraceptives such as progestin-only injectables, copper-bearing IUDs, or LNG-IUDs. If using these medications short-term, a backup method can be used in combination with progestogen-only pills (POPs).",
    "action_key": 245
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method as long as she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance, as long as she is not pregnant",
    "action_key": 246
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method as long as she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance, as long as she is not pregnant",
    "action_key": 247
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 248
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 18,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method, \nassuming menarche has already occurred and have history of sexual intercourse\nYoung women using Cu-IUDs may have an increased risk of expulsion compared with older Cu-IUD users",
    "action_key": 249
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 250
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria category 2 \u2013 Generally use method",
    "action_key": 251
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 1.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 252
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 2,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 253
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "minValue": 2,
        "maxValue": 28,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 254
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 28.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 255
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Puerperal sepsis postpartum",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used, in postpartum period",
    "action_key": 256
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 257
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria category 2 \u2013 Generally use method",
    "action_key": 258
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 259
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 260
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 261
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 262
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 263
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 264
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 265
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 266
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 267
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 268
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 269
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 270
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 271
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 272
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 273
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 274
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 275
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 276
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 277
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 278
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 279
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 280
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 281
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, History of ischaemic heart disease OR Current ;;ll heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 282
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 283
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 284
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Uncomplicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 285
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 286
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 287
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method for initiation.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nSevere thrombocytopenia increases the risk of bleeding. The category should be assessed according to the severity of the thrombocytopenia and its clinical manifestations. In women with very severe thrombocytopenia who are at risk for spontaneous bleeding, consultation with a specialist and certain pretreatments may be warranted.",
    "action_key": 288
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 289
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 290
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 291
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 292
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 293
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 294
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 295
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 296
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 297
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification based on data for selected depressive disorders. No data available for bipolar disorder or postpartum depression. Potential for drug interactions between certain antidepressants and hormonal contraceptives.",
    "action_key": 298
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance (irregular vaginal bleeding patterns without heavy bleeding)",
    "action_key": 299
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (heavy or prolonged bleeding, including regular and irregular patterns)",
    "action_key": 300
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method for initiation.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used for initiation (suspect for serious condition before evaluation)",
    "action_key": 301
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible to continue with this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method (suspect for serious condition before evaluation)",
    "action_key": 302
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria category 2 \u2013 Generally use method",
    "action_key": 303
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 304
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria category 2 \u2013 Generally use method",
    "action_key": 305
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u00ce\u00b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 306
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u00ce\u00b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 307
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 308
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 309
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 310
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 311
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 312
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 313
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance (family history of breast cancer)",
    "action_key": 314
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 315
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 316
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 317
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 318
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable for initiation",
    "action_key": 319
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 320
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Uterine fibroids without distortion of the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 321
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Uterine fibroids with distortion of the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 322
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Anatomical abnormalities that distort the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 323
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Anatomical abnormalities that distort the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 324
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method.",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 325
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 326
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 327
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 328
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 329
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 330
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Current purulent cervicitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 331
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Current chlamydia",
        "operator": "="
      },
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 332
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Current purulent cervicitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method.",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u00e2\u20ac\u201c Generally use method ",
    "action_key": 333
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Current chlamydia",
        "operator": "="
      },
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u00e2\u20ac\u201c Generally use method ",
    "action_key": 334
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 335
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 336
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 337
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 338
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she may or may not be medical eligible for this method depending on the provider's judgement and national policies",
    "annotation": "Exercise clinical judgment for IUD insertion in women at increased STI risk. While the overall risk of PID is low, some individuals may have a higher risk. Risk of STIs varies by individual behaviour and local STI prevalenceConsider appropriate testing and treatment for those with a very high likelihood of STIs before IUD insertion.",
    "action_key": 339
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 340
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 341
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 342
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 1",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 343
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 2",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 344
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection.",
    "action_key": 345
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection.",
    "action_key": 346
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection",
    "action_key": 347
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection",
    "action_key": 348
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 349
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Schistosomiasis with liver fibrosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 350
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Non-pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 351
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Non-pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 352
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Known pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 353
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Known pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 354
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 355
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 356
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Non-insulin dependent diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 357
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Insulin-dependent diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 358
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes with nephropathy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 359
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes with retinopathy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 360
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes with neuropathy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 361
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 362
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 363
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Simple goitre",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 364
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hyperthyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 365
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hypothyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 366
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 367
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (medically treated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 368
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Current symptoms of gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 369
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Asymptomatic gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 370
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, History of pregnancy-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 371
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Past combined oral contraceptives-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 372
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Acute or flare viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 373
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Carrier viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 374
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Chronic viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 375
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 376
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 377
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 378
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 379
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 380
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 381
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 382
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 383
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 1",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation",
    "action_key": 384
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 2",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation",
    "action_key": 385
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3  (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 386
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3  (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 387
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 388
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 1",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method. \n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 389
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 2",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method. \n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 390
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between ART and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 391
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between ART and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 392
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 393
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 1",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 394
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 2",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 395
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 396
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 397
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 398
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 1",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 399
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 2",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 400
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease stage 3",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 401
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, HIV disease 4",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as Category 3 for initiation.",
    "action_key": 402
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 403
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 404
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 405
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 406
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 407
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 408
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method, assuming menarche has occurred",
    "action_key": 409
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, age (calculated)",
        "minValue": 18.0,
        "maxValue": 45.0,
        "operator": "between"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 410
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 45.0,
        "operator": ">"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 411
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 412
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Parity",
        "value": 1.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 413
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nIn settings where  pregnancy-related morbidity and mortality risks are high, and access to services is limited,  DMPA/NET-EN may be among the few methods widely available and accessible to breastfeeding women immediately postpartum.",
    "action_key": 414
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 415
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 0.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 416
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nMay be started immediately post-abortion.",
    "action_key": 417
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 418
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 419
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 420
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 421
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Client smokes < 15 cigarettes per day",
          "DAK, Client smokes >= 15 cigarettes per day"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 422
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 423
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "age",
        "value": 18.0,
        "operator": "<"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method, if menarche has occurred.\n\nDMPA has evidence of differential weight gain between normal-weight and obese adolescents, while such evidence is not observed for NET-EN. However, NET-EN is classified as Category 2 due to potential effects on bone mineral density (BMD) in adolescents.",
    "action_key": 424
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nWhen multiple major risk factors exist, the risk of cardiovascular disease may increase substantially. The effects of DMPA and NET-EN may persist for some time after discontinuation.",
    "action_key": 425
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nBlood pressure measurements before initiating progestogen-only contraceptive (POC) use are desirable, but women should not be denied POCs solely because their blood pressure cannot be measured.",
    "action_key": 426
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nWomen adequately treated for hypertension are at reduced risk of acute myocardial infarction (MI) and stroke as compared with untreated women.",
    "action_key": 427
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method\nWomen uncotrolled hypertension are at increased risk of acute myocardial infarction (MI) and stroke as compared with women with controlled hypertention.",
    "action_key": 428
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.",
    "action_key": 429
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 430
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 431
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 432
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 433
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 434
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 435
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 436
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 437
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 438
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Major surgery without prolonged immobilization",
          "DAK, Minor surgery without immobilization"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 439
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the conditions and the high cost of screening.",
    "action_key": 440
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 441
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 442
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 443
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 444
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 445
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 446
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "orValues": [
          "DAK, Uncomplicated valvular heart disease",
          "DAK, Complicated valvular heart disease"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 447
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 448
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 449
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 450
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 451
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 452
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance.",
    "action_key": 453
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAccurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke.",
    "action_key": 454
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "NONE"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAccurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke.",
    "action_key": 455
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 456
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 457
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 458
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nAsk if client is taking any medications for epilepsy. Certain anticonvulsants lower effectiveness of progestogen-only contraceptive (POC).",
    "action_key": 459
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "",
    "action_key": 460
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 461
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nUnusually heavy bleeding (regular or irregular) should raise the suspicion of a serious underlying condition.",
    "action_key": 462
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nIf pregnancy or an underlying pathological condition (e.g. pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation.",
    "action_key": 463
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 464
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 465
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 466
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u00ce\u00b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 467
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u03b2-human chorionic gonadotropin (\u03b2-hCG) levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 468
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 469
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 470
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 471
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method\n\nEvaluation should be pursued as early as possible.",
    "action_key": 472
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 473
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 474
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 475
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 476
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 477
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 478
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Uterine fibroids",
        "orValues": [
          "DAK, Uterine fibroids without distortion of the uterine cavity",
          "DAK, Uterine fibroids with distortion of the uterine cavity"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 479
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "orValues": [
          "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
          "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 480
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 481
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 482
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 483
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 484
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 485
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 486
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain antiretroviral drugs may interact with hormonal contraceptives. Ask if client is taking any medication and check for contraindications.",
    "action_key": 487
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain antiretroviral drugs may interact with hormonal\ncontraceptives. Ask if client is taking any medication and check for contraindications.",
    "action_key": 488
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 489
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "orValues": [
          "DAK, Non-pelvic tuberculosis",
          "DAK, Known pelvic tuberculosis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\nCertain drugs that are used to treat tuberculosis may interact with POCs. Ask if the woman is taking drugs for treatment of tuberculosis and check for contraindications.",
    "action_key": 490
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 491
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 492
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Non-insulin dependent diabetes",
          "DAK, Insulin-dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 493
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 494
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 495
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 496
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Thyroid disorders",
        "orValues": [
          "DAK, Simple goitre",
          "DAK, Hyperthyroidism",
          "DAK, Hypothyroidism"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 497
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
          "DAK, Symptomatic gall bladder disease (medically treated)",
          "DAK, Asymptomatic gall bladder disease"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 498
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, History of pregnancy-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 499
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Past combined oral contraceptives-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 500
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
          "DAK, Acute or flare viral hepatitis",
          "DAK, Carrier viral hepatitis",
          "DAK, Chronic viral hepatitis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 501
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 502
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 503
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 504
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 505
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 506
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 507
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 508
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 509
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 510
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, EFV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 511
  },
  {
    "conditions": [
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, ETR",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 512
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NVP",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 513
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, RPV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 514
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, RPV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 515
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nPotential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness.",
    "action_key": 516
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 517
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nCertain anticonvulsant medications may reduce the effectiveness of NET-EN. Women on long-term use of these drugs should be encouraged to consider alternative contraceptives. However, the use of DMPA is categorized as Category 1, as its effectiveness is not decreased by the use of certain anticonvulsants.",
    "action_key": 518
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 519
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 520
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nDMPA is category 1 because its effectiveness is not decreased by the use of rifampicin or rifabutin.",
    "action_key": 521
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action_key": 522,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": "18",
        "operator": "<"
      }
    ],
    "action_key": 523,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance Assuming menarche has already occurred \u00e2\u20ac\u201c age does not affect medical eligibility"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": " age",
        "value": 18,
        "operator": ">="
      }
    ],
    "action_key": 524,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action_key": 525,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 1,
        "operator": ">="
      }
    ],
    "action_key": 526,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": "<"
      }
    ],
    "action_key": 527,
    "action": "Counsel client that she is medically eligible for this methode",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": ">="
      }
    ],
    "action_key": 528,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 0,
        "operator": ">="
      }
    ],
    "action_key": 529,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "orValues": [
          "DAK, First trimester less than 13 weeks GA",
          "DAK, Second trimester between 13 and 24 Weeks"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 530,
    "action": "Counsel client that she is medically eligible for this method.May be started immediately post-abortion.",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action_key": 531,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action_key": 532,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action_key": 533,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Client smokes < 15 cigarettes per day",
          "DAK, Client smokes >= 15 cigarettes per day"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 534,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action_key": 535,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action_key": 536,
    "action": "Counsel client that she is medically eligible for this method. Some progestogen-only contraceptives (POCs) may increase the risk of thrombosis, although this increase is substantially less than with combined oral contraceptives (COCs).",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action_key": 537,
    "action": "Counsel client that she is medically eligible for this method. It is desirable to have blood pressure measurements taken before initiation of progestogen-only contraceptive (POC) use. However, women should not be denied the use of POCs simply because their blood pressure cannot be measured.",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action_key": 538,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <="
      }
    ],
    "action_key": 539,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action_key": 540,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action_key": 541,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action_key": 542,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action_key": 543,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action_key": 544,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action_key": 545,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action_key": 546,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action_key": 547,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action_key": 548,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action_key": 549,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization",
        "operator": "="
      }
    ],
    "action_key": 550,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action_key": 551,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action_key": 552,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method. Routine screening is not appropriate because of the rarity of the conditions and the high cost of screening."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action_key": 553,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action_key": 554,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 555,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action_key": 556,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 557,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action_key": 558,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action_key": 559,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method. Routine screening is not appropriate because of the rarity of the conditions and the high cost of screening."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "orValues": [
          "DAK, Complicated valvular heart disease",
          "DAK, Uncomplicated valvular heart disease"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 560,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action_key": 561,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3(both for initiation and continuation) \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action_key": 562,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action_key": 563,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action_key": 564,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 565,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation ) \u00e2\u20ac\u201c Use method in any circumstance. Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 566,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u00e2\u20ac\u201c Use method in any circumstance. Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": "<"
      }
    ],
    "action_key": 567,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u00e2\u20ac\u201c Use method in any circumstance. Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      },
      {
        "key": " age",
        "value": 35.0,
        "operator": ">"
      }
    ],
    "action_key": 568,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u00e2\u20ac\u201c Use method in any circumstance. Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 569,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u00e2\u20ac\u201c Generally use method. Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "!="
      }
    ],
    "action_key": 570,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u00e2\u20ac\u201c Generally use method.Accurate diagnosis of severe headaches is crucial to determine if they are migrainous or not. New headaches or significant changes in headaches should be evaluated. The classification mentioned is applicable to women without any additional risk factors for stroke"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action_key": 571,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance. Ask if client is taking any medications for epilepsy. Certain anticonvulsants lower effectiveness of progestogen-only contraceptive (POC). "
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action_key": 572,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance. The classification is based on data for women with selected depressive disorders. No data on bipolar disorder or postpartum depression were available. There is a potential for drug interactions between certain antidepressant medications and hormonal contraceptives.                               POP use did not increase depressive symptoms in womenwith depression capmared with baseline"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action_key": 573,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action_key": 574,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method. Unusually heavy bleeding (regular or irregular) should raise the suspicion of a serious underlying condition."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action_key": 575,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method. If pregnancy or an underlying pathological condition (e.g. pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action_key": 576,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action_key": 577,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhoea",
        "operator": "="
      }
    ],
    "action_key": 578,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u00ce\u00b2-hCG level",
        "operator": "="
      }
    ],
    "action_key": 579,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u00ce\u00b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action_key": 580,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action_key": 581,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action_key": 582,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      }
    ],
    "action_key": 583,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action_key": 584,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method   - Evaluation should be pusued as early as possible"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action_key": 585,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action_key": 586,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action_key": 587,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "NonMedical eligibility criteria (MEC) category 4 \u00e2\u20ac\u201c Method NOT to be used"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action_key": 588,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action_key": 589,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      }
    ],
    "action_key": 590,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "orValues": [
          "DAK, Uterine fibroids without distortion of the uterine cavity",
          "DAK, Uterine fibroids with distortion of the uterine cavity"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 591,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstancee"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "orValues": [
          "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
          "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 592,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      }
    ],
    "action_key": 593,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 594,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      }
    ],
    "action_key": 595,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      }
    ],
    "action_key": 596,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      }
    ],
    "action_key": 597,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action_key": 598,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 599,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 600,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      }
    ],
    "action_key": 601,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "orValues": [
          "DAK, Non-pelvic tuberculosis",
          "DAK, Known pelvic tuberculosis"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 602,
    "action": "Counsel client that she is medically eligible for this method. Rifampicin is likely to decrease the effectiveness of some progestogen-only contraceptives (POCs).  Whether increasing the hormone dose of POPs alleviates this concern remains unclear. Use of other contraceptives should be encouraged for women who are long-term users of any of these drugs.",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action_key": 603,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action_key": 604,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Non-insulin dependent diabetes",
          "DAK, Insulin-dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 605,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method.  - Among women with insuline or non-insuline dependent diabetes limited evidence on the use of POP method suggests that this method have little effect on short term or ling term diabetes control, eg.HbA1c level or lipid profile"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 606,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action_key": 607,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action_key": 608,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method   "
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "orValues": [
          "DAK, Simple goitre",
          "DAK, Hyperthyroidism",
          "DAK, Hypothyroidism"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 609,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
          "DAK, Symptomatic gall bladder disease (medically treated)",
          "DAK, Asymptomatic gall bladder disease"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 610,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, History of pregnancy-related cholestasis",
        "operator": "="
      }
    ],
    "action_key": 611,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Past combined oral contraceptives-related cholestasis",
        "operator": "="
      }
    ],
    "action_key": 612,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
          "DAK, Acute or flare viral hepatitis",
          "DAK, Carrier viral hepatitis",
          "DAK, Chronic viral hepatitis"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 613,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action_key": 614,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action_key": 615,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action_key": 616,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method - There is limited evidence that hormonal contracptives use does not influence either progression or regression of liver lesions among women with focal nodular hyperplasia."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action_key": 617,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)S",
        "operator": "="
      }
    ],
    "action_key": 618,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action_key": 619,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action_key": 620,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action_key": 621,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action_key": 622,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance                                                                                                    - NRTIs do not appear to have significant risk of interactions with hormonal contraceptive methods"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action_key": 623,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Antiretroviral drugs have the potential to either decrease or increase the levels of steroid hormones in women using hormonal contraceptives.Pharmacokinetic data suggest potential drug interactions between some antiretroviral drugs (particularly NNRTIs and ritonavir-boosted PIs) and some hormonal contraceptives. These interaction may reduce the effectiveness of hormonal contraceptive."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, EFV",
        "operator": "="
      }
    ],
    "action_key": 624,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, ETR",
        "operator": "="
      }
    ],
    "action_key": 625,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NVP",
        "operator": "="
      }
    ],
    "action_key": 626,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, RPV",
        "operator": "="
      }
    ],
    "action_key": 627,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      }
    ],
    "action_key": 628,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method. Potential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      }
    ],
    "action_key": 629,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action_key": 630,
    "action": "Counsel client that she is NOT medically eligible for this method. Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable.- Although the interaction of certain anticonvulsants with POPs is not harmful to women, it is likely to reduce the effectiveness of POPs. Whether increasing the hormone dose of POPs alleviates this concern remains unclear. Use of other contraceptives should be encouraged. If using these medications long-term, she may want a different method, such as progestin-only injectables or a copper-bearing IUD or LNG-IUD.- If using these medications short-term, she can use a backup method along with POPs."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action_key": 631,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance - No drug interactions have been reported among women with epilepsy taking lamotrigin and POPs"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action_key": 632,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action_key": 633,
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable- Although the interaction of rifampicin or rifabutin with POPs is not harmful to women, it is likelt to reduce the effectivenss of POPs. Whether increasing the hormone dose of POPs alleviate this concer remains unclear. -Long-term use of rifampicin or rifabutin may reduce the effectiveness of POPs. Women on these medications should be encouraged to consider alternative contraceptives such as progestin-only injectables, copper-bearing IUDs, or LNG-IUDs. If using these medications short-term, a backup method can be used in combination with progestogen-only pills (POPs)."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 634
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 40.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance, if menarche has occurred                       - Evidence  about whether COC use affects fracture risk is inconsistent. COC use may decrease bone mineral density in adolescents specially in those choosing very low dose formulation ( < 30ug ethinyl estradiol - containing COCs). COC use has little to no effect on bone mineral density in premenppausal women and may preserve bone mass on those who are premenopausal.",
    "action_key": 635
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 40.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method  - Evidence  about whether COC use affects fracture risk is inconsistent. COC use may decrease bone mineral density in adolescents specially in those choosing very low dose formulation ( < 30ug ethinyl estradiol - containing COCs). COC use has little to no effect on bone mineral density in premenppausal women and may preserve bone mass on those who are premenopausal.",
    "action_key": 636
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 637
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 1.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 638
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used  -",
    "action_key": 639
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.                                                                                                                                                                                                                                        The evidence regarding long-term exposure of estrogens through breast milk and its potential adverse effects on infants is inadequate.",
    "action_key": 640
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 180,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 641
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 21,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.                                                                                                                                                    VTE risk is elevated during pregnancy and the postpartum period, with the highest risk in the first 3 weeks after delivery. Combined hormonal contraceptives pose an additional risk during this time. The risk of pregnancy is low in the first 3 weeks postpartum but increases afterward in non-breastfeeding women, even before the first menses.",
    "action_key": 642
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 21,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used.                      For women up to 6 weeks postpartum with additional risk factors for VTE, such as immobility, high BMI, postpartum hemorrhage, or preeclampsia, or smoking , the use of COCs may further increase the risk of VTE.",
    "action_key": 643
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "minValue": 21,
        "maxValue": 42,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 644
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "minValue": 21,
        "maxValue": 42,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.                                                                                                                                                   For women up to 6 weeks postpartum with additional risk factors for VTE, such as immobility, high BMI, postpartum hemorrhage, or preeclampsia, or smoking , the use of COCs may further increase the risk of VTE.",
    "action_key": 645
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Date of last birth",
        "value": 180,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 646
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n- Women who started taking COCs immediately after first trimester medical or surgical abortion did not experience more side effects or adverse vaginal bleeding outcomes or clinically significant changes in coagulation parameters compared with women who used a placebo, an IUD, a non-hormonal contracptive method or delayed COC initiation.\nCOCs, combined contraceptive patch, CVR or combined injectable contraceptives (CICs) may be started immediately post-abortion.",
    "action_key": 647
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 648
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 649
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 650
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 651
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": "<"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Smokes cigarettes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.                          -  COC users who smoked were at increased risk of cardiovascular disease specially myocardial infarction(MI) compared with those who did not smoke. Studies also showed an increased risk of MI with increasing number of cigarettes smoked per day.",
    "action_key": 652
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": ">="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client smokes < 15 cigarettes per day",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable. COC users who smoke are at increased risk of cardiovascular diseases, especially myocardial infarction (MI), compared with those who do not smoke. The risk of MI increases with increasing number of cigarettes smoked per day.",
    "action_key": 653
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": ">="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client smokes >= 15 cigarettes per day",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used. COC users who smoke are at increased risk of cardiovascular diseases, especially myocardial infarction (MI), compared with those who do not smoke. The risk of MI increases with increasing number of cigarettes smoked per day.",
    "action_key": 654
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method. - Obese womenwho use COCs are more likely to experience venous thromoboembolisim (VTE) than obese women who do not use COCs.",
    "action_key": 655
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for not taking blood pressure",
        "value": "DAK, BP apparatus not available",
        "operator": "="
      }
    ],
    "action": "Counsel client that her medical eligibility for this this method will be determined after her blood pressure has been measured. In the meantime she can use the method.",
    "annotation": "In settings where blood pressure measurements are unavailable, women should not be denied access to COCs due to the lack of measurement. COCs may be among the few widely available methods in settings with high pregnancy-related risks. However, it is important to prioritize blood pressure measurement as soon as possible for appropriate monitoring.",
    "action_key": 656
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable OR 4 \u2013 Method NOT to be used \u2013 depending on the severity of the condition. Use clinical judgement.\n\nMultiple major cardiovascular risk factors can increase a woman's risk to an unacceptable level when using certain methods like COCs, CVR, or CICs. Assigning a higher category based solely on the combination of risk factors is not a simple addition. Each case should be evaluated individually, as a combination of two risk factors assigned a lower category does not automatically warrant a higher category.",
    "action_key": 657
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThis includes hypertension from past pregnancies as well. Evaluation of cause and level of hypertension is recommended, as soon as feasible.",
    "action_key": 658
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nWomen adequately treated for hypertension are at reduced risk of acute MI and stroke as compared with untreated women. Among women with hypertension, COC users are at increased risk of stroke, acute MI, and peripheral arterial disease compared with non-users. Discontinuation of COCs in women with hypertension may improve blood pressure control.",
    "action_key": 659
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable. Among women with hypertension, COC users are at increased risk of stroke, acute MI, and peripheral arterial disease compared with non-users. Discontinuation of COCs in women with hypertension may improve blood pressure control.",
    "action_key": 660
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used. Among women with hypertension, COC users are at increased risk of stroke, acute MI, and peripheral arterial disease compared with non-users. Discontinuation of COCs in women with hypertension may improve blood pressure control.",
    "action_key": 661
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used. Among women with hypertension, COC users are at increased risk of stroke, acute MI, and peripheral arterial disease compared with non-users. Discontinuation of COCs in women with hypertension may improve blood pressure control.",
    "action_key": 662
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method. The absolute risks of acute MI and VTE in women with history of high blood pressure in pregnancy using COCs is low.",
    "action_key": 663
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, History of deep vein thrombosis (DVT)",
          "DAK, History of pulmonary embolism (PE)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 664
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 665
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 666
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 667
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 668
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 669
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 670
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 671
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used.\n\nRoutine screening is not appropriate because of the rarity of the conditions and the high cost of screening.",
    "action_key": 672
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance  -",
    "action_key": 673
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nSuperficial venous thrombosis (SVT) may be associated with an increased risk of venous thromboembolism (VTE).",
    "action_key": 674
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 675
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 676
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening. - Increased levels of total cholesterol, low density lipoprotein (LDL) and triglycerides, as well as decreased level of high-density lipoprotein (HDL), are known risk factors for cardiovascular disease and may warrant further clinical considerations.",
    "action_key": 677
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Uncomplicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 678
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used\n\nComplicated valvular heart disease includes pulmonary hypertension, risk of atrial fibrillation, history of infective endocarditis.",
    "action_key": 679
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used. Antiphospholipid antibodies are associated with a higher risk for both arterial and venous thrombosis.",
    "action_key": 680
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 681
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 682
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 683
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1  \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke.",
    "action_key": 684
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nAny new headaches or marked changes in headaches should be evaluated. Classification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Classification is for women without any other risk factors for stroke.",
    "action_key": 685
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2  \u2013 Generally use method.\n\nAny new headaches or marked changes in headaches should be evaluated.",
    "action_key": 686
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3  \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nAny new headaches or marked changes in headaches should be evaluated. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 687
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3  \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nAny new headaches or marked changes in headaches should be evaluated. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 688
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "age",
        "value": 35.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4  \u2013 Method NOT to be used.\n\nAny new headaches or marked changes in headaches should be evaluated. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 689
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for continuation) \u2013 Method NOT to be used",
    "action_key": 690
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nAsk if client is taking any medications for epilepsy.",
    "action_key": 691
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification based on selected depressive disorders; no data for bipolar disorder or postpartum depression. Potential antidepressant and hormonal contraceptive interactions. COC use does not worsen depressive symptoms in women with depression.",
    "action_key": 692
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 693
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nUnusually heavy bleeding (regular or irregular) should raise the suspicion of a serious underlying condition.",
    "action_key": 694
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nIf pregnancy or an underlying pathological condition (e.g. pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation.",
    "action_key": 695
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 696
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 697
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. Some COC users are associated with reduced pain and bleeding.",
    "action_key": 698
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u00ce\u00b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. COC use does not increase the risk of post-molar trophoblastic disease, and some COC users experience a more rapid regression in \u03b2-hCG levels, compared with non-users.",
    "action_key": 699
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u00ce\u00b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 700
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 701
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "orValues": [
          "DAK, Cervical intraepithelial neoplasia (CIN)",
          "DAK, Cervical cancer (awaiting treatment)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method - Among women with persistent human papillomavirus (HPV) infection, long term COC use (>5years) may increase the risk of carcinoma in situ and invasive carcinoma",
    "action_key": 702
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nEvaluation should be pursued as early as possible.",
    "action_key": 703
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 704
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 705
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 706
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 707
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 708
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 709
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "orValues": [
          "DAK, Uterine fibroids without distortion of the uterine cavity",
          "DAK, Uterine fibroids with distortion of the uterine cavity"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 710
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "orValues": [
          "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
          "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 711
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 712
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 713
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 714
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 715
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 716
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 717
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 718
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 719
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 720
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Schistosomiasis with liver fibrosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 721
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "orValues": [
          "DAK, Non-pelvic tuberculosis",
          "DAK, Known pelvic tuberculosis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nRifampicin is likely to decrease COC effectiveness. Encourage other methods for long-term users of rifampicin. If a COC is selected, choose a formulation with at least 30 \u00b5g ethinyl estradiol (EE) for improved effectiveness.",
    "action_key": 722
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 723
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 724
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Insulin-dependent diabetes",
          "DAK, Non-insulin dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method  -Among womenwith insulin or non-insulin dependent diabetes COC use had limited effect on daily insulin requirment and no effect on long term diabetes control",
    "action_key": 725
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable OR 4 \u2013 Method NOT to be used \u2013 depending on the severity of the condition. Use clinical judgement.",
    "action_key": 726
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable OR 4 \u2013 Method NOT to be used \u2013 depending on the severity of the condition. Use clinical judgement.",
    "action_key": 727
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable OR 4 \u2013 Method NOT to be used \u2013 depending on the severity of the condition. Use clinical judgement.",
    "action_key": 728
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "orValues": [
          "DAK, Simple goitre",
          "DAK, Hyperthyroidism",
          "DAK, Hypothyroidism"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 729
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 730
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (medically treated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 731
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, Asymptomatic gall bladder disease",
          "DAK, History of pregnancy-related cholestasis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 732
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Past combined oral contraceptives-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 733
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Acute or flare viral hepatitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable OR 4 \u2013 Method NOT to be used \u2013 depending on the severity of the condition. Use clinical judgement.\n\nThe category should be assessed according to the severity of the condition.",
    "action_key": 734
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "Orvalues": [
          "DAK, Carrier viral hepatitis",
          "DAK, Chronic viral hepatitis"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 735
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Acute or flare viral hepatitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 736
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Carrier viral hepatitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 737
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Chronic viral hepatitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 738
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 739
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 740
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method - There is limited evidence that hormonal contracptives use does not influence either progression or regression of liver lesions among women with focal nodular hyperplasia.",
    "action_key": 741
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 742
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 743
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 744
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 745
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 746
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 747
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 748
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, EFV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 749
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, ETR",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nPotential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness..",
    "action_key": 750
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NVP",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\nPotential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness.",
    "action_key": 751
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, RPV",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\n\nPotential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness..",
    "action_key": 752
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method\n\nPotential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness",
    "action_key": 753
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance Potential drug interactions between certain antiretroviral drugs (specifically NNRTIs and ritonavir-boosted PIs) and hormonal contraceptives may affect contraceptive effectiveness.",
    "action_key": 754
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThe recommendation for lamotrigen does not apply when lamotrigen is already being taken with other drugs. Pharmakokinetic studies show leveles of lamotrigen decrease significantly during COC use and increase significantly during the pill free interval",
    "action_key": 755
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 756
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable.The recommendation for lamotrigen does not apply when lamotrigen is already being taken with other drugs. Pharmakokinetic studies show leveles of lamotrigen decrease significantly during COC use and increase significantly during the pill free interval ",
    "action_key": 757
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nRifampicin or rifabutin therapy can reduce the effectiveness of COCs, combined contraceptive patch, CVR, or CICs. Women on long-term medication should consider using other contraceptives, such as progestin-only injectables, implants, Cu-IUDs, or LNG-IUDs. If a COC is chosen, it should contain at least 30 \u00b5g ethinyl estradiol (EE). For short-term medication use, using a back-up method with COCs provides greater pregnancy protection",
    "action_key": 758
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Withdrawal",
        "operator": "="
      }
    ],
    "action_key": 759,
    "action": "Counsel client that s/he is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstance"
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 180,
        "operator": "<"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action_key": 760,
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "All breastfeeding women who fulfil the criteia can safely use LAM, but a woman in the following circumstances may want to consider other contraceptive methods:\u00e2\u20ac\u201c Has HIV infection\u00e2\u20ac\u201c Is using certain medications during breastfeeding\u00e2\u20ac\u201c The newborn has a condition that makes it difficult to breastfeed."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">="
      }
    ],
    "action_key": 761,
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "If the conditions required to use LAM are not met, a client's chances of pregnancy increase. Advise her to begin using another family planning method and to continue breastfeeding for the child's health."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action_key": 762,
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "If the conditions required to use LAM are not met, a client's chances of pregnancy increase. Advise her to begin using another family planning method and to continue breastfeeding for the child's health."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": "DAK, Partially breastfeeding",
        "operator": "="
      }
    ],
    "action_key": 763,
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "If the conditions required to use LAM are not met, a client's chances of pregnancy increase. Advise her to begin using another family planning method and to continue breastfeeding for the child's health."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action_key": 764,
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "If the conditions required to use LAM are not met, a client's chances of pregnancy increase. Advise her to begin using another family planning method and to continue breastfeeding for the child's health."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that s/he is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 765
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Allergy to latex",
        "operator": "="
      }
    ],
    "action_key": 766,
    "action": "Counsel client that s/he is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable.This DOES NOT APPLY to plastic condoms."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Allergy to latex",
        "operator": "!="
      }
    ],
    "action_key": 767,
    "action": "Counsel client that s/he is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstanceNote: If the client has any medical condition other than allergy to latex, there are no restrictions on condom use."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Current medications FP form",
        "value": "null",
        "operator": "!="
      }
    ],
    "action_key": 768,
    "action": "Counsel client that s/he is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u00e2\u20ac\u201c Use method in any circumstanceNote: If the client has any medical condition is taking any medication, there are no restrictions on condom use."
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
          "key": "DAK, Reasonably certain a woman is not pregnant",
          "value": true,
          "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 769
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
          "key": "DAK, Pregnancy test result",
          "value": "DAK, Not pregnant",
          "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 770
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.",
    "action_key": 771
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 772
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },            
      {
                "key": "DAK, Risk factors for venous thromboembolism (VTE)",
                "value": "DAK, Client is Obese",
                "operator": "="
            }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\nECP may be less effective among women with BMI \u2265 30 kg/m^2 than among women with BMI < 25 kg/m^2. Despite this, there are no safety concerns.",
    "action_key": 773
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 774
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "orValues": [
            "DAK, Ischaemic heart disease",
            "DAK, Stroke"
        ],
        "operator": "OR"
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 775
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
            "DAK, History of deep vein thrombosis (DVT)",
            "DAK, Stroke",
            "DAK, Acute deep vein thrombosis (DVT)",
            "DAK, Acute pulmonary embolism (PE)",
            "DAK, Minor surgery without immobilization",
            "DAK, Major surgery without prolonged immobilization",
            "DAK, Major surgery with prolonged immobilization"
        ],
        "operator": "OR"
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 776
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 777
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 778
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 779
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 780
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 781
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 782
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "orValues": [
            "DAK, Migraine headache without aura",
            "DAK, Migraine headache with aura"
        ],
        "operator": "OR"
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 783
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 784
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
            "DAK, Severe (decompensated) cirrhosis",
            "DAK, Benign hepatocellular adenoma",
            "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
            "DAK, Acute or flare viral hepatitis"
        ],
        "operator": "OR"
    }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 785
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications",
        "value": "DAK, CYP3A4 inducers",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 787
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications",
        "value": "DAK, Repeated emergency contraceptive pills (ECP) use",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\n\nRepeated ECP use is an indication that the woman requires further counselling on other contraceptive options. Frequently repeated ECP use may be harmful for women with conditions classified as medical eligibility category 2, 3 or 4 for combined hormonal contraception or progestogen-only contraceptives.",
    "action_key": 788
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Sexual violence",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance\n\nThere are no restrictions for the use of ECPs in cases of rape. If the client is at an increased risk of STIs due to sexual violence/forced sex, use of an IUD for purposes of emergency contraception is not recommended.",
    "action_key": 789
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Symptom-based methods can be used in this circumstance without any medical restrictions. FAB methods do not provide protection against s STIs or HIV. If there is a risk of STI/HIV, it is recommended to use condoms correctly and consistently.",
    "action_key": 790
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Calender-based methods can be used in this circumstance without any medical restrictions. FAB methods do not provide protection against s STIs or HIV. If there is a risk of STI/HIV, it is recommended to use condoms correctly and consistently.",
    "action_key": 791
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client to delay use of this method until regular menstrual cycles have returned.",
    "annotation": "Use of FAB methods should be delayed until the condition is evaluated or corrected.\nGive the client another method to use until she can start the symptoms-based method.",
    "action_key": 792
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client to delay use this method until regular menstrual cycles have returned.",
    "annotation": "Use of calendar-based FAB methods should be delayed until the condition is evaluated or corrected.\nGive the client another method to use until she can start the calendar-based method.",
    "action_key": 793
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Perimenopause",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Use of symptom-based FAB methods should be used with caution",
    "action_key": 794
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Perimenopause",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Use of calendar-based FAB methods should be used with caution",
    "action_key": 795
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": "<"
      }
    ],
    "action": "Counsel client to delay use of this method until normal secretions have returned.",
    "annotation": "Delay FAB methods until normal vaginal secretions return. Breastfeeding can delay the return of normal vaginal secretions.FAB methods may be less effective during breastfeeding.",
    "action_key": 796
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": "<"
      }
    ],
    "action": "Counsel client to delay use of this method until she has had 3 menstrual cycles and the last one was 26-32 days long.",
    "annotation": "Dealy FAB methods until she has had 3 menustral cycles and the last one was 26 to 32 days long.",
    "action_key": 797
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, <, <"
      }
    ],
    "action": "Counsel client to delay use of this method until she has had 3 menstrual cycles and the last one was 26-32 days long.",
    "annotation": "Delay FAB methods until regular menstrual cycles return. Menstrual cycles may return later in breastfeeding women compared to non-breastfeeding women. FAB methods during breastfeeding may be less effective than when not breastfeeding.",
    "action_key": 798
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, <, <"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method if normal vaginal secretions have returned",
    "annotation": "Counsel client that she is medically eligible for this method if normal vaginal secretions and regular menstrual bleeding have returned.",
    "action_key": 799
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": "<"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method if she is exclusively breastfeeding",
    "annotation": "FAB methods during breastfeeding may be less effective. After the onset of menses, a symptoms-based method can be used when fertility signs are observed. It takes several cycles for menstrual regularity to return. The Calendar Rhythm Method can be used after three regular postpartum menses, and the Standard Days Method after four menses with a cycle length of 26-32 days. Prior to that, a barrier method should be offered for women planning to use FAB methods later.",
    "action_key": 800
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": "<"
      }
    ],
    "action": "Counsel client to delay this method until normal vaginal secretions have returned.",
    "annotation": "Non-breastfeeding women typically do not require FAB methods or experience detectable fertility signs or hormonal changes before four weeks postpartum. While the risk of pregnancy is low, it is still recommended to offer a postpartum-appropriate contraceptive method.",
    "action_key": 801
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "No medical reason to deny symptoms-based and calendar-based methods in this circumstance.  \n                                                                                                                                   Postpartum (non-breastfeeding) \u2265 4 weeks: non-breastfeeding women can use calendar-based methods after at least three regular postpartum menstrual cycles. The Standard Days Method can be used after at least four postpartum cycles with a recent cycle length of 26-32 days. Offer appropriate methods for the postpartum period prior to that time. No medical reason to deny symptoms-based and calendar-based methods in this circumstance.",
    "action_key": 802
  },
  {
    "conditions": [
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method if she has no infection-related secretions or bleeding due to injury to the genital tract.",
    "annotation": "Post-abortion, women typically regain ovarian function and can observe fertility signs and hormonal changes. The likelihood increases over time post-abortion. Calendar-based methods can be used after one post-abortion menstrual cycle. If most cycles prior to the pregnancy were 26-32 days long, the Standard Days Method can be used. Offer appropriate methods for the post-abortion period prior to that time.",
    "action_key": 803
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Vaginal discharge",
        "operator": "="
      }
    ],
    "action": "Counsel client to delay use of this method",
    "annotation": "Use of symptom-based methods should be delayed until the condition is corrected or resolved  Advice the client to use another method",
    "action_key": 804
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action": "Counsel client to delay use of this method",
    "annotation": "Use of FAB methods should be delayed until the condition is corrected or resolved for both symptoms- and calendar-based methods Advice the client to use another method",
    "action_key": 805
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Has client given birth in the last six months",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "FAB methods may be less effective during breastfeeding. Once menses begin, a woman can use symptoms-based methods when fertility signs are noticed . After at least three regular postpartum menses her cycles are regular again, she can use the Calendar Rhythm Method. After at least four postpartum menses with a 26-32 day cycle, she can use the Standard Days Method. A barrier method should be offered before using FAB methods.",
    "action_key": 806
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "value": 28.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client to delay use of this method",
    "annotation": "Non-breastfeeding women generally do not require FAB methods or have detectable fertility signs prior to four weeks postpartum. However, a postpartum-appropriate method should still be offered considering the low risk of pregnancy.",
    "action_key": 807
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "value": 28.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client to delay use of this method",
    "annotation": "Postpartum \u2265 4 weeks: Non-breastfeeding women can start using calendar-based methods as their ovarian function and fertility signs return. They should have completed at least three postpartum menses and have regular cycles. The Standard Days Method can be used when they have had at least four postpartum menses and their most recent cycle was 26-32 days long.Methods appropriate for the postpartum period should be offered prior to that time.",
    "action_key": 808
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client to delay use of this method until the start of her next monthly bleeding when she can start if she has no bleeding due to injury to the genital tract.",
    "annotation": "Delay the use of calendar-based FAB methods until normal menstrual cycles have resumed. Give the client another method to use until she can start the calendar-based method. Recommend the use of a symptoms-based method and provide special counseling to ensure its correct use in this situation.",
    "action_key": 809
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Vaginal discharge",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "There is no medical reason to deny calendar-based FAB methods to a woman in this circumstance",
    "action_key": 810
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Use of FAB methods should be delayed until the condition is corrected or resolved. Provide another method she can use.",
    "action_key": 811
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to FAB",
        "value": "DAK, Acute disease that elevates body temperature",
        "operator": "="
      }
    ],
    "action": "",
    "annotation": "Use of symptoms-based FAB methods should be delayed until the condition is corrected or resolved. Provide another method she can use.",
    "action_key": 812
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to FAB",
        "value": "DAK, Chronic disease that elevates body temperature",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Use of symptoms-based FAB methods should be used with caution until the condition is corrected or resolved.",
    "action_key": 813
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to FAB",
        "orValues": [
          "DAK, Acute disease that elevates body temperature",
          "DAK, Chronic disease that elevates body temperature"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "There is no medical reason to deny calendar-based FAB methods to a woman in this circumstance.",
    "action_key": 814
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "\"Medically eligible\" = TRUE",
    "annotation": "Counsel client that he is medically eligible for this method.\n\nMedical eligibility criteria (MEC) category A \u2013 Accept: There is no medical reason to deny sterilization to a person in this circumstance.Counseling on  the permanency of sterilization and discuss alternative, long-term, highly effective methods. Counsel the client that he is eligible for this method.",
    "action_key": 815
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "age",
        "value": 30,
        "operator": "<"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. Extra preparation and precautions should be taken during the procedure in a routine setting.Counseling on  the permanency of sterilization and discuss alternative, long-term, highly effective methods. Emphasize that young men who undergo vasectomy are more likely to seek reversal compared to those who have the procedure at older ages.",
    "action_key": 816
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 817
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is eligible for sterilization. Counseling should include information about the permanency of the procedure and the availability of alternative, long-term, highly effective methods. Routine screening is not required. Adherence to  infection prevention procedures and universal precautions during the surgical procedure. Following sterilization, the use of condoms is recommended.",
    "action_key": 818
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is eligible for sterilization. Counseling should include information about the permanency of the procedure and the availability of alternative, long-term, highly effective methods. Routine screening is not required. Adherence to  infection prevention procedures and universal precautions during the surgical procedure. Following sterilization, the use of condoms is recommended.",
    "action_key": 819
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "The client is eligible for sterilization, but it is necessary to make special arrangements for the procedure in a setting with experienced surgical staff, and adequate medical support. Counseling should include information about the permanent nature of sterilization and the availability of alternative, long-term, highly effective methods.\n\nIf the client has an AIDS-related illness, it may be necessary to delay the procedure.",
    "action_key": 820
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Non-insulin dependent diabetes",
          "DAK, Insulin-dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization in a routine setting with extra precautions based on their condition. Counsel about the permanency of sterilization and alternative, long-term, highly effective methods. Diabtetics have an increased likelihood of of postoperative infection. Correct hyperglycemia before vasectomy and perform vasectomy only with local anesthesia. Referral to a higher-level facility is recommended if blood glucose is not well controlled .",
    "action_key": 821
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with neuropathy",
          "DAK, Diabetes with retinopathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization in a routine setting with extra precautions based on their condition. Counsel about the permanency of sterilization and alternative, long-term, highly effective methods. Referral to a higher-level facility is recommended if blood glucose is not well controlled .",
    "action_key": 822
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes > 20 years duration",
          "DAK, Other vascular disease > 20 years duration"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization in a routine setting with extra precautions based on their condition. Counsel about the permanency of sterilization and alternative, long-term, highly effective methods. Referral to a higher-level facility is recommended if blood glucose is not well controlled .",
    "action_key": 823
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "orValues": [
          "DAK, Sickle cell anaemia",
          "DAK, Thalassemia",
          "DAK, Iron-deficiency anaemia"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is eligible for this method, and there is no medical reason to deny sterilization to a person with this condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 824
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "orValues": [
          "DAK, Scrotal skin infection",
          "DAK, Balanitis",
          "DAK, Epididymitis",
          "DAK, Orchitis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options.",
    "action_key": 825
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Signs and symptoms of STIs in males",
        "orValues": [
          "DAK, Discharge from the penis",
          "DAK, swollen and/or painful testicles",
          "DAK, Warts and/or ulcers on the genitals, anus, or surrounding areas"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options.",
    "action_key": 826
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Coagulation disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "The client is eligible for sterilization, but it is necessary to make special arrangements for the procedure in a setting with experienced surgical staff, and adequate medical support.Bleeding disorders lead to an increased risk of postoperative hemorrhage and  hematoma formation, which leads to an increased risk of infection. Evaluate before performing vasectomy. If the client has significant bleeding disorder that can not be corrected before surgery, do not perform vasectomy.Counseling should include information about the permanent nature of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 827
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Previous scrotal injury",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 828
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Systemic infection or gasteroenteritis",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options.",
    "action_key": 829
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "orValues": [
          "DAK, Large varicocele",
          "DAK, Large hydrocele"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 830
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Filiariasis or elephantiasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options.",
    "action_key": 831
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Intrascrotal mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options.",
    "action_key": 832
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Cryptorchidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "The client is eligible for sterilization, but it is necessary to make special arrangements for the procedure in a setting with experienced surgical staff, and adequate medical support. Counseling should include information about the permanent nature of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 833
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Male sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Inguinal hernia",
        "operator": "="
      }
    ],
    "action": "Counsel client that he is medically eligible for this method",
    "annotation": "The client is eligible for sterilization, but it is necessary to make special arrangements for the procedure in a setting with experienced surgical staff, and adequate medical support. Counseling should include information about the permanent nature of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 834
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, No reported health conditions",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category A\u2013 Accept: There is no medical reason to deny sterilization to a person in this circumstance. Counsel the client that she is eligible for this method.",
    "action_key": 835
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "age",
        "value": 19.0,
        "operator": ">"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but may want to consider other methods. Counsel client that she is medically eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 836
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "age",
        "value": 30.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Young women, like all women, should be counselled about the permanency of sterilization and the availability of alternative, long-term, highly effective methods. Client is medically eligible for this method, but may want to consider other methods. Counsel client that she is eligible for this method but \"emphasize\" about the permanency of sterilization and the availability of alternative, long-term, highly effective methods. Clients who are young are more likely to regret sterilization than those who are older. Therefore the provider should make sure that the client makes an informed thoughtful choice and will not want any children in future.",
    "action_key": 837
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Pregnant",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization until childbirth or after. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 838
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods. Clients who have no or few children are more likely to regret sterilization than those who have more children. Therefore the provider should make sure that the client makes an informed thoughtful choice and will not want any children in future.",
    "action_key": 839
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 1,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 840
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 841
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "value": 7.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 842
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "minValue": 7,
        "maxValue": 42,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. Do not perform the procedure if the client is between 7 and 42 days postpartum. Help the client choose another method to use until after 42 days when the procedure can be performed. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 843
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 844
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Puerperal sepsis postpartum",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. These conditions must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 845
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Mild pre-eclampsia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 846
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Preeclampsia with a severity feature",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. This condition must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 847
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Prolonged rupture of membranes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. Prolonged rupture of membranes for 24 hours or more increases the risk of intrapartum or puerperal fever or puerperal sepsis. Delay female sterilization until after 42 days postpartum. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 848
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Severe antepartum or postpartum haemorrhage",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. These conditions must be treated and resolved before female sterilization can be performed. Correct the anaemia resulting from haemorrhage. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 849
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Severe trauma to the genital tract",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. This condition must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 850
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Uterine rupture or perforation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but special arrangements should be made to perform the procedure in a setting with an experienced surgeon and staff, equipment to provide general anaesthesia, and other back-up medical support. For these conditions, the capacity to decide on the most appropriate procedure and anaesthesia regimen also is needed. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 851
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Abortion/miscarriage",
        "value": "DAK, Uncomplicated abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 852
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Abortion/miscarriage",
        "value": "DAK, Post-abortion sepsis or fever",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. This condition must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 853
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Abortion/miscarriage",
        "value": "DAK, Severe post-abortion haemorrhage",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. This condition must be treated and resolved before female sterilization can be performed.",
    "action_key": 854
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Abortion/miscarriage",
        "value": "DAK, Post-abortion uterine perforation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but arrange for the procedure to be performed in a setting with an experienced surgeon, trained staff, and the necessary equipment to provide general anesthesia and backup medical support\n\nIf exploratory surgery or laparoscopy is conducted and the patient is stable, tubal sterilization can be performed concurrently if there are no additional risks involved.",
    "action_key": 855
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Acute haematometra",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 856
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 857
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Client smokes < 15 cigarettes per day",
          "DAK, Client smokes >= 15 cigarettes per day"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 858
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but it is recommended to discuss other contraceptive options as well. Emphasize the permanency of sterilization and the availability of alternative, long-term, highly effective methods. The procedure may be more difficult with an increased risk of wound infection and disruption.",
    "action_key": 859
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but the procedure requires a specialized setting with experienced staff, equipment for general anesthesia, and adequate medical support. In the meantime. Discussion on ralternative long-term, highly effective methods with the client and help them choose an interim method until the sterilization procedure can be performed.Discuss permanent sterilization and alternatives.",
    "action_key": 860
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140,
        "maxValue": 159,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90,
        "maxValue": 99,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. Counsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nControl elevated blood pressure before surgery to reduce risks. Uncontrolled hypertension increases anesthesia-related risks and cardiac arrhythmia. Monitor blood pressure closely intraoperatively is necessary.",
    "action_key": 861
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. Counsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nControl elevated blood pressure before surgery to reduce risks. Uncontrolled hypertension increases anesthesia-related risks and cardiac arrhythmia. Monitor blood pressure closely intraoperatively is necessary.",
    "action_key": 862
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. Counsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nControl elevated blood pressure before surgery to reduce risks. Uncontrolled hypertension increases anesthesia-related risks and cardiac arrhythmia. Monitor blood pressure closely intraoperatively is necessary.",
    "action_key": 863
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "",
    "action_key": 864
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 865
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 866
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 867
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 868
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 869
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesi.",
    "action_key": 870
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 871
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 872
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 873
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 874
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 875
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 876
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 877
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 878
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 879
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 880
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 881
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Uncomplicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, however, the  woman requires prophylactic antibiotics.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 882
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.                           \n                                                                                                                                            Delay the procedure if the woman is at high risk for complications associated with anesthesia and surgery, such as unmanaged atrial fibrillation or current subacute bacterial endocarditis.",
    "action_key": 883
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 884
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 885
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 886
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 887
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 888
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "orValues": [
          "DAK, Migraine headache without aura",
          "DAK, Migraine headache with aura"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 889
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 890
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 891
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "orValues": [
          "DAK, Irregular vaginal bleeding patterns",
          "DAK, Heavy or prolonged vaginal bleeding patterns"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 892
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 893
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 894
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 895
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 896
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u00ce\u00b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 897
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u00ce\u00b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 898
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 899
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 900
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 901
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 902
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 903
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 904
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 905
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 906
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 907
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 908
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "orValues": [
          "DAK, Uterine fibroids without distortion of the uterine cavity",
          "DAK, Uterine fibroids with distortion of the uterine cavity"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 909
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method. Counsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nA careful pelvic examination must be performed to rule out recurrent or persistent infection and to determine the mobility of the uterus",
    "action_key": 910
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nA careful pelvic examination must be performed to rule out recurrent or persistent infection and to determine the mobility of the uterus",
    "action_key": 911
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 912
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. These conditions must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed.",
    "action_key": 913
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.\n\nExcluding HIV and hepatitis \u2013 if no symptoms persist following treatment, sterilization may be performed",
    "action_key": 914
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nIf no symptoms persist following treatment, sterilization may be performed\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 915
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\n\nIf no symptoms persist following treatment, sterilization may be performed.\n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 916
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method. \nNo routine screening is needed. Appropriate infection prevention procedures, including universal precautions, must be carefully observed with all surgical procedures. The use of condoms is recommended following sterilization. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 917
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\n\nNo routine screening is needed. Appropriate infection prevention procedures, including universal precautions, must be carefully observed with all surgical procedures. The use of condoms is recommended following sterilization. \n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 918
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but special arrangements should be made to perform the procedure in a setting with an experienced surgeon and staff, equipment to provide general anaesthesia, and other back-up medical support. The presence of an AIDS-related illness may require that the procedure be delayed",
    "action_key": 919
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 920
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Schistosomiasis with liver fibrosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 921
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Non-pelvic tuberculosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 922
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Known pelvic tuberculosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 923
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 924
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 925
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Non-insulin dependent diabetes",
          "DAK, Insulin-dependent diabetes"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 926
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 927
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 928
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 929
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Simple goitre",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 930
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hyperthyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 931
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hypothyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 932
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
          "DAK, Symptomatic gall bladder disease (medically treated)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 933
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Current symptoms of gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options",
    "action_key": 934
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Asymptomatic gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 935
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "orValues": [
          "DAK, History of pregnancy-related cholestasis",
          "DAK, Past combined oral contraceptives-related cholestasis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 936
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Acute or flare viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but must postpone female sterilization. These conditions must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 937
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "orValues": [
          "DAK, Carrier viral hepatitis",
          "DAK, Chronic viral hepatitis"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 938
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method. Liver function and clotting might be altered. Liver function should be evaluated. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 939
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesia.",
    "action_key": 940
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\n\nLiver function and clotting might be altered. Liver function should be evaluated. \nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 941
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\n\nLiver function and clotting might be altered. Liver function should be evaluated. \n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 942
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 943
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "orValues": [
          "DAK, Thalassemia",
          "DAK, Sickle cell anaemia"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method. The procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition.\n\nLiver function and clotting might be altered. Liver function should be evaluated. \n\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 944
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "\"Haemoglobin test needed\" = TRUE",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options                                                                           Identify underlying disease. Consider preoperative Hb level, blood loss, and wound healing in anaemic women.nadequate peripheral perfusion may adversely affect wound healing.",
    "action_key": 945
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Haemoglobin levels",
        "value": 7.0,
        "operator": "<"
      },
      {
        "key": "DAK, Haemoglobin test available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\"Haemoglobin test needed\" = TRUE",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options                                                                           Identify underlying disease. Consider preoperative Hb level, blood loss, and wound healing in anaemic women.nadequate peripheral perfusion may adversely affect wound healing.",
    "action_key": 946
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in use",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Haemoglobin levels",
        "minValue": 7.0,
        "maxValue": 10.0,
        "operator": "between"
      },
      {
        "key": "DAK, Haemoglobin test available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\"Haemoglobin test needed\" = TRUE",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options                                                                           Identify underlying disease. Consider preoperative Hb level, blood loss, and wound healing in anaemic women.nadequate peripheral perfusion may adversely affect wound healing.",
    "action_key": 947
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Local infection",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for this method, but postpone female sterilization until condition resolved . Assist the client in selecting an alternative contraceptive method until the procedure can be performed. Provide counseling on the permanent nature of sterilization and present other long-term, highly effective contraceptive options                                                                         \nThere is an increased risk of postoperative infection.",
    "action_key": 948
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Coagulation disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for sterilization, but the procedure requires a specialized setting with experienced staff, equipment for general anesthesia, and adequate medical support. In the meantime. Discussion on ralternative long-term, highly effective methods with the client and help them choose an interim method until the sterilization procedure can be performed.Discuss permanent sterilization and alternatives.",
    "action_key": 949
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Acute respiratory disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medically eligible for sterilizationbut due to certain medical conditions, the client must delay female sterilization. There are increases in anaesthesia-related and other perioperative risks.Assist the client select an alternative method of contraception. Counsel about the permanent nature of sterilization and explore the availability of other long-term and highly effective contraceptive options.",
    "action_key": 950
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Chronic respiratory disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medically eligible for sterilization, but requires specialized setting, experienced staff, and general anesthesia. Increased anesthesia and perioperative risks. Help choose alternative method. Counsel about permanency of sterilization and availability of other long-term options.",
    "action_key": 951
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Systemic infection or gasteroenteritis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for method but postpone female sterilization due to medical condition. Treat and resolve the condition before proceeding until the procedure can be performed. Assist with alternative method selection. Counsel on sterilization permanency and availability of long-term options.",
    "action_key": 952
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Fixed uterus due to previous surgery or infection",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medically eligible for sterilization, but needs specialized setting, staff, and anesthesia. Help choose alternative method until the procedure can be performed. Counsel on sterilization permanency and long-term options. Decision-making capacity required for appropriate procedure and anesthesi.",
    "action_key": 953
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Abdominal wall or umbilical hernia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medically eligible for sterilization but requires specialized setting and support for procedure. Consider concurrent hernia repair and sterilization if possible. Assist with alternative method selection until procedure can be performed. Counsel on sterilization permanency and availability of long-term options.",
    "action_key": 954
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Diaphragmatic hernia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client medically eligible. Procedure can be done in routine setting with precautions. Counsel on sterilization permanency and alternative long-term methods",
    "action_key": 955
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Kidney disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client medically eligible. Procedure can be done in routine setting with precautions. Counsel on sterilization permanency and alternative long-term methods",
    "action_key": 956
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Severe nutritional deficiencies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client medically eligible. Procedure can be done in routine setting with precautions. Counsel on sterilization permanency and alternative long-term methods",
    "action_key": 957
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Previous abdominal or pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client medically eligible. Procedure can be performed in routine setting with extra precautions. Prior abdominal or pelvic surgery increases risk of complications. Counsel on sterilization permanency and alternative long-term methods.",
    "action_key": 958
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Elective abdominal surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for method. Assist with alternative method selection. Counsel on sterilization permanency and availability of long-term options.",
    "action_key": 959
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Emergency (without previous counselling) abdominal surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for method but postpone female sterilization due to medical condition. Treat and resolve the condition before proceeding until the procedure can be performed. Assist with alternative method selection. Counsel on sterilization permanency and availability of long-term options.",
    "action_key": 960
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Abdominal surgery due to infectious condition",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible for method but postpone female sterilization due to medical condition. Treat and resolve the condition before proceeding until the procedure can be performed. Assist with alternative method selection. Counsel on sterilization permanency and availability of long-term options.",
    "action_key": 961
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Sterilization concurrent with caesarean section",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is eligible for this method.\nCounsel about the permanency of sterilization and the availability of alternative, long-term, highly effective methods.",
    "action_key": 962
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": "<="
      }
    ],
    "action": "Get informed consent",
    "annotation": "For a clent who has been ammenorrheic and presented within 7 days of bleeding, we need to be certain that this is not related to pregnancy",
    "action_key": 963
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": "<="
      }
    ],
    "action": "\u2013 Assess Symptoms: Evaluate the patient\u2019s symptoms and concerns in detail to determine if they might be related to other conditions rather than pregnancy.\n \u2013 Provide Reassurance: Since the menstrual period is not missed and it is still early in the cycle, reassure the patient that their situation may be within normal parameters, especially if they are seeking pregnancy-related testing.\n \u2013 Confirm Timing and Regularity: Verify the regularity of the patient\u2019s menstrual cycle. Ensure the cycle tracking is accurate and consider any recent changes in cycle patterns. \n\u2013 Suggest Follow-Up: If there are concerns about pregnancy or other conditions, advise the patient to follow up in a few days or weeks, especially if symptoms persist or if their next period is missed.\n\u2013 Conduct Additional Tests: If appropriate, consider performing or recommending additional diagnostic tests based on the patient\u2019s symptoms and medical history. \n\u2013 Provide Guidance: Offer advice on what to watch for and when to seek further medical evaluation, particularly if the patient has symptoms or issues that do not align with their current menstrual status.",
    "annotation": " -Indicates that the patient\u2019s menstruation has occurred as expected and has not been missed or delayed. -Indicates that it has been less than or equal to 7 days since the patient\u2019s last normal menstrual period began.",
    "action_key": 964
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Abstained from sexual intercourse since last normal menses, delivery, miscarriage or abortion",
        "operator": "="
      }
    ],
    "action": "\u2013 Assess the Cause: Investigate potential causes of amenorrhea, such as hormonal imbalances or health conditions.\nu2013 Review History: Check the patient\u2019s menstrual and reproductive history.\n\u2013 Consider Tests: Perform necessary diagnostic tests to determine the cause.\n\u2013 Provide Guidance: Offer counseling and follow-up based on findings.\n\u2013Address Contraception: Discuss contraceptive needs if relevant.",
    "annotation": "If the client has abstained from sexual intercourse since her last monthly bleeding, delivery, abortion, or miscarriage, it is reasonably certain that she is not pregnant.",
    "action_key": 965
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Abstained from sexual intercourse since last normal menses, delivery, miscarriage or abortion",
        "operator": "="
      }
    ],
    "action": "\u2013Verify Information: Confirm the patient's report of no sexual intercourse since the last normal menstrual cycle, delivery, miscarriage, or abortion.\n\u2013 Reassure the Patient: Explain that the likelihood of pregnancy is very low if there has been no sexual activity.\n\u2013 Assess for Other Causes: Evaluate other potential reasons for any menstrual irregularities or concerns, such as stress, hormonal imbalances, or medical conditions. \n\u2013 Provide Guidance: Offer advice on tracking menstrual cycles and when to seek further medical advice if irregularities continue.",
    "annotation": "\u2013 Amenorrhea Assessment: Patient reports no missed or late menses and has abstained from sexual intercourse since the last normal menses, delivery, miscarriage, or abortion.\n\u2013 Pregnancy Risk: The risk of pregnancy is negligible given the absence of sexual activity.\n\u2013 Further Evaluation: Consider other potential causes for any menstrual concerns, ensuring a comprehensive approach to the patient's reproductive health.\n\u2013 Patient Education: Emphasize the importance of monitoring menstrual cycles and maintaining open communication with healthcare providers for ongoing reproductive health management.",
    "action_key": 966
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Consistently and correctly using reliable contraceptive method",
        "operator": "="
      }
    ],
    "action": "\u2013 Verify Contraceptive Use: Confirm the proper use of the contraceptive method.\nu2013 Assess for Pregnancy: Evaluate the possibility of pregnancy through appropriate tests, despite contraceptive use.\nu2013 Investigate Other Causes: Explore other potential causes of amenorrhea, such as hormonal imbalances or underlying health conditions.\nu2013 Review Medical History: Consider any relevant medical or reproductive history that could explain amenorrhea. \nu2013 Provide Follow-Up: Recommend further tests or specialist referrals if necessary and discuss management options based on findings.",
    "annotation": "If the client has been using a reliable contraceptive method consistently and correctly since her last monthly bleeding, delivery, abortion, or miscarriage, it is reasonably certain that she is not pregnant.",
    "action_key": 967
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Consistently and correctly using reliable contraceptive method",
        "operator": "="
      }
    ],
    "action": "\u2013 Verify Contraceptive Use: Confirm the patient's consistent and correct use of a reliable contraceptive method. \nu2013 Reassure the Patient: Explain that the likelihood of pregnancy is very low given the consistent use of contraception.\nu2013 Assess for Other Causes: Evaluate for other potential reasons for any menstrual irregularities or concerns, such as stress, hormonal imbalances, or medical conditions.\nu2013 Provide Guidance: Offer advice on tracking menstrual cycles and discuss any potential side effects of the contraceptive method being used.",
    "annotation": "\u2013 Contraceptive Use: Patient reports no missed or late menses and has consistently and correctly used a reliable contraceptive method.\nu2013 Pregnancy Risk: The risk of pregnancy is minimal due to consistent and correct contraceptive use.\nu2013 Further Evaluation: Consider other potential causes for any menstrual concerns, ensuring a comprehensive approach to the patient's reproductive health.",
    "action_key": 968
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": "<="
      }
    ],
    "action": "\u2013 Reassure the Patient: Explain that amenorrhea within 28 days postpartum is normal and expected.\n\u2013 Postpartum Care: Provide standard postpartum care and counseling, including information on what to expect in the weeks following delivery.\n\u2013 Monitor for Complications: Advise the patient to report any unusual symptoms such as heavy bleeding, severe pain, or signs of infection. \n\u2013 Schedule Follow-Up: Arrange a follow-up appointment to monitor the patient's recovery and address any concerns. \n\u2013 Discuss Contraception: If appropriate, discuss postpartum contraceptive options and family planning to ensure the patient is informed about their choices.Reassure the Patient: Explain that amenorrhea within 28 days postpartum is normal and expected. \n\u2013 Postpartum Care: Provide standard postpartum care and counseling, including information on what to expect in the weeks following delivery.\n\u2013 Monitor for Complications: Advise the patient to report any unusual symptoms such as heavy bleeding, severe pain, or signs of infection.\n\u2013 Schedule Follow-Up: Arrange a follow-up appointment to monitor the patient's recovery and address any concerns.\n\u2013 Discuss Contraception: If appropriate, discuss postpartum contraceptive options and family planning to ensure the patient is informed about their choices.",
    "annotation": "Have you had a baby in the last 4 weeks? \nIf the client has had a baby in the last 4 weeks, then you can be reasonably sure she is not pregnant.",
    "action_key": 969
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": "<="
      }
    ],
    "action": "\u2013 Reassure the Patient: Inform the patient that it is normal to not have had a menstrual period within 28 days postpartum. \n\u2013 Postpartum Care: Provide standard postpartum care and counseling. \n\u2013 Monitor for Complications: Advise the patient to watch for any signs of complications such as heavy bleeding, severe pain, or infection.\n\u2013 Schedule Follow-Up: Arrange a follow-up appointment to ensure the patient's recovery is on track.\n\u2013 Discuss Contraception: If appropriate, discuss postpartum contraceptive options and family planning.",
    "annotation": "\u2013 Postpartum Amenorrhea: Patient is within 28 days postpartum, and the absence of menstruation is normal.\n\u2013 Patient Reassurance: Reassured the patient that not having a period within 28 days postpartum is expected.\n\u2013 Monitoring and Follow-Up: Advised the patient on symptoms to monitor and scheduled a follow-up appointment. \n\u2013 Contraceptive Counseling: Discussed postpartum contraceptive options with the patient.",
    "action_key": 970
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": "<="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "\u2013 Reassure the Patient: Inform the patient that amenorrhea within 28 days postpartum is normal, especially when fully or nearly fully breastfeeding.\n\u2013 Postpartum and Breastfeeding Care: Provide standard postpartum and breastfeeding care, ensuring the patient is comfortable and well-informed. \n\u2013 Monitor for Complications: Advise the patient to be aware of any signs of complications such as heavy bleeding, severe pain, or infection. \n\u2013 Schedule Follow-Up: Arrange a follow-up appointment to check on the patient's recovery and breastfeeding progress.\n\u2013 Discuss Contraception: If appropriate, discuss postpartum contraceptive options, particularly those suitable for breastfeeding mothers.",
    "annotation": "Did you have your baby less than 6 months ago, are you fully or nearly-fully breastfeeding, and have you had no monthly bleeding since then? \n If these conditions are met, you can be reasonably sure she is not pregnant.",
    "action_key": 971
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180.0,
        "operator": "<="
      }
    ],
    "action": "\u2013 Reassure the Patient: Explain that it is normal not to have a period up to 180 days postpartum, especially if breastfeeding.\n\u2013 Evaluate Breastfeeding Status: Check if the patient is breastfeeding, as this can influence the return of menstruation.\n\u2013 Postpartum Care: Continue with standard postpartum care and monitoring. \n\u2013 Monitor for Complications: Advise the patient to report any unusual symptoms such as excessive bleeding, severe pain, or signs of infection.\n\u2013 Discuss Contraceptive Options: Discuss appropriate postpartum contraceptive methods, particularly those suitable for breastfeeding mothers, if applicable.\n\u2013 Schedule Follow-Up: Arrange a follow-up visit to monitor the patient's recovery and provide ongoing support.",
    "annotation": "\u2013 Postpartum Amenorrhea: Patient is within 180 days postpartum, and the absence of menstruation is expected. \n\u2013 Patient Reassurance: Informed the patient that it is normal not to have a period up to 180 days postpartum, especially if breastfeeding.\n\u2013 Breastfeeding Influence: Explained the impact of breastfeeding on the return of menstruation.\n\u2013 Monitoring and Follow-Up: Advised the patient on symptoms to monitor and scheduled a follow-up appointment.\n\u2013 Contraceptive Counseling: Discussed postpartum contraceptive options, emphasizing methods compatible with breastfeeding.",
    "action_key": 972
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "\u2013 Counseling on Contraception: Discuss the chosen method of contraception with the patient, ensuring they understand its use and effectiveness.\nu2013 Confirm Amenorrhea Cause: Explain that it is normal to experience amenorrhea shortly after a miscarriage or abortion within 7 days. \nu2013 Monitor for Complications: Advise the patient to watch for signs of complications such as heavy bleeding, severe pain, or infection. \nu2013 Ensure Follow-Up Care: Schedule a follow-up visit to monitor the patient's recovery and address any concerns.\nu2013 Reinforce Contraceptive Use: Emphasize the importance of correctly and consistently using the chosen contraceptive method to prevent unintended pregnancy.\nu2013 Provide Support and Resources: Offer emotional support and provide information on resources for further care and support if needed.",
    "annotation": "Have you had a miscarriage or abortion in the last 7 days?\nIf the client has had a miscarriage or abortion in the last 7 days, you can be reasonably sure she is not pregnant.",
    "action_key": 973
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "\u2013 Counsel on Contraceptive Use: Ensure the patient understands how to properly use their chosen method of contraception and discuss its effectiveness. \n\u2013 Address Any Concerns: Ask the patient if they have any concerns or questions about their contraceptive method.  \n\u2013 Assess Adherence: Confirm that the patient is using their contraceptive method consistently and correctly.\n\u2013 Routine Follow-Up: Schedule a routine follow-up visit to monitor contraceptive use and address any ongoing concerns.\n\u2013 Provide Education: Educate the patient on signs of contraceptive failure and what steps to take if they suspect an issue.",
    "annotation": "\u2013 Contraceptive Counseling: Patient received counseling on the proper use and effectiveness of their chosen contraceptive method.\n\u2013 Patient Concerns: Addressed any concerns or questions the patient had about their contraceptive method. \n\u2013 Adherence Check: Confirmed that the patient is using their contraceptive method consistently and correctly. \n\u2013 Routine Follow-Up: Scheduled a follow-up visit to monitor contraceptive use. \n\u2013 Education Provided: Educated the patient on signs of contraceptive failure and necessary actions if an issue arises.",
    "action_key": 974
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "\u2013 Counsel on IUD Use: Ensure the patient understands how to use their Copper-bearing intrauterine device (Cu-IUD) properly. \n\u2013 Confirm Insertion: Confirm that the Cu-IUD was inserted correctly if it was placed after the miscarriage or abortion. \n\u2013 Assess for Complications: Check for any signs of complications related to the Cu-IUD insertion. \n\u2013 Monitor Symptoms: Monitor the patient for any symptoms of infection or other issues related to the Cu-IUD. \n\u2013 Schedule Follow-Up: Arrange a follow-up visit to reassess the patient's condition and the placement of the Cu-IUD.",
    "annotation": "If the client has had a miscarriage or abortion in the past 12 days, it can reasonably be assumed that she is not pregnant. If the client is planning to use a Cu-IUD, the 7-day window for ruling out pregnancy is extended to 12 days.",
    "action_key": 975
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "\u2013 Verify IUD Placement: Ensure that the Copper-bearing intrauterine device (Cu-IUD) is correctly placed and functioning.\n\u2013 Provide Contraceptive Counseling: Review and confirm the patient\u2019s understanding of how the Cu-IUD works and its effectiveness.\n\u2013 Assess Patient Symptoms: Check for any symptoms of discomfort or complications related to the Cu-IUD. \n\u2013 Schedule Routine Check-Up: Arrange for routine follow-up visits to monitor the position and effectiveness of the Cu-IUDt",
    "annotation": "IUD Placement Verification: Confirmed that the Copper-bearing intrauterine device (Cu-IUD) is properly placed. Contraceptive Counseling: Patient received information on the use and effectiveness of the Cu-IUD. Symptom Assessment: Evaluated the patient for any discomfort or potential complications related to the Cu-IUD. Follow-Up Scheduling: Scheduled routine check-ups to ensure ongoing effectiveness and proper placement of the Cu-IUD",
    "action_key": 976
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Last menstrual bleeding started within the past 7 days",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Abstained from sexual intercourse since last normal menses, delivery, miscarriage or abortion",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Gave birth in the last 4 weeks",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Consistently and correctly using reliable contraceptive method",
        "operator": "!="
      }
    ],
    "action": "FP.C5. Perform pregnancy test",
    "annotation": "If the client answered \"No\" to any of the questions, pregnancy cannot be ruled out using the pregnancy checklist. A pregnancy test is recommended to confirm. Depending on the test sensitivity, a follow-up appointment may be needed. Provide condoms or advise abstinence until the test is performed.\nDepending on the sensitivity of the pregnancy test, the client might have to come back for a follow-up appointment. It is recommended that you provide the client with condoms or that she abstain from sexual intercourse in the interim.",
    "action_key": 977
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "!="
      }
    ],
    "action": "\u2013 Confirm Contraceptive Method: Ensure that the chosen contraceptive method is appropriate and properly used by the patient. \n\u2013 Evaluate Contraceptive Use: Review the patient\u2019s adherence to the chosen contraceptive method and its effectiveness. \n\u2013 Provide Education: Offer information about the selected contraceptive method, including its effectiveness and what to do if there are any concerns.",
    "annotation": "\u2013 Contraceptive Method Confirmation: Verified that the patient\u2019s chosen method is not a Copper-bearing intrauterine device (Cu-IUD). \u2013 Adherence and Effectiveness: Assessed the patient\u2019s use and effectiveness of the chosen contraceptive method. \u2013 Patient Education: Provided information about the selected contraceptive method and addressed any questions or concerns.",
    "action_key": 978
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Last menstrual bleeding started within the past 7 days",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Abstained from sexual intercourse since last normal menses, delivery, miscarriage or abortion",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Gave birth in the last 4 weeks",
        "operator": "!="
      },
      {
        "key": "DAK, Reason for being certain",
        "value": "DAK, Consistently and correctly using reliable contraceptive method",
        "operator": "!="
      }
    ],
    "action": "\u2013 Review Contraceptive Use: Assess the patient\u2019s use of the Copper-bearing intrauterine device (Cu-IUD) and ensure it is properly placed and functioning.\n\u2013  Investigate Symptoms: Conduct a thorough evaluation to understand any symptoms or issues the patient may be experiencing. \n\u2013  Evaluate Menstrual and Sexual History: Review the patient\u2019s menstrual history and sexual activity to determine if there are any factors affecting the contraceptive effectiveness.",
    "annotation": "If the client plans to use a Cu-IUD, the 7-day window is extended to 12 days. If the client answers \"No\" to any of the questions, pregnancy cannot be ruled out using the checklist. A pregnancy test is recommended to confirm. Follow-up may be needed based on the test sensitivity. Provide condoms or advise abstinence until the test is performed.                                                                   Depending on the sensitivity of the pregnancy test, the client might have to come back for a follow-up appointment. It is recommended that you provide the client with condoms or that she abstain from sexual intercourse in the interim.",
    "action_key": 979
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "\u2013 Confirm Contraceptive Effectiveness: Verify that the Copper-bearing intrauterine device (Cu-IUD) is correctly positioned and functioning properly. \n\u2013 Monitor for Any Symptoms: Check for any potential symptoms or issues that might suggest contraceptive failure or other underlying problems. \n\u2013 Review Patient's Menstrual History: Ensure that the absence of missed or late menses is consistent with the effectiveness of the chosen contraceptive method.",
    "annotation": "\u2013 Contraceptive Method: Confirmed the use of Copper-bearing intrauterine device (Cu-IUD) as the chosen method.\n\u2013 Menstrual Status: No missed or late menses reported, indicating that the menstrual cycle is regular or consistent with the use of the Cu-IUD.",
    "action_key": 980
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "\u2013 Perform Pregnancy Test: Conduct a pregnancy test to rule out the possibility of pregnancy.\n\u2013 Evaluate Cu-IUD Position: Ensure that the Copper-bearing intrauterine device (Cu-IUD) is in the correct position through physical examination or imaging, if necessary.\n\u2013 Review Medical History: Discuss any recent changes in health, medications, or lifestyle that could affect menstrual cycles.\n\u2013 Provide Counseling: Offer counseling on what to expect with Cu-IUD usage and potential reasons for missed or late menses.",
    "annotation": "If the client presents with a late/missed menses, use a pregnancy test to rule out pregnancy.",
    "action_key": 981
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Pregnant",
        "operator": "="
      }
    ],
    "action": "Refer to antenatal care (ANC) services",
    "annotation": "Client is pregnant, refer her to receive antenatal care (ANC) services",
    "action_key": 982
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Pregnant",
        "operator": "="
      }
    ],
    "action": "\u2013 Confirm Pregnancy: Verify the positive pregnancy test result with a second test if necessary.\n\u2013 Provide Counseling: Offer counseling on the available options, including continuation of the pregnancy, prenatal care, or other alternatives based on the patient's circumstances and wishes. \n\u2013 Refer to Prenatal Care: If the patient chooses to continue the pregnancy, refer her to appropriate prenatal care services. \n\u2013 Discuss Contraceptive \n\u2013 Use: Review the patient's contraceptive use and discuss why it may have failed, offering guidance on future contraceptive options post-pregnancy.",
    "annotation": "\u2013 Menstrual Status: The patient does not report missed or late menses. \n\u2013 Pregnancy Status: A positive pregnancy test confirms that the patient is pregnant. \n\u2013 Counseling Provided: The patient was counseled on options and next steps after confirming the pregnancy. \n\u2013 Referral: The patient was referred to prenatal care services for further management.",
    "action_key": 983
  },
  {
    "conditions": [
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "FP.C6. Get informed consent",
    "annotation": "Client is not pregnant, continue to provide family planning services",
    "action_key": 984
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "\u2013 Rule Out Pregnancy: Confirm the negative pregnancy test result. \n\u2013 Assess Menstrual Cycle: Evaluate the patient's menstrual history and any possible reasons for the absence of missed or late menses despite negative pregnancy. \n\u2013 Investigate Other Causes: Look into other potential causes for the symptoms or concerns the patient has, such as hormonal imbalances, stress, or underlying health issues. \n\u2013 Provide Guidance: Offer advice on maintaining a healthy menstrual cycle and discuss any lifestyle changes or medical follow-ups that may be needed",
    "annotation": "\u2013 Menstrual Status: The patient does not report missed or late menses. \n\u2013 Pregnancy Status: A negative pregnancy test confirms that the patient is not pregnant. \n\u2013 Further Evaluation: The patient was evaluated for other possible causes of their symptoms or concerns. \n\u2013 Advice Given: Guidance was provided on maintaining menstrual health and any necessary follow-ups were discussed.",
    "action_key": 985
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test sensitivity",
        "value": "DAK, 25 mIU/ml (depends on local setting)",
        "operator": "="
      }
    ],
    "action": "\u2013 Confirm Negative Pregnancy Test: Reaffirm the negative pregnancy test result and its sensitivity.\n\u2013 Re-Evaluate Pregnancy Possibility: Discuss the timing of the test relative to the menstrual cycle. Consider repeating the test in a week if menses still do not occur.\n\u2013 Investigate Other Causes: Assess for other potential causes of missed or late menses, such as hormonal imbalances, stress, thyroid issues, or other health conditions.\n\u2013 Counseling: Provide counseling on what steps to take next and when to seek further medical evaluation if the issue persists.",
    "annotation": "If using a highly sensitive pregnancy test (e.g. 25 mIU/ml) and it is negative, provide her desired contraceptive method",
    "action_key": 986
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test sensitivity",
        "value": "DAK, 50 mIU/ml (depends on local setting)",
        "operator": "="
      }
    ],
    "action": "Schedule follow-up visit = \"Visit date\" + 10 days",
    "annotation": "If a lower sensitivity pregnancy test is negative during the missed period, wait at least 10 days after the expected date of menses to repeat the test. Advise condom use or abstinence meantime . If the test remains negative, provide the desired  method.",
    "action_key": 987
  },
  {
    "conditions": [
      {
        "key": "DAK, Missed or late menses",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test sensitivity",
        "value": "DAK, UNKNOWN (depends on local setting)",
        "operator": "="
      }
    ],
    "action": "",
    "annotation": "If an unknown sensitivity pregnancy test is negative during the missed period, wait at least 10 days after the expected date of menses to repeat the test. Advise condom use or abstinence meantime. If the test remains negative, provide the desired method.",
    "action_key": 988
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STI risk assessment: medical history and physical examination available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\u2013 Perform a pelvic/genital examination\n\u2013 Conduct an STI risk assessment (if not already conducted during counselling)\n\u2013 If available, perform haemoglobin test and/or STI/HIV screening: laboratory test",
    "annotation": "\u2013 In healthy women, the only examinations and tests that are essential and mandatory before IUD insertion are a pelvic/genital examination and STI risk assessment. \n\u2013 A \"Pelvic/genital examination\" and \"STI risk assessment: medical history and physical examination\" are Class A: Essential and mandatory in all circumstances for safe and effective use of the contraceptive method. \n\u2013 \"STI/HIV screening: laboratory tests\" and \"Haemoglobin test\" are Class B: The examination or test contributes substantially to safe and effective use, but implementation may be considered within the public health and/or service context. The risk of not performing the examination or test should be balanced against the benefits of making the contraceptive method available, i.e. they contribute substantially to safe and effective use.",
    "action_key": 989
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "\u2013 Perform a pelvic/genital examination",
    "annotation": "\u2013 A \"Pelvic/genital examination\" is Class A: Essential and mandatory in all circumstances for safe and effective use of the contraceptive method. \n\u2013 \"Blood pressure screening\" is Class C: The examination or test does not contribute substantially to safe and effective use of the contraceptive method; for procedures performed using only local anaesthesia.",
    "action_key": 990
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Blood pressure measurement available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\u2013 Perform a pelvic/genital examination\n\u2013 measure  blood pressure \n\u2013 If available, perform haemoglobin test",
    "annotation": "\u2013 A \"Pelvic/genital examination\" and \"Blood pressure measurment   are Class A: Essential and mandatory in all circumstances for safe and effective use of the contraceptive method. \n\u2013 \"Haemoglobin test\" is Class B: The examination or test contributes substantially to safe and effective use, but implementation may be considered within the public health and/or service context. The risk of not performing the examination or test should be balanced against the benefits of making the contraceptive method available, contributes substantially to safe and effective use.",
    "action_key": 991
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Blood pressure screening available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "-Measure Blood Presure",
    "annotation": "\u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "action_key": 992
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Blood pressure measurement available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "-Measure Blood Presure",
    "annotation": "\u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "action_key": 993
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Blood pressure measurement available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "-Measure Blood Presure",
    "annotation": "\u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "action_key": 994
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Blood pressure measurement available",
        "value": true,
        "operator": "="
      }
    ],
    "action": "-Measure Blood Presure",
    "annotation": "\u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "action_key": 995
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms"
        ],
        "operator": "OR"
      }
    ],
    "action": "-Measure Blood Presure",
    "annotation": "\u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "action_key": 996
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation, not just during menstruation",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant\n- pregnancy is ruled out by check list and also pregancy test.",
    "action_key": 997
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at  the time of consultation if it is reasonably certain that she is not pregnant",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant\n if pregnancy is ruled out by check list and also pregancy test.",
    "action_key": 998
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that she is not pregnant",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation  pregnancy is ruled out by check list and also pregancy test.)",
    "actiosn_key": 1132,
    "action_key": 999
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that she is not pregnant",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation  pregnancy is ruled out by check list and also pregancy test.)",
    "actiosn_key": 1132,
    "action_key": 999
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if \nit is reasonably certain that she is not pregnant",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation (pregnancy is ruled out by check list and also pregancy test.)",
    "action_key": 1000
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if \nit is reasonably certain that she is not pregnant",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation (pregnancy is ruled out by check list and also pregancy test.)",
    "action_key": 1000
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that she is not pregnant",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation   (pregnancy is ruled out by check list and also pregancy test.)",
    "action_key": 1001
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that she is not pregnant",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation   (pregnancy is ruled out by check list and also pregancy test.)",
    "action_key": 1001
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 2,
        "operator": "<="
      }
    ],
    "action": "\u2013 Within 48 hours after delivery: a Cu-IUD can be inserted, including immediately after delivery of the placenta.\n\u2013 If the delivery is by caesarean section, the Cu-IUD can be placed after delivery of the placenta, before closing the uterus.",
    "annotation": "\u2013 Within 48 hours after delivery: a Cu-IUD can be inserted, including immediately after delivery of the placenta.\n\u2013 If the delivery is by caesarean section, the Cu-IUD can be placed after delivery of the placenta, before closing the uterus.",
    "action_key": 1002
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since deliver",
        "value": 28,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 If the IUD is not inserted within the first 48 hours and her monthly bleeding has not returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving birth.",
    "action_key": 1003
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since deliver",
        "value": 28,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 If the IUD is not inserted within the first 48 hours and her monthly bleeding has not returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving birth.",
    "action_key": 1003
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since deliver",
        "value": 28,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.",
    "annotation": "\u2013 A Cu-IUD can be inserted (pregnancy is ruled out by check list and also pregancy test.) No additional contraceptive protection is needed.",
    "action_key": 1004
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since deliver",
        "value": 28,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.",
    "annotation": "\u2013 A Cu-IUD can be inserted (pregnancy is ruled out by check list and also pregancy test.) No additional contraceptive protection is needed.",
    "action_key": 1004
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": "<="
      }
    ],
    "action": "A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.",
    "action_key": 1005
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": "<="
      }
    ],
    "action": "A Cu-IUD can be inserted immediately after a second-trimester abortion or miscarriage if no infection is present",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a second-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.",
    "action_key": 1006
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "A Cu-IUD can be inserted any time after a first-trimester abortion or miscarriage if no infection is present and it is reasonably certain she is not pregnant",
    "annotation": "\u2013 A Cu-IUD can be inserted any time after a first-trimester abortion or miscarriage if no infection is present and (pregnancy is ruled out by check list and also pregancy test.)\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.",
    "action_key": 1007
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted any time after a first-trimester abortion or miscarriage if no infection is present and it is reasonably certain she is not pregnant",
    "annotation": "\u2013 A Cu-IUD can be inserted any time after a first-trimester abortion or miscarriage if no infection is present and (pregnancy is ruled out by check list and also pregancy test.)\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.",
    "action_key": 1007
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "To be considered--Method to be provided by a provider with specific training.",
    "annotation": "Cu-IUD insertion after a second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion.",
    "action_key": 1008
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "To be considered--Method to be provided by a provider with specific training.",
    "annotation": "Cu-IUD insertion after a second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion.",
    "action_key": 1008
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period",
    "annotation": "\u2013 For a client switching from another method, a Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1009
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "A Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period",
    "annotation": "\u2013 For a client switching from another method, a Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1009
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Days since unprotected sex",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "A Cu-IUD can be inserted within 5 days of unprotected intercourse as an emergency contraceptive",
    "annotation": "\u2013 A Cu-IUD can be inserted within 5 days of unprotected intercourse as an emergency contraceptive.\n\u2013 Women who use the Cu-IUD for emergency contraception should be medically eligible for the insertion.",
    "action_key": 1010
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Days since unprotected sex",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "When the time of ovulation can be estimated, a Cu-IUD can be inserted beyond 5 days after intercourse, as long as insertion does not occur more than 5 days after ovulation. \nWomen who use a Cu-IUD for emergency contraception should be medically eligible for the insertion.",
    "annotation": "When the time of ovulation can be estimated, a Cu-IUD can be inserted beyond 5 days after intercourse, as long as insertion does not occur more than 5 days after ovulation. \nWomen who use the Cu-IUD for emergency contraception should be medically eligible for the insertion.",
    "action_key": 1011
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      }
    ],
    "action": "Provide method the same day on which the ECPs are taken",
    "annotation": "The Cu-IUD can be inserted on the same day that the client takes the ECPs (progestin-only, combined or ulipristal acetate EDPs)",
    "action_key": 1012
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Puerperal sepsis postpartum",
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "Women who have puerperal sepsis should not have a Cu-IUD inserted (medical eligibility category 4).\nNote that the chosen method should not have been chosen given the client's health conditions \u2013 counsel and discuss alternative options.",
    "action_key": 1013
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "A Cu-IUD should not be inserted immediately following septic abortion (medical eligibility category 4)\nCounsel and discuss alternative options.",
    "action_key": 1014
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 28,
        "maxValue": 42,
        "operator": "beyond, <=, >="
      }
    ],
    "action": "Delay until 4 weeks or more after delivery.",
    "annotation": "48 hours to less than 4 weeks postpartum: use of Cu-IUDs is not usually recommended unless other more appropriate methods are not available or not acceptable (medical eligibility category 3)",
    "action_key": 1015
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 An implant can generally inserted less than 6 weeks postpartum",
    "action_key": 1016
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": "DAK, Partially breastfeeding",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if pregnancy is ruled out",
    "annotation": "\u2013An implant can be inserted at the time of consultation if pregnancy is ruled out by check list and also pregancy test.",
    "action_key": 1017
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "beyound, <=,>="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding,",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 6 weeks to 6 months postpartum and amenorrhoeic: an implant can be inserted",
    "action_key": 1018
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation",
    "action_key": 1019
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": "42",
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 The implant can be inserted as  at the time of consultation, not just during menstruation",
    "action_key": 1020
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": "21",
        "operator": "<"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 An implant can be inserted at the woman's convenience 21 days  postpartum.\n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum.",
    "action_key": 1021
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": "21",
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation",
    "action_key": 1022
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 The implant can be inserted immediately post-abortion/miscarriage",
    "action_key": 1023
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if pregnancy is  (pregnancy is ruled out by check list and also pregancy test) , the implant can be inserted immediately; there is no need to wait for her next menstrual period",
    "action_key": 1024
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)"
        ],
        "operator": "OR"
      },
     
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if pregnancy is  (pregnancy is ruled out by check list and also pregancy test) , the implant can be inserted immediately; there is no need to wait for her next menstrual period",
    "action_key": 1024
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD); the implant can be inserted immediately  there is no need to wait for her next menstrual period",
    "action_key": 1025
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Insert implant at the time of consultation and remove IUD",
    "annotation": "\u2013 If the client is switching from an IUD (including the Cu-IUD within 7 days after the start of menstrual bleeding: an implant can be inserted. The IUD can be removed at that time.",
    "action_key": 1026
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. Provide backup method for 7 days.",
    "action_key": 1027
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. Provide backup method for 7 days.",
    "action_key": 1027
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 The implant can be inserted at any time if pregnancy can be ruled out by checklist and pregnacy test \u2013 Provide back-up method.\n.",
    "action_key": 1028
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 The implant can be inserted at any time if pregnancy can be ruled out by checklist and pregnacy test \u2013 Provide back-up method.\n.",
    "action_key": 1028
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted  at the time of consultation if pregnancy can be ruled out by checklist and pregnacy test",
    "action_key": 1029
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted  at the time of consultation if pregnancy can be ruled out by checklist and pregnacy test",
    "action_key": 1029
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 An implant can be inserted  if pregnancy can be ruled out by checklist and pregnacy test",
    "action_key": 1030
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 An implant can be inserted  if pregnancy can be ruled out by checklist and pregnacy test",
    "action_key": 1030
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if pregnancy can be ruled out by checklist or pregnancy test",
    "action_key": 1031
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if pregnancy can be ruled out by checklist or pregnancy test",
    "action_key": 1031
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular  bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 If the client is switching from an IUD (including Cu-IUD); the implant can be inserted at any time if it can be determined that the woman is not pregnant.                                                                     Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1032
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular  bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 If the client is switching from an IUD (including Cu-IUD); the implant can be inserted at any time if it can be determined that the woman is not pregnant.                                                                     Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1032
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation  (pregnancy is ruled out by check list and also pregancy test)  certain she is not pregnant.  Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1033
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 The implant can be inserted at the time of consultation  (pregnancy is ruled out by check list and also pregancy test)  certain she is not pregnant.  Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1033
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultationcertain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD); the implant can be inserted immediately i (pregnancy is ruled out by check list and also pregancy test)  the woman is not pregnant; there is no need to wait for her next menstrual period Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1034
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultationcertain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD); the implant can be inserted immediately i (pregnancy is ruled out by check list and also pregancy test)  the woman is not pregnant; there is no need to wait for her next menstrual period Provide back-up method for 7 days. I.e\n\u2013 Client must abstain from sex or use barrier methods or witdrawal method for the next 7 days.",
    "action_key": 1034
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\u2013 Insert implant at the time of consultation if reasonably certain she is not pregnant. \n\u2013 Remove IUD at the time of client's next menstrual period.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and  (pregnancy is ruled out by check list and also pregancy test) , the implant can be inserted.\n\u2013 Sexually active with IUD: If more than 7 days since the start of menstrual bleeding, remove IUD at next menstrual period.",
    "action_key": 1035
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "\u2013 Insert implant at the time of consultation if reasonably certain she is not pregnant. \n\u2013 Remove IUD at the time of client's next menstrual period.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and  (pregnancy is ruled out by check list and also pregancy test) , the implant can be inserted.\n\u2013 Sexually active with IUD: If more than 7 days since the start of menstrual bleeding, remove IUD at next menstrual period.",
    "action_key": 1035
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method. If the back-up method is the current IUD, the IUD should be removed at the time of client's next menstrual period. Otherwise remove IUD at the time of consultation.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and \n\u2013 Not sexually active . since the last day of her mensus either keep the IUD and remove at next menustral period or remove the IUD immediately and use a backup method for 7 days,",
    "action_key": 1036
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if reasonably certain she is not pregnant. Provide back-up method. If the back-up method is the current IUD, the IUD should be removed at the time of client's next menstrual period. Otherwise remove IUD at the time of consultation.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and \n\u2013 Not sexually active . since the last day of her mensus either keep the IUD and remove at next menustral period or remove the IUD immediately and use a backup method for 7 days,",
    "action_key": 1036
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "OR FP.C.14. Schedule follow-up visit\n\u2013 Provide implant on the same day as the client takes ECPs if they are combined or progestin-only pills. Also provide a back-up method.",
    "annotation": "\u2013 After progestin-only or combined ECPs: Implants can be inserted on the same day or at any time if reasonably certain she is not pregnant.                                                 Also provide a back-up method.",
    "action_key": 1037
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide method at the time in which the repeat injection would have been given",
    "annotation": "\u2013 If the client is switching from a hormonal injectable contraceptive, the implant should be inserted when the repeat injection would have been given.\n Back-up contraception is not needed.",
    "action_key": 1038
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42.0,
        "maxValue": 180.0,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given at the time of consultation",
    "action_key": 1039
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 49.0,
        "maxValue": 180.0,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding,",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given. If the woman is fully or nearly fully breastfeeding, no additional contraceptive protection is needed.",
    "action_key": 1040
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21.0,
        "operator": "<"
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given. \n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.",
    "action_key": 1041
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)",
          "DAK, Etonogestrel (ETG) one-rod"
        ],
        "operator": "OR"
      }
    ],
    "action": "Insert implant at the time of consultation",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the first injection can be given immediately; there is no need to wait for her next menstrual period",
    "action_key": 1042
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide method at the time in which the repeat injection would have been given",
    "annotation": "\u2013 If the client is switching from another, different, hormonal injectable contraceptive, the injection can be given when the repeat injection would have been given",
    "action_key": 1043
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given at the time of consultation, not just during menstruation",
    "action_key": 1044
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 294,
        "operator": ">"
      },
      {
        "key": " DAK, Amenorrhoea",
        "value": false,
        "operator": ">"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation",
    "action_key": 1045
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": " DAK, Amenorrhoea",
        "value": false,
        "operator": ">"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation",
    "action_key": 1046
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 The first injection can be given immediately post-abortion/miscarriage",
    "action_key": 1047
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB),",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1048
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB),",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1048
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide first injection at the time of consultation and remove IUD",
    "annotation": "\u2013 If the client is switching from an IUD (including Cu-IUD or LNG-IUD) within 7 days after the start of menstrual bleeding: the first injection can be given. The IUD can be removed at that time.",
    "action_key": 1049
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1050
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1050
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given at any time if it is reasonably certain that the woman is not pregnant. She will need to abstain from sex or use additional contraceptive protection for the following 7 days.",
    "action_key": 1051
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given at any time if it is reasonably certain that the woman is not pregnant. She will need to abstain from sex or use additional contraceptive protection for the following 7 days.",
    "action_key": 1051
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42.0,
        "maxValue": 180.0,
        "operator": "between, >, <"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1052
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42.0,
        "maxValue": 180.0,
        "operator": "between, >, <"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1052
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "values": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given if it is reasonably certain that the woman is not pregnant",
    "action_key": 1053
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "values": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given if it is reasonably certain that the woman is not pregnant",
    "action_key": 1053
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1054
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant",
    "action_key": 1054
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1055
  },

  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method.",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period",
    "action_key": 1055
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method. Remove IUD at time of first injection.",
    "annotation": "\u2013 If the client is switching from an IUD (including Cu-IUD, LNG-IUD), the first injection can be given at any time if it is reasonably certain that the woman is not pregnant",
    "action_key": 1056
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service if reasonably certain she is not pregnant. Provide back-up method. Remove IUD at time of first injection.",
    "annotation": "\u2013 If the client is switching from an IUD (including Cu-IUD, LNG-IUD), the first injection can be given at any time if it is reasonably certain that the woman is not pregnant",
    "action_key": 1056
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Provide injection at the time of consultation or at a time convenient for the client at a later date through an appropriate service. Provide back-up method.",
    "annotation": "\u2013 The first injection can be given immediately post-abortion",
    "action_key": 1057
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation if reasonably certain she is not pregnant. \nRemove IUD at the time of client's next menstrual period.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and reasonably certain not pregnant, the implant can be inserted.\n\u2013 Sexually active with IUD: If more than 7 days since the start of menstrual bleeding, remove IUD at next menstrual period.",
    "action_key": 1058
  },

  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation if reasonably certain she is not pregnant. \nRemove IUD at the time of client's next menstrual period.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and reasonably certain not pregnant, the implant can be inserted.\n\u2013 Sexually active with IUD: If more than 7 days since the start of menstrual bleeding, remove IUD at next menstrual period.",
    "action_key": 1058
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation if reasonably certain she is not pregnant. Provide back-up method. If the back-up method is the current IUD, the IUD should be removed at the time of client's next menstrual period. Otherwise remove IUD at the time of consultation.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and reasonably certain not pregnant, the implant can be inserted.\n\u2013 Not sexually active with IUD: If more than 7 days since the start of menstrual bleeding, she should abstain from sex or use additional contraceptive protection for the next 7 days. If using the IUD for additional protection, remove it at the next menstrual period.",
    "action_key": 1059
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide first injection at the time of consultation if reasonably certain she is not pregnant. Provide back-up method. If the back-up method is the current IUD, the IUD should be removed at the time of client's next menstrual period. Otherwise remove IUD at the time of consultation.",
    "annotation": "\u2013 Switching from an IUD: If more than 7 days since the start of menstrual bleeding and reasonably certain not pregnant, the implant can be inserted.\n\u2013 Not sexually active with IUD: If more than 7 days since the start of menstrual bleeding, she should abstain from sex or use additional contraceptive protection for the next 7 days. If using the IUD for additional protection, remove it at the next menstrual period.",
    "action_key": 1059
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "OR FP.C.14. Schedule follow-up visit\n\u2013 Provide injection on the same day as the client takes ECPs if they are combined or progestin-only pills. Also provide a back-up method.\n\u2013 If the client took a ulipristal acetate (UPA) ECP, then wait to provide the injection on the 6th day or later after taking UPA ECP. In this case also schedule follow-up appointment to receive the injection.",
    "annotation": "\u2013 After progestin-only or combined ECPs: Implants can be inserted on the same day or at any time if reasonably certain she is not pregnant.\n\u2013 After ulipristal acetate ECPs: Implants can be inserted on the 6th day after taking the ECPs, no need to wait for the next monthly bleeding. Be cautious of interactions between implants and UPA.",
    "action_key": 1060
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "Less than 6 weeks postpartum and primarily breastfeeding: use of injections is not usually recommended unless other more appropriate methods are not available or not acceptable (medical eligibility category 3).",
    "action_key": 1061
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": "DAK, Partially breastfeeding",
        "operator": "="
      }
    ],
    "action": "Method should be delayed until at least 6 weeks after giving birth. \nSchedule follow-up visit and/or counsel for alternative methods.",
    "annotation": "For women less than 6 weeks after giving birth who are only partially breastfeeding: delay first injection",
    "action_key": 1062
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated. Provide as many packs as possible pack even up to 1 year's supply  with appropriate instructions on initiation",
    "action_key": 1063
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Has client given birth in the last six months",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).",
    "action_key": 1064
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding,",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic:  POPs can generally be initiated (medical eligibility category 2).",
    "action_key": 1065
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days of the start of menstrual bleeding: POPs can be initiated.",
    "action_key": 1066
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 21,
        "operator": "<"
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 21 days postpartum: POPs can be initiated. No additional contraceptive protection is needed. It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum.",
    "action_key": 1067
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated.",
    "action_key": 1068
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.",
    "action_key": 1069
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)",
          "DAK, Etonogestrel (ETG) one-rod"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from another hormonal method: POPs can be initiated immediately if the woman has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant; there is no need to wait for her next menstrual period.",
    "action_key": 1070
  },

  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)",
          "DAK, Etonogestrel (ETG) one-rod"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from another hormonal method: POPs can be initiated immediately if the woman has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant; there is no need to wait for her next menstrual period.",
    "action_key": 1070
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 If the woman\u2019s previous method was an injectable contraceptive, POPs can be initiated when the repeat injection would have been given",
    "action_key": 1071
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. No additional contraceptive protection is needed.",
    "action_key": 1072
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine devices (Cu-IUDs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide up to 1 year's supply of POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD  within 5 days after the start of menstrual bleeding: POPs can be initiated. The IUD can be removed at that time.",
    "action_key": 1073
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).",
    "action_key": 1074
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic: POPs can generally be initiated (medical eligibility category 2).",
    "action_key": 1075
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated at any time",
    "action_key": 1076
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated at any time",
    "action_key": 1076
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1077
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1077
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 21,
        "operator": ">"
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 21 or more days postpartum and menstrual cycles have not returned: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1078
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1079
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1079
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.",
    "action_key": 1080
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.",
    "action_key": 1080
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1081
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1081
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "After taking progestin-only or combined ECPs:\n\u2013 She can start or restart POPs immediately after she takes the ECPs. No need to wait for her next monthly bleeding.\n\u2013 A continuing user who needed ECPs due to pill-taking errors can continue where she left off with her current pack.\n\u2013 If she does not start immediately, but returns for POPs, she can start at any time if it is reasonably certain she is not pregnant.\nAfter taking ulipristal acetate (UPA) ECPs:\n\u2013 She can start or restart POPs on the 6th day after taking UPA ECPs. No need to wait for her next monthly bleeding. POPs and UPA interact. If POPs are started sooner, and thus both are present in the body, one or both may be less effective.\n\u2013 Give her a supply of pills and tell her to start them on the 6th day after taking the UPA ECPs.",
    "action_key": 1082
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply  POPs with appropriate instructions on initiation.\nRemove IUD at the time of her next menstrual period.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including the LNG-IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 If she is also sexually active in this menstrual cycle: it is recommended that the IUD be removed at the time of her next menstrual period.",
    "action_key": 1083
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply  POPs with appropriate instructions on initiation.\nRemove IUD at the time of her next menstrual period.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including the LNG-IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 If she is also sexually active in this menstrual cycle: it is recommended that the IUD be removed at the time of her next menstrual period.",
    "action_key": 1083
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply  POPs with appropriate instructions on initiation.\nRemove IUD and provide back-up method OR Remove IUD at the time of her next menstrual period.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including the LNG-IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1084
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply  POPs with appropriate instructions on initiation.\nRemove IUD and provide back-up method OR Remove IUD at the time of her next menstrual period.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including the LNG-IUD) more than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1084
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1085
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1085
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation.\nProvide back-up method.\nRemove IUD.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 If the woman is amenorrhoeic or has irregular bleeding, POPs can be initiated as advised for other amenorrhoeic women.\n\u2013 POPs can be initiated at any time.",
    "action_key": 1086
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply POPs with appropriate instructions on initiation.\nProvide back-up method.\nRemove IUD.",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 If the woman is amenorrhoeic or has irregular bleeding, POPs can be initiated as advised for other amenorrhoeic women.\n\u2013 POPs can be initiated at any time.",
    "action_key": 1086
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days of the start of menstrual bleeding COCs,  can be initiated.",
    "action_key": 1087
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 months postpartum and menstrual cycles have returned: COCs, can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days of the start of menstrual bleeding: COCs, can be initiated. No additional contraceptive protection is needed.",
    "action_key": 1088
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 21 or more days postpartum: for women with no other risk factors for venous thromboembolism (VTE), COCs,  can generally be initiated (medical eligibility category 2).\n\u2013 Client can start COCs at any time on days 21\u201328 after giving birth. Give her pills any time to start during these 7 days. If additional risk for VTE, wait until 6 weeks postpartum.",
    "action_key": 1089
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days after the start of menstrual bleeding: COCs,  can be initiated. No additional contraceptive protection is needed.",
    "action_key": 1090
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs, with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs,  can be initiated immediately post-abortion or miscarriage. No additional contraceptive protection is needed.",
    "action_key": 1091
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1092
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1092
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1092
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1092
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs, with appropriate instructions on initiation",
    "annotation": "\u2013 If a woman\u2019s previous method was an injectable contraceptive, COCs,  should be initiated when the repeat injection would have been given",
    "action_key": 1093
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) within 5 days of the start of menstrual bleeding: COCs,  can be initiated immediately",
    "action_key": 1094
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 Switching from an IUD within 5 days after the start of menstrual bleeding: COCs,  can be initiated. The IUD can be removed at that time.",
    "action_key": 1095
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs, can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1096
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months) supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs, can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1096
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1097
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1097
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 months postpartum and amenorrhoeic: COCs, can be initiated as advised for other amenorrhoeic women.\n\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible.\n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1098
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 months postpartum and amenorrhoeic: COCs, can be initiated as advised for other amenorrhoeic women.\n\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible.\n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1098
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 months postpartum and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1099
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide as much as possible up to 3 packs (for three months)  supply COCs,  with appropriate instructions on initiation",
    "annotation": "\u2013 More than 6 months postpartum and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1099
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Medically eligible and menstrual cycles have not returned: COCs,  can be initiated immediately if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1100
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Medically eligible and menstrual cycles have not returned: COCs,  can be initiated immediately if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1100
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1101
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1101
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a back-up method for the first 7 days of taking pills.",
    "action_key": 1102
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a back-up method for the first 7 days of taking pills.",
    "action_key": 1102
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) more than 5 days since the start of menstrual bleeding: COCs,  can be initiated immediately if it is reasonably certain that the woman is not pregnant",
    "action_key": 1103
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) more than 5 days since the start of menstrual bleeding: COCs,  can be initiated immediately if it is reasonably certain that the woman is not pregnant",
    "action_key": 1103
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation. Provide back-up method.",
    "annotation": "\u2013 After taking progestin-only or combined ECPs: client can start or restart COCs immediately after she takes the ECPs. No need to wait for her next monthly bleeding. A continuing user who needed ECPs due to pill-taking errors can continue where she left off with her current pack. If she does not start immediately but returns for COCs, she can start at any time if it is reasonably certain she is not pregnant.",
    "action_key": 1104
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs, patches or CVRs with appropriate instructions on initiation. Remove IUD at the time of her next menstrual cycle.",
    "annotation": "\u2013 Switching from an IUD more than 5 days after the start of menstrual bleeding: COCs, the patch and the CVR can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2212 Sexually active in this menstrual cycle: it is recommended that the IUD be removed at the time of her next menstrual period.",
    "action_key": 1105
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs, patches or CVRs with appropriate instructions on initiation. Remove IUD at the time of her next menstrual cycle.",
    "annotation": "\u2013 Switching from an IUD more than 5 days after the start of menstrual bleeding: COCs, the patch and the CVR can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2212 Sexually active in this menstrual cycle: it is recommended that the IUD be removed at the time of her next menstrual period.",
    "action_key": 1105
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation.\nProvide back-up method and remove IUD OR Remove IUD at the time of her next menstrual cycle.",
    "annotation": "\u2013 Switching from an IUD more than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant",
    "action_key": 1106
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation.\nProvide back-up method and remove IUD OR Remove IUD at the time of her next menstrual cycle.",
    "annotation": "\u2013 Switching from an IUD more than 5 days since the start of menstrual bleeding: COCs,  can be initiated if it is reasonably certain that the woman is not pregnant",
    "action_key": 1106
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation.\nProvide back-up method. Remove IUD.",
    "annotation": "\u2013 Switching from an IUD: if the woman is amenorrhoeic or has irregular bleeding, COCs,  can be initiated as advised for other amenorrhoeic women.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1107
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide up to 1 year's supply COCs,  with appropriate instructions on initiation.\nProvide back-up method. Remove IUD.",
    "annotation": "\u2013 Switching from an IUD: if the woman is amenorrhoeic or has irregular bleeding, COCs,  can be initiated as advised for other amenorrhoeic women.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs,  can be initiated if it is reasonably certain that the woman is not pregnant.",
    "action_key": 1107
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options. \nOR\nProvide COCs,  with appropriate instructions on initiation to start 6 weeks after giving birth. Provide back-up method.",
    "annotation": "\u2013 Less than 6 weeks postpartum and primarily breastfeeding: the woman should NOT use COCs,  (medical eligibility category 4)",
    "action_key": 1108
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42.0,
        "maxValue": 180,
        "operator": "between, >, <="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "\u2013 6 weeks to 6 months postpartum and primarily breastfeeding: use of COCs,  is generally not recommended unless other more appropriate methods are not available or not acceptable (medical eligibility category 3)",
    "action_key": 1109
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21.0,
        "operator": "<"
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "\u2013 Less than 21 days postpartum: use of COCs, is generally not recommended unless other more appropriate methods are not available or not acceptable (medical eligibility category 3). \n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum.",
    "action_key": 1110
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Provide pill(s) and guide client to take immediately",
    "annotation": "\u2013 Ideally, combined ECPs should be taken as early as possible after unprotected intercourse, within 120 hours (or 5 days). However, the woman should be advised that the effectiveness of the ECP(s) is reduced the longer the interval between having unprotected intercourse and taking ECP(s).",
    "action_key": 1111
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide and guide client on how to use this method",
    "annotation": "\u2013 She may start LAM at any time if she meets all 3 criteria required for using the method.\n\u2013 Within 6 months after childbirth,if she has been fully or nearly breastfeeding her baby since birth and                                                           -her monthly bleeding has not returned.",
    "action_key": 1112
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180.0,
        "operator": ">"
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "\u2013 the client should not be starting LAM method as the conditions are not met                                                                                                                                                                                        cousel and discuss alternative options.",
    "action_key": 1113
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "'\u2013 If conditions for LAM are not met, the client should not be starting LAM method as the conditions are not met                                                                                                                                                                                        cousel and discuss alternative options.",
    "action_key": 1114
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Method should not be started. Counsel and discuss alternative options.",
    "annotation": "'\u2013 If conditions for LAM are not met, the client should not be starting LAM method as the conditions are not met                                                                                                                                                                                        cousel and discuss alternative options.",
    "action_key": 1115
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Withdrawal",
          "DAK, No method"
        ],
        "operator": "OR"
      }
    ],
    "action": "Provide appropriate supplies and provide guidance on proper use",
    "annotation": "Client can begin using these methods immediately                When used correctly and consistently, condoms offer one of the most effective methods of protection against STIs, including HIV.",
    "action_key": 1116
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      }
    ],
    "action": "",
    "annotation": "\u2013 There are multiple FAB methods, such as calendar-based methods (e.g. Standard Days Method) and symptoms-based methods (e.g. cervical secretions, basal body temperature, TwoDay Method, Ovulation Method, Symptothermal method) \u2013 provide counselling on when to start as appropriate to each of these types of methods",
    "action_key": 1117
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method after counselling",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "Provide procedure when the man requests it, provides informed consent and there is no medical reason to delay. Provide back-up method for 3 months after the procedure.",
    "annotation": "\u2013 Male sterilization, or vasectomy, is a low-risk procedure that involves occlusion of the vas deferens and can be performed in an outpatient setting. Both the no-scalpel and conventional incision procedures are quick, safe and effective.                                                                                                                                                                                            Provide back-up method for 3 months after the procedure.\n\u2013 Sterilization does not protect against sexually transmitted infections (STIs), including HIV. If there is a risk of STI/HIV, the correct and consistent use of condoms is recommended.",
    "action_key": 1118
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method after counselling",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Provide procedure when the woman requests it, provides informed consent and there is no medical reason to delay",
    "annotation": "\u2013 If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where or how the female sterilization procedure should be performed",
    "action_key": 1119
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method after counselling",
        "value": "DAK, Female sterilization",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Provide procedure when the woman requests it, provides informed consent and there is no medical reason to delay",
    "annotation": "\u2013 If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where or how the female sterilization procedure should be performed",
    "action_key": 1119
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection for STIs with male or female condoms",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1120
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection for STIs with male or female condoms",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1121
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection for STIs with male or female condoms",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1121
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1122
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1122
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of previous delivery/Date last birth",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1123
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of previous delivery/Date last birth",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1123
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1124
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1124
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 2,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Within 48 hours of delivery: a Cu-IUD can be inserted, including immediately after delivery of the placenta.\n\u2013 If the delivery is by caesarean section, the Cu-IUD can be placed after delivery of the placenta, before closing the uterus.",
    "action_key": 1125
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 If the IUD is not inserted within the first 48 hours postpartum and her monthly bleeding has not returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving birth.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1126
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 28,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 If the IUD is not inserted within the first 48 hours postpartum and her monthly bleeding has not returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving birth.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1126
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 4.0,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1127
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1128
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a second-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1129
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1130
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1130
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Cu-IUD insertion after a second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion.",
    "action_key": 1131
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 12.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Cu-IUD insertion after a second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion.",
    "action_key": 1131
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 For a client switching from another method, a Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1132
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Keep method?",
        "value": "DAK, Method change",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 For a client switching from another method, a Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1132
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Days since unprotected sex",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted within 5 days of unprotected intercourse as an emergency contraceptive.\n\u2013 Women who use the Cu-IUD for emergency contraception should be medically eligible for the insertion (1).",
    "action_key": 1133
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Days since unprotected sex",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 When the time of ovulation can be estimated, a Cu-IUD can be inserted beyond 5 days after intercourse, as long as insertion does not occur  with in 7 days after ovulation. \n\u2013 Women who use the Cu-IUD for emergency contraception should be medically eligible for the insertion (1).",
    "action_key": 1134
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The Cu-IUD can be inserted on the same day that the client takes the ECPs (progestin-only, combined or ulipristal acetate ECPs). \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1135
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 An implant can generally inserted less than 6 weeks postpartum",
    "action_key": 1136
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >=, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 6 weeks to 6 months postpartum and amenorrhoeic: an implant can be inserted                                    - Breast Feeding soulid Exclusivele and Frequint ( 10-12 times per 24 hrs)",
    "action_key": 1137
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 6 weeks to 6 months postpartum and amenorrhoeic: an implant can be inserted. \n\u2013 Back-up method recommendation: if the woman is fully or nearly fully breastfeeding, no additional contraceptive protection is needed.",
    "action_key": 1138
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1139
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1140
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 An implant can be inserted at the woman's convenience 21 days after postpartum.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.\n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.",
    "action_key": 1141
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1142
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted immediately post-abortion or miscarriage. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1143
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Progesterone-releasing vaginal ring (PVR)",
          "DAK, Combined contraceptive vaginal ring (CVR) provided"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the implant can be inserted immediately; there is no need to wait for her next menstrual period",
    "action_key": 1144
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Progesterone-releasing vaginal ring (PVR)",
          "DAK, Combined contraceptive vaginal ring (CVR) provided"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the implant can be inserted immediately; there is no need to wait for her next menstrual period",
    "action_key": 1144
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation within 7 days of the start of her menstrual bleeding: no additional contraceptive protection is needed.",
    "action_key": 1145
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation within 7 days of the start of her menstrual bleeding: no additional contraceptive protection is needed.",
    "action_key": 1145
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD) within 7 days after the start of menstrual bleeding: an implant can be inserted. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1146
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Copper-bearing intrauterine device (Cu-IUD)",
          "DAK, Levonorgestrel intrauterine device (LNG-IUD)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD) within 7 days after the start of menstrual bleeding: an implant can be inserted. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1146
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain the client is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1147
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain the client is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1147
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at any time if it can be determined that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1148
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at any time if it can be determined that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1148
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1149
  },

  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1149
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 An implant can be inserted if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1150
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 An implant can be inserted if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1150
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1151
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1151
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }

    ],
    "action": "Discuss dual protection and  Back up Method not needed",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the implant can be inserted at any time if it can be determined that the woman is not pregnant. \n\u2013 Back-up method recommendation:  Back up Method not needed",
    "action_key": 1152
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }

    ],
    "action": "Discuss dual protection and  Back up Method not needed",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the implant can be inserted at any time if it can be determined that the woman is not pregnant. \n\u2013 Back-up method recommendation:  Back up Method not needed",
    "action_key": 1152
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1153
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1154
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1154
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 7 days after the start of menstrual bleeding: The implant can be inserted if pregnancy abscence is reasonably certain.\n\u2013 If sexually active and more than 7 days since the start of menstrual bleeding: Remove the IUD at the next menstrual period.\n\u2013 Back-up method  Keep the existing IUD until the next menstrual period for back-up protection.",
    "action_key": 1155
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 7 days after the start of menstrual bleeding: The implant can be inserted if pregnancy abscence is reasonably certain.\n\u2013 If sexually active and more than 7 days since the start of menstrual bleeding: Remove the IUD at the next menstrual period.\n\u2013 Back-up method  Keep the existing IUD until the next menstrual period for back-up protection.",
    "action_key": 1155
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If Switching from IUD more than 7 days after menstrual bleeding: Implant can be inserted if pregnancy is reasonably ruled out.\n\u2013 Not sexually active this cycle and more than 7 days since menstrual bleeding:                \u2013 Abstain from sex or use additional contraception for 7 days. Consider removing IUD at next period.\n\u2013 Back-up method: Abstain or use additional contraception for 7 days, or keep IUD as back-up until next cycle.",
    "action_key": 1156
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Back-up method: Use a back-up method for the first 7 days after receiving the implant.\n\u2013 After taking progestin-only or combined ECPs: Implants can be inserted on the same day as ECPs. If delayed, start at any time if reasonably certain she is not pregnant.\n\u2013 After taking ulipristal acetate (UPA) ECPs: Implants can be inserted on the 6th day after UPA ECPs. No need to wait for next monthly bleeding. Caution regarding interaction with UPA if implanted sooner.",
    "action_key": 1157
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a hormonal injectible contraceptive, the implant should be inserted when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1158
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, From 6 wks of delivery to",
        "value": 6.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given at the time of consultation",
    "action_key": 1159
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, From 6 wks of delivery to",
        "value": 6.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given. If the woman is fully or nearly fully breastfeeding, no additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1160
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21.0,
        "operator": "<"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given. \n\u2013 Back-up method recommedation: no additional contraceptive protection is needed. \n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.",
    "action_key": 1161
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs) OR Combined oral contraceptives (COCs)  OR Levonorgestrel (LNG) two-rod OR Etonogestrel (ETG) one-rod",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the first injection can be given immediately; there is no need to wait for her next menstrual period",
    "action_key": 1162
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another, different, hormonal injectible contraceptive, the injection can be given when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1163
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) OR",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1164
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1165
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1166
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given immediately post-abortion .\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1167
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: within 7 days of the start of her menstrual bleeding, no additional contraceptive protection is needed.",
    "action_key": 1168
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD) within 7 days after the start of menstrual bleeding: the first injection can be given. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1169
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at the time of consultation if it is reasonably certain  is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1170
  },

  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at any time if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1171
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Six months post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 6.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1172
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 21.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1173
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1174
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1175
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the first injection can be given at any time if it is reasonably certain that the woman is not pregnant. \n\u2013 Backup method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1176
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given immediately post-abortion . \n\u2013 Back-up method recommendation: a back-up method is needed for the first 7 days after the injection.",
    "action_key": 1177
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "- Switching from an IUD (Cu-IUD, LNG-IUD) more than 7 days since the start of menstrual bleeding: First injection can be given if reasonably certain she is not pregnant.\n - If sexually active in this menstrual cycle and more than 7 days since the start of menstrual bleeding: It is recommended to remove the IUD at her next menstrual period.\n - Back-up method: Do not remove the existing IUD until the next menstrual period to use it as a back-up method.",
    "action_key": 1178
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from IUD: First injection can be given if reasonably certain the woman is not pregnant.\n\u2013 Not sexually active in this cycle: Abstain from sex or use additional contraceptive protection for the next 7 days. If using IUD as additional protection, remove it at next menstrual period.\n\u2013 Back-up method: Abstain from sex or use additional contraceptive protection for the next 7 days OR keep the IUD in until next menstrual cycle and use it as the back-up method of choice.",
    "action_key": 1179
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) OR Norethisterone enanthate (NET-EN) injected",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Back-up method: Use a back-up method for the first 7 days after receiving the injection.\n\u2013 After taking progestin-only or combined ECPs: Injections can be provided on the same day as ECPs. If delayed, start at any time if certain she is not pregnant.\n\u2013 After taking ulipristal acetate  ECPs: Injections can be inserted on the 6th day after taking UPA ECPs. No need to wait for next monthly bleeding. Caution regarding interaction with UPA if injected sooner.",
    "action_key": 1180
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1181
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding status",
        "value": "DAK, Fully breastfeeding OR Nearly fully breastfeeding OR Exclusive breastfeeding",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed if the woman if fully or nearly fully breastfeeding.",
    "action_key": 1182
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed if the woman if fully or nearly fully breastfeeding.",
    "action_key": 1183
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days of the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1184
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 21.0,
        "operator": "<"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 21 days postpartum: POPs can be initiated. No additional contraceptive protection is needed. It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1185
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1186
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1187
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs) OR Levonorgestrel (LNG) two-rod OR Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from another hormonal method: POPs can be initiated immediately if the woman has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1188
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the woman\u2019s previous method was an injectable contraceptive, POPs can be initiated when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1189
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1190
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including LNG-IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1191
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1192
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1193
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1194
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1195
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 6.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1196
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 21.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 21 or more days postpartum and menstrual cycles have not returned: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1197
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1198
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1199
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) more than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1200
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "After progestin-only or combined emergency contraceptive pills (ECPs):\nClient can start or restart progestin-only pills (POPs) immediately after ECPs, no need to wait for next bleeding.\nContinuing users can continue with their current pack.\nIf not started immediately, she can start POPs at any time if reasonably certain she is not pregnant.\nBack-up method: Use additional contraception for the first 2 days of taking POPs.\n                                                                                                                                                                                                      After ulipristal acetate (UPA) ECPs:\nStart or restart POPs on the 6th day after UPA ECPs, regardless of next bleeding.\nGive a supply of pills and start on the 6th day.\nBack-up method: Use additional contraception until taking POPs for 2 days.\nIf not started on the 6th day, she can start at any time if reasonably certain she is not pregnant.",
    "action_key": 1201
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided in advance to a medically eligible woman with instructions on pill initiation.\n\u2013 Switching from an IUD  more than 5 days after the start of menstrual bleeding: POPs can be initiated if reasonably certain she is not pregnant.\n\u2013 If sexually active in this menstrual cycle,  \n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for the next 2 days OR keep the IUD in until the next menstrual cycle and use it as the back-up method.",
    "action_key": 1202
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided in advance with appropriate instructions for pill initiation, if medically eligible.\n\u2013 Switching from an IUD  more than 5 days after the start of menstrual bleeding: POPs can be initiated if pregnancy is reasonably certain.\n\u2013 If not sexually active in this menstrual cycle: Abstain from sex or use additional method protection for the next 2 days. \n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for the next 2 days OR keep the IUD in until the next menstrual cycle as the preferred back-up method.",
    "action_key": 1203
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 If the woman is amenorrhoeic or has irregular bleeding, POPs can be initiated as advised for other amenorrhoeic women.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1204
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days after the start of menstrual bleeding: COCs.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1205
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery'",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 More than 6 months postpartum and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days of the start of menstrual bleeding: COCs, the patch and the CVR can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1206
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 21 or more days postpartum: for women with no other risk factors for venous thromboembolism (VTE), COCs,  can generally be initiated (medical eligibility category 2).\n\u2013 She can start COCs at any time on days 21\u201328 after giving birth. Give her pills any time to start during these 7 days. If additional risk for VTE, wait until 6 weeks postpartum.\n\u2013 Back-up method recommendation:  Backup Method is needed",
    "action_key": 1207
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days after the start of menstrual bleeding: COCs,  can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1208
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs, can be initiated immediately post-abortion or miscarriage. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1209
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs) OR Combined oral contraceptives (COCs)  OR Levonorgestrel (LNG) two-rod OR Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1210
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Intramuscular depot medroxyprogesterone acetate (DMPA-IM) OR Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If a woman\u2019s previous method was an injectable contraceptive, COCs, should be initiated when the repeat injection would have been given.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1211
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) within 5 days after the start of menstrual bleeding: COCs,  can be initiated immediately. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1212
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Switching from an IUD within 5 days of the start of menstrual bleeding: COCs, can be initiated. The IUD can be removed at that time.\n\u2013 Backup method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1213
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy, More than 5 days after the start of menstrual bleeding.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1214
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1215
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery'",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum and amenorrheic for over 6 months: COCs,  can be initiated following standard guidelines.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, requires reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method n for 7 days after method initiation.",
    "action_key": 1216
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery'",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum with resumed menstrual cycles: COCs,  can be initiated following standard guidelines for women with regular cycles.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, is possible if more than 5 days have passed since the start of menstrual bleeding and there is reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for 7 days after method initiation.",
    "action_key": 1217
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Medically eligible and menstrual cycles have not returned: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1218
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs, can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1219
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a back-up method for the first 7 days of taking pills. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1220
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) more than 5 days from the start of menstrual bleeding: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1221
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 After taking progestin-only or combined ECPs, the client can start or restart COCs immediately, without waiting for the next monthly bleeding.                                                     Back-up contraception is recommended for the first 7 days of taking pills.\n\u2013 After taking ulipristal acetate (UPA) emergency contraceptive pills, the client can start or restart COCs on the 6th day after taking UPA ECPs, without waiting for the next monthly bleeding. It is important to use a back-up method from the time of UPA ECP intake until taking COCs for 7 days.\n\u2013 Back-up method : client will need to use a back-up method from the time she takes the UPA ECPs until she has been taking COCs for 7 days",
    "action_key": 1222
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 If sexually active in this menstrual cycle,  recommended to remove the IUD at the time of the next menstrual period.\n\u2013Back-up method : Keep the IUD in until her next menstrual cycle and use the IUD as her back-up method of choice.",
    "action_key": 1223
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 Back-up method : If not sexually active in this menstrual cycle, abstain from sex or use additional method for the next 7 days. If relying on the IUD for additional protection,  recommended to remove it at the time of the next menstrual period.",
    "action_key": 1224
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD: COCs, can be initiated for amenorrhoeic or irregular bleeding.\n\u2013 Advance provision of COCs, is possible if medically eligible.\n\u2013 COCs, can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method: Abstain from sex or use additional contraception for 7 days from method initiation. Remove the IUD, unless chosen as the back-up method, at the next menstrual period.",
    "action_key": 1225
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Client should take ulipristal acetate (UPA) ECPs, , or combined ECPs as early as possible after unprotected intercourse, ideally within 120 hours (or 5 days).Note that the effectiveness of the ECP(s) decreases with a longer interval between unprotected intercourse and taking the ECP(s).\n\u2013 UPA ECPs may be more effective between 72 hours and 120 hours after unprotected intercourse compared to other ECPs.",
    "action_key": 1226
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) consultation",
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 6.0,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "LAM can be started at any time if the client meets all criteria.\nCriteria for LAM: started breastfeeding immediately or as soon as possible after childbirth, fully or nearly fully breastfeeding since birth, and no return of monthly bleeding. LAM offers a continued method option beyond 6 months.",
    "action_key": 1227
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Male condoms OR Female condoms OR Withdrawal OR No method",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Client can begin using these methods immediately",
    "action_key": 1228
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Fertility awareness-based methods (FAB) consultation",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Various  FAB methods are available, including calendar-based methods (e.g., Standard Days Method) and symptoms-based methods (e.g., cervical secretions, \nProvide detailed counseling on when to start each specific FAB method.\n\u2013 Back-up method recommended on days 8-19 if desired.Consider emergency contraception if appropriate.\n\u2013 FAB methods do not protect against STIs, condom use is advised for STI/HIV protection.",
    "action_key": 1229
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Male sterilization,Vasectomy is a low-risk procedure that can be done in an outpatient setting.procedure is  quick, safe and effective.\n\u2013 Back-up method recommended for three months after vasectomy.During this period, he can resume sexual activity with back_up Method\n'\u2013 Sterilization does not protect against STIs, condom use is advised for STI/HIV protection.",
    "action_key": 1230
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where or how the female sterilization procedure  be performed",
    "action_key": 1231
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection for STIs with male or female condoms",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1232
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 12.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection for STIs with male or female condoms",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1233
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that the client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1234
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 4.0,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1235
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 4.0,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 4 or more weeks postpartum and menstrual cycles have returned: a Cu-IUD can be inserted as advised for other women having menstrual cycles.\n\u2013 A Cu-IUD can be inserted at the time of consultation if it is reasonably certain that client is not pregnant. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1236
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 48.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Within 48 hours of delivery: a Cu-IUD can be inserted, including immediately after delivery of the placenta.\n\u2013 If the delivery is by caesarean section, the Cu-IUD can be placed after delivery of the placenta, before closing the uterus.",
    "action_key": 1237
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 4.0,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 If the IUD is not inserted within the first 48 hours postpartum and her monthly bleeding has not returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving birth.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1238
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 4.0,
        "operator": ">="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted if it is reasonably certain that the woman is not pregnant. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1239
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion stage of pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1240
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion stage of pregnancy",
        "value": "DAK, Second trimester",
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 12.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a second-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1241
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion stage of pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 12.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted immediately after a first-trimester abortion or miscarriage if no infection is present.\n\u2013 If infection is present, treat or refer, and help the client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1242
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion stage of pregnancy",
        "value": "DAK, Second trimester",
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 12.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Cu-IUD insertion after a second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion.",
    "action_key": 1243
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method switch",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 For a client switching from another method, a Cu-IUD can be inserted immediately if it is reasonably certain the woman is not pregnant; there is no need to wait for her next menstrual period. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1244
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      },
      {
        "key": "DAK, Days since unprotected sex",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A Cu-IUD can be inserted within 5 days of unprotected intercourse as an emergency contraceptive.\n\u2013 Women who use the Cu-IUD for emergency contraception should be medically eligible for the insertion (1).",
    "action_key": 1245
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 When the time of ovulation can be estimated, a Cu-IUD can be inserted beyond 5 days after intercourse, as long as insertion does not occur  with in 7 days after ovulation. \n\u2013 Women who use the Cu-IUD for emergency contraception should be medically eligible for the insertion (1).",
    "action_key": 1246
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Emergency contraception",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The Cu-IUD can be inserted on the same day that the client takes the ECPs (progestin-only, combined or ulipristal acetate ECPs). \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1247
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 An implant can generally inserted less than 6 weeks postpartum",
    "action_key": 1248
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 6 weeks to 6 months postpartum and amenorrhoeic: an implant can be inserted   - Breast Feeding soulid Exclusivele and Frequint ( 10-12 times per 24 hrs)",
    "action_key": 1249
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 6.0,
        "maxValue": 6.0,
        "operator": "between"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding status",
        "value": "DAK, Fully breastfeeding OR Nearly fully breastfeeding OR Exclusive breastfeeding",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 6 weeks to 6 months postpartum and amenorrhoeic: an implant can be inserted. \n\u2013 Back-up method recommendation: if the woman is fully or nearly fully breastfeeding, no additional contraceptive protection is needed.",
    "action_key": 1250
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1251
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1252
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21.0,
        "operator": ">"
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 An implant can be inserted at the woman's convenience 21 days after postpartum.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.\n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.",
    "action_key": 1253
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1254
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The implant can be inserted immediately post-abortion or miscarriage. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1255
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs) OR Combined oral contraceptives (COCs) OR Combined contraceptive patch OR Combined contraceptive vaginal ring (CVR) OR Progesterone-releasing vaginal ring (PVR)",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the implant can be inserted immediately; there is no need to wait for her next menstrual period",
    "action_key": 1256
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation within 7 days of the start of her menstrual bleeding: no additional contraceptive protection is needed.",
    "action_key": 1257
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD) OR Levonorgestrel-releasing intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD) within 7 days after the start of menstrual bleeding: an implant can be inserted. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1258
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain the client is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1259
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at any time if it can be determined that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1260
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 6.0,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1261
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 21.0,
        "operator": ">"
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 An implant can be inserted if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1262
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of delivery",
        "value": 21.0,
        "operator": ">"
      },
      {
        "key": "DAK, Breastfeeding",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1263
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD) OR ",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and  Back up Method not needed",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the implant can be inserted at any time if it can be determined that the woman is not pregnant. \n\u2013 Back-up method recommendation:  Back up Method not needed",
    "action_key": 1264
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Visit date \u2013 Date of miscarriage or abortion",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1265
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Lactational Amenorrhoea Method (LAM) OR Male condoms OR Female condoms OR Fertility awareness-based methods (FAB) OR Withdrawal",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the implant can be inserted immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1266
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle) insertion OR Etonogestrel (ETG) one-rod implant insertion",
        "operator": "="
      },
      {
        "key": "DAK, Reason for visit",
        "value": "DAK, Method Change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 7 days after the start of menstrual bleeding: The implant can be inserted if pregnancy abscence is reasonably certain.\n\u2013 If sexually active and more than 7 days since the start of menstrual bleeding: Remove the IUD at the next menstrual period.\n\u2013 Back-up method  Keep the existing IUD until the next menstrual period for back-up protection.",
    "action_key": 1267
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Back-up method: Use a back-up method for the first 7 days after receiving the implant.\n\u2013 After taking progestin-only or combined ECPs: Implants can be inserted on the same day as ECPs. If delayed, start at any time if reasonably certain she is not pregnant.\n\u2013 After taking ulipristal acetate (UPA) ECPs: Implants can be inserted on the 6th day after UPA ECPs. No need to wait for next monthly bleeding. Caution regarding interaction with UPA if implanted sooner.",
    "action_key": 1269
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a hormonal injectible contraceptive, the implant should be inserted when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1270
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given at the time of consultation",
    "action_key": 1271
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given. If the woman is fully or nearly fully breastfeeding, no additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1272
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": "<"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given. \n\u2013 Back-up method recommedation: no additional contraceptive protection is needed. \n\u2013 It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.",
    "action_key": 1273
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another hormonal method, and has been using her hormonal method consistently and correctly, or if it is reasonably certain that she is not pregnant, the first injection can be given immediately; there is no need to wait for her next menstrual period",
    "action_key": 1274
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from another, different, hormonal injectible contraceptive, the injection can be given when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1275
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1276
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1277
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation, not just during menstruation. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1278
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 The first injection can be given immediately post-abortion .\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1279
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: within 7 days of the start of her menstrual bleeding, no additional contraceptive protection is needed.",
    "action_key": 1280
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: within 7 days of the start of her menstrual bleeding, no additional contraceptive protection is needed.",
    "action_key": 1280
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD) within 7 days after the start of menstrual bleeding: the first injection can be given. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1281
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at the time of consultation if it is reasonably certain  is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1282
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at the time of consultation if it is reasonably certain  is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1282
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at any time if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1283
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given at any time if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1283
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1284
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, 180 days post-delivery",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1284
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1285
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1285
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1286
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given, as advised for other women having menstrual cycles, at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1286
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1287
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from a nonhormonal method (excluding the IUD), the first injection can be given immediately if it is reasonably certain that the woman is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up recommendation: more than 7 days since the start of menstrual bleeding she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1287
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the first injection can be given at any time if it is reasonably certain that the woman is not pregnant. \n\u2013 Backup method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1288
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from an IUD (Cu-IUD, LNG-IUD), the first injection can be given at any time if it is reasonably certain that the woman is not pregnant. \n\u2013 Backup method recommendation: she will need to abstain from sex or use additional contraceptive protection for the next 7 days.",
    "action_key": 1288
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 The first injection can be given immediately post-abortion . \n\u2013 Back-up method recommendation: a back-up method is needed for the first 7 days after the injection.",
    "action_key": 1289
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "- Switching from an IUD (Cu-IUD, LNG-IUD) more than 7 days since the start of menstrual bleeding: First injection can be given if reasonably certain she is not pregnant.\n - If sexually active in this menstrual cycle and more than 7 days since the start of menstrual bleeding: It is recommended to remove the IUD at her next menstrual period.\n - Back-up method: Do not remove the existing IUD until the next menstrual period to use it as a back-up method.",
    "action_key": 1290
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "- Switching from an IUD (Cu-IUD, LNG-IUD) more than 7 days since the start of menstrual bleeding: First injection can be given if reasonably certain she is not pregnant.\n - If sexually active in this menstrual cycle and more than 7 days since the start of menstrual bleeding: It is recommended to remove the IUD at her next menstrual period.\n - Back-up method: Do not remove the existing IUD until the next menstrual period to use it as a back-up method.",
    "action_key": 1290
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from IUD: First injection can be given if reasonably certain the woman is not pregnant.\n\u2013 Not sexually active in this cycle: Abstain from sex or use additional contraceptive protection for the next 7 days. If using IUD as additional protection, remove it at next menstrual period.\n\u2013 Back-up method: Abstain from sex or use additional contraceptive protection for the next 7 days OR keep the IUD in until next menstrual cycle and use it as the back-up method of choice.",
    "action_key": 1291
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 If the client is switching from IUD: First injection can be given if reasonably certain the woman is not pregnant.\n\u2013 Not sexually active in this cycle: Abstain from sex or use additional contraceptive protection for the next 7 days. If using IUD as additional protection, remove it at next menstrual period.\n\u2013 Back-up method: Abstain from sex or use additional contraceptive protection for the next 7 days OR keep the IUD in until next menstrual cycle and use it as the back-up method of choice.",
    "action_key": 1291
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Back-up method: Use a back-up method for the first 7 days after receiving the injection.\n\u2013 After taking progestin-only or combined ECPs: Injections can be provided on the same day as ECPs. If delayed, start at any time if certain she is not pregnant.\n\u2013 After taking ulipristal acetate  ECPs: Injections can be inserted on the 6th day after taking UPA ECPs. No need to wait for next monthly bleeding. Caution regarding interaction with UPA if injected sooner.",
    "action_key": 1292
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1293
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed if the woman if fully or nearly fully breastfeeding.",
    "action_key": 1294
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed if the woman if fully or nearly fully breastfeeding.",
    "action_key": 1295
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Within 5 days of the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1296
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21.0,
        "operator": "<"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 21 days postpartum: POPs can be initiated. No additional contraceptive protection is needed. It is highly unlikely that a woman will ovulate and be at risk of pregnancy during the first 21 days postpartum. However, for programmatic reasons (i.e. depending on national, regional and/or local programme protocols), some contraceptive methods may be provided during this period.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1297
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 Within 5 days after the start of menstrual bleeding: POPs can be initiated.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1298
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1299
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from another hormonal method: POPs can be initiated immediately if the woman has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1300
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from another hormonal method: POPs can be initiated immediately if the woman has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant; there is no need to wait for her next menstrual period.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1300
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the woman\u2019s previous method was an injectable contraceptive, POPs can be initiated when the repeat injection would have been given. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1301
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1302
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1302
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from an IUD (including LNG-IUD) within 5 days of the start of menstrual bleeding: POPs can be initiated. The IUD can be removed at that time.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1303
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Less than 6 weeks postpartum: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1304
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "minValue": 42,
        "maxValue": 180,
        "operator": "between, >, <="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 6 weeks to 6 months postpartum and amenorrhoeic: POPs can generally be initiated (medical eligibility category 2).\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1305
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1306
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1306
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1307
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1307
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1308
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 More than 6 weeks postpartum and menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles (medical eligibility category 1).\n\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 More than 5 days since the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1308
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 21 or more days postpartum and menstrual cycles have not returned: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1309
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 21,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 21 or more days postpartum and menstrual cycles have not returned: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1309
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1310
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Menstrual cycles have returned: POPs can be initiated as advised for other women having menstrual cycles.\n\u2013 More than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1310
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1311
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 POPs can be initiated immediately post-abortion or miscarriage.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1311
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) more than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1312
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 Switching from a nonhormonal method (excluding IUD) more than 5 days after the start of menstrual bleeding: POPs can be initiated if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation.",
    "action_key": 1312
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "After progestin-only or combined emergency contraceptive pills (ECPs):\nClient can start or restart progestin-only pills (POPs) immediately after ECPs, no need to wait for next bleeding.\nContinuing users can continue with their current pack.\nIf not started immediately, she can start POPs at any time if reasonably certain she is not pregnant.\nBack-up method: Use additional contraception for the first 2 days of taking POPs.\n                                                                                                                                                                                                      After ulipristal acetate (UPA) ECPs:\nStart or restart POPs on the 6th day after UPA ECPs, regardless of next bleeding.\nGive a supply of pills and start on the 6th day.\nBack-up method: Use additional contraception until taking POPs for 2 days.\nIf not started on the 6th day, she can start at any time if reasonably certain she is not pregnant.",
    "action_key": 1313
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided in advance to a medically eligible woman with instructions on pill initiation.\n\u2013 Switching from an IUD  more than 5 days after the start of menstrual bleeding: POPs can be initiated if reasonably certain she is not pregnant.\n\u2013 If sexually active in this menstrual cycle,  \n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for the next 2 days OR keep the IUD in until the next menstrual cycle and use it as the back-up method.",
    "action_key": 1314
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided in advance to a medically eligible woman with instructions on pill initiation.\n\u2013 Switching from an IUD  more than 5 days after the start of menstrual bleeding: POPs can be initiated if reasonably certain she is not pregnant.\n\u2013 If sexually active in this menstrual cycle,  \n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for the next 2 days OR keep the IUD in until the next menstrual cycle and use it as the back-up method.",
    "action_key": 1314
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 If the woman is amenorrhoeic or has irregular bleeding, POPs can be initiated as advised for other amenorrhoeic women.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1316
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 POPs may be provided to a woman in advance with appropriate instructions on pill initiation, provided she is medically eligible.\n\u2013 If the woman is amenorrhoeic or has irregular bleeding, POPs can be initiated as advised for other amenorrhoeic women.\n\u2013 POPs can be initiated at any time.\n\u2013 Back-up method recommendation: she will need to abstain from sex or use additional contraceptive protection for the 2 days following initiation of POPs.",
    "action_key": 1316
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days after the start of menstrual bleeding: COCs.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1317
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 More than 6 months postpartum and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days of the start of menstrual bleeding: COCs, the patch and the CVR can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1318
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42,
        "operator": ">"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 21 or more days postpartum: for women with no other risk factors for venous thromboembolism (VTE), COCs,  can generally be initiated (medical eligibility category 2).\n\u2013 She can start COCs at any time on days 21\u201328 after giving birth. Give her pills any time to start during these 7 days. If additional risk for VTE, wait until 6 weeks postpartum.\n\u2013 Back-up method recommendation:  Backup Method is needed",
    "action_key": 1319
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Within 5 days after the start of menstrual bleeding: COCs,  can be initiated. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1320
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Have you had a recent miscarriage or abortion",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 A client may be provided with COCs, in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 COCs, can be initiated immediately post-abortion or miscarriage. No additional contraceptive protection is needed.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1321
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1322
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Combined oral contraceptives (COCs)",
          "DAK, Progestogen-only pills (POPs)",
          "DAK, Etonogestrel (ETG) one-rod implant",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If the woman is switching from another hormonal method and has been using her hormonal method consistently and correctly or if it is reasonably certain that she is not pregnant, COCs,  can be initiated immediately; there is no need to wait for her next menstrual period",
    "action_key": 1322
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-SC",
          "DAK, DMPA-IM"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If a woman\u2019s previous method was an injectable contraceptive, COCs, should be initiated when the repeat injection would have been given.\n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1323
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) within 5 days after the start of menstrual bleeding: COCs,  can be initiated immediately. \n\u2013 Back-up method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1324
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": "<="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Switching from an IUD within 5 days of the start of menstrual bleeding: COCs, can be initiated. The IUD can be removed at that time.\n\u2013 Backup method recommendation: no additional contraceptive protection is needed.",
    "action_key": 1325
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy, More than 5 days after the start of menstrual bleeding.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1326
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy, More than 5 days after the start of menstrual bleeding.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1326
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1327
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Advance provision of COCs,  is possible for medically eligible clients with appropriate initiation instructions.\n\u2013 COCs,  can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method for 7 days after method initiation.",
    "action_key": 1327
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum and amenorrheic for over 6 months: COCs,  can be initiated following standard guidelines.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, requires reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method n for 7 days after method initiation.",
    "action_key": 1328
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum and amenorrheic for over 6 months: COCs,  can be initiated following standard guidelines.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, requires reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional method n for 7 days after method initiation.",
    "action_key": 1328
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum with resumed menstrual cycles: COCs,  can be initiated following standard guidelines for women with regular cycles.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, is possible if more than 5 days have passed since the start of menstrual bleeding and there is reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for 7 days after method initiation.",
    "action_key": 1329
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": ">"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Postpartum with resumed menstrual cycles: COCs,  can be initiated following standard guidelines for women with regular cycles.\n\u2013 Clients eligible for advance provision of COCs,  can receive them with appropriate initiation instructions.\n\u2013 Initiation of COCs, is possible if more than 5 days have passed since the start of menstrual bleeding and there is reasonable certainty of non-pregnancy.\n\u2013 Back-up method : Abstain from sex or use additional contraceptive protection for 7 days after method initiation.",
    "action_key": 1329
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Medically eligible and menstrual cycles have not returned: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1330
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 Medically eligible and menstrual cycles have not returned: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1330
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs, can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1331
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Medically eligible",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Medically eligible and menstrual cycles have returned: COCs,  can be initiated as advised for other women having menstrual cycles.\n\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 More than 5 days since the start of menstrual bleeding: COCs, can be initiated if it is reasonably certain that the woman is not pregnant. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1331
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a back-up method for the first 7 days of taking pills. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1332
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of miscarriage or abortion FP",
        "value": 7.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 A client may be provided with COCs,  in advance with appropriate instructions on initiation, provided she is medically eligible. \n\u2013 If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a back-up method for the first 7 days of taking pills. \n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1332
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) more than 5 days from the start of menstrual bleeding: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1333
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Lactational amenorrhea method (LAM)",
          "DAK, Fertility awareness-based methods (FAB)",
          "DAK, Withdrawal"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from a nonhormonal method (other than the IUD) more than 5 days from the start of menstrual bleeding: COCs, can be initiated immediately if it is reasonably certain that the woman is not pregnant.\n\u2013 Back-up method recommendation: client will need to abstain from sex or use additional contraceptive protection for 7 days from initiation of the method.",
    "action_key": 1333
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 After taking progestin-only or combined ECPs, the client can start or restart COCs immediately, without waiting for the next monthly bleeding.                                                     Back-up contraception is recommended for the first 7 days of taking pills.\n\u2013 After taking ulipristal acetate (UPA) emergency contraceptive pills, the client can start or restart COCs on the 6th day after taking UPA ECPs, without waiting for the next monthly bleeding. It is important to use a back-up method from the time of UPA ECP intake until taking COCs for 7 days.\n\u2013 Back-up method : client will need to use a back-up method from the time she takes the UPA ECPs until she has been taking COCs for 7 days",
    "action_key": 1334
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 If sexually active in this menstrual cycle,  recommended to remove the IUD at the time of the next menstrual period.\n\u2013Back-up method : Keep the IUD in until her next menstrual cycle and use the IUD as her back-up method of choice.",
    "action_key": 1335
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 If sexually active in this menstrual cycle,  recommended to remove the IUD at the time of the next menstrual period.\n\u2013Back-up method : Keep the IUD in until her next menstrual cycle and use the IUD as her back-up method of choice.",
    "action_key": 1335
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      },

      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 Back-up method : If not sexually active in this menstrual cycle, abstain from sex or use additional method for the next 7 days. If relying on the IUD for additional protection,  recommended to remove it at the time of the next menstrual period.",
    "action_key": 1336
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Days since start of last normal menses",
        "value": 5.0,
        "operator": ">"
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      },
      {
        "key": "DAK, Sexually active",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD more than 5 days after the start of menstrual bleeding allows for initiation of COCs,  if reasonably certain of non-pregnancy.\n\u2013 Back-up method : If not sexually active in this menstrual cycle, abstain from sex or use additional method for the next 7 days. If relying on the IUD for additional protection,  recommended to remove it at the time of the next menstrual period.",
    "action_key": 1336
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD: COCs, can be initiated for amenorrhoeic or irregular bleeding.\n\u2013 Advance provision of COCs, is possible if medically eligible.\n\u2013 COCs, can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method: Abstain from sex or use additional contraception for 7 days from method initiation. Remove the IUD, unless chosen as the back-up method, at the next menstrual period.",
    "action_key": 1337
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      },
      {
        "key": "DAK, Reason for follow-up",
        "value": "DAK, Method change",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Switching from an IUD: COCs, can be initiated for amenorrhoeic or irregular bleeding.\n\u2013 Advance provision of COCs, is possible if medically eligible.\n\u2013 COCs, can be initiated if reasonably certain of non-pregnancy.\n\u2013 Back-up method: Abstain from sex or use additional contraception for 7 days from method initiation. Remove the IUD, unless chosen as the back-up method, at the next menstrual period.",
    "action_key": 1337
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Emergency contraceptive pills (ECPs)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Client should take ulipristal acetate (UPA) ECPs, , or combined ECPs as early as possible after unprotected intercourse, ideally within 120 hours (or 5 days).Note that the effectiveness of the ECP(s) decreases with a longer interval between unprotected intercourse and taking the ECP(s).\n\u2013 UPA ECPs may be more effective between 72 hours and 120 hours after unprotected intercourse compared to other ECPs.",
    "action_key": 1338
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "LAM can be started at any time if the client meets all criteria.\nCriteria for LAM: started breastfeeding immediately or as soon as possible after childbirth, fully or nearly fully breastfeeding since birth, and no return of monthly bleeding. LAM offers a continued method option beyond 6 months.",
    "action_key": 1339
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "orValues": [
          "DAK, Male condoms",
          "DAK, Female condoms",
          "DAK, Withdrawal",
          "DAK, No method provided"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 Client can begin using these methods immediately",
    "action_key": 1340
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Fertility awareness-based methods (FAB)",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Various  FAB methods are available, including calendar-based methods (e.g., Standard Days Method) and symptoms-based methods (e.g., cervical secretions, \nProvide detailed counseling on when to start each specific FAB method.\n\u2013 Back-up method recommended on days 8-19 if desired.Consider emergency contraception if appropriate.\n\u2013 FAB methods do not protect against STIs, condom use is advised for STI/HIV protection.",
    "action_key": 1341
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Male sterilization",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection and provide back-up method",
    "annotation": "\u2013 Male sterilization,Vasectomy is a low-risk procedure that can be done in an outpatient setting.procedure is  quick, safe and effective.\n\u2013 Back-up method recommended for three months after vasectomy.During this period, he can resume sexual activity with back_up Method\n'\u2013 Sterilization does not protect against STIs, condom use is advised for STI/HIV protection.",
    "action_key": 1342
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Female sterilization",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where or how the female sterilization procedure  be performed",
    "action_key": 1343
  },
  {
    "conditions": [
      {
        "key": "DAK, Method or service provided",
        "value": "DAK, Female sterilization",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Discuss dual protection",
    "annotation": "\u2013 If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where or how the female sterilization procedure  be performed",
    "action_key": 1343
  },
  {
    "conditions": [
      {
        "key": "DAK, HIV test result",
        "value": "DAK, HIV-negative",
        "operator": "="
      }
    ],
    "action": "Counsel clients on: \u2013- Test confidentiality \u2013 -Available HIV prevention measures \u2013 -Partner disclosure and  testing .\u2013 -Condom use for STI/HIV risk reduction.\u2013 -Consider Offering  PrEP or PEP for high-risk clients.",
    "annotation": "\u2013Counsel clients on: \u2013 -Test confidentiality \u2013 -Available HIV prevention measures \u2013-Partner disclosure and  testing . \u2013 -Condom use for STI/HIV risk reduction.\u2013 -Consider Offering  PrEP or PEP for high-risk clients. ",
    "action_key": 1344
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "\u2013 The implant can be inserted at the time of consultation if it is reasonably certain she is not pregnant. \n\u2013 Provide back-up method.\n\u2013 Client must abstain from sex or use additional contraceptive protection for the next 7 days.",
    "annotation": "\u2013 The implant can be inserted at any time if pregnancy can be ruled out by checklist and pregnacy test \u2013 Provide back-up method.\n.",
    "action_key": 1345
  },
  {
    "conditions": [
      {
        "key": "DAK, HIV test result",
        "value": "DAK, HIV-positive",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "\u2013Refer for immediate HIV services, treatment, and support decisions.Counsel clients on:\u2013Test Result confidentiality \n\u2013HIV treatment effectiveness and viral load suppression. \n\u2013Partner disclosure and  testing .\u2013Condom use for STI prevention.",
    "annotation": "\u2013Refer for immediate HIV services, treatment, and support decisions. Counsel clients on:\u2013Test Result confidentiality \n\u2013HIV treatment effectiveness and viral load suppression. \n\u2013Partner disclosure and  testing .\u2013Condom use for STI prevention.",
    "action_key": 1346
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-IM",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Progestogen-only injectables can cause spotting or light bleeding.\u2013 Exclude gynecological issues, treat or refer if necessary. If no gynaecologic problem is found but she finds the bleeding unacceptable, short-term treatment with NSAIDs may be helpful. Assist clients in choosing another method if client decides to  discontinue injectables.                                                                                                                        \u2013 Clients with STI/PID can continue injections during treatment with condom use. using injections while receiving treatment and be counselled on condom use.",
    "action_key": 1347
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Progestogen-only injectables can cause spotting or light bleeding.\u2013 Exclude gynecological issues, treat or refer if necessary. If no gynaecologic problem is found but she finds the bleeding unacceptable, short-term treatment with NSAIDs may be helpful. Assist clients in choosing another method if client decides to  discontinue injectables.                                                                                                                        \u2013 Clients with STI/PID can continue injections during treatment with condom use. using injections while receiving treatment and be counselled on condom use.",
    "action_key": 1348
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Progestogen-only injectables can cause spotting or light bleeding.\u2013 Exclude gynecological issues, treat or refer if necessary. If no gynaecologic problem is found but she finds the bleeding unacceptable, short-term treatment with NSAIDs may be helpful. Assist clients in choosing another method if client decides to  discontinue injectables.                                                                                                                        \u2013 Clients with STI/PID can continue injections during treatment with condom use. using injections while receiving treatment and be counselled on condom use.",
    "action_key": 1349
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Spotting or light bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Etonogestrel (ETG)or Levonorgestrel(LNG)  implant use may cause spotting or light bleeding, which is not harmful  and decreases over time.\n\u2013 Exclude gynecologic issues for persistent spotting and bleeding. If a gynaecologic problem is identified, treat or refer if necessary .\n\u2013 If bleeding is unacceptable and no gynecologic problems exist, discuss implant removal and alternative method.",
    "action_key": 1350
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial Implant use may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                   \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                     \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss implant removal and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 1351
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial injection may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                                                                                            \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                        \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss injection discontinuation  and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 1352
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial injection may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                                                                                            \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                        \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss injection discontinuation  and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 1353
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial injection may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                                                                                            \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                        \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss injection discontinuation  and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 1354
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Initial injection may cause heavier or longer menstrual bleeding, which improves over time.                                                                                                                                                          \u2013 If client has no gynaecologic problems and the woman desires treatment, NSAIDs, COCs or ethinyl estradiol may be helpful. COCs with 50 \u03bcg of ethinyl estradiol recommended                                                                                                            \u2013 Exclude gynecologic issues and provide treatment or referral if necessary.                                                                                                                                                        \u2013 If bleeding remains excessive or unacceptable especially if there are clinical signs of anaemia, discuss injection discontinuation  and alternative methods. Recommend iron supplements and iron-rich foods to prevent anaemia",
    "action_key": 1355
  },
  {
    "conditions": [
      {
        "key": "DAK, Related to bleeding",
        "value": "DAK, Irregular bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that irregular bleeding is common with implants and usually improves over the first year. NSAIDs can provide short-term relief, and if needed, COCs or 50 \u03bcg ethinyl estradiol can be tried when irregular bleeding starts. If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, evaluate for unrelated underlying conditions.",
    "action_key": 1356
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Irregular vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reasure client that irregular bleeding is common with progestogen-only injectables , is not harmful and usually improves over the first few months. NSAIDs can provide short-term relief. If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, evaluate for unrelated underlying conditions.",
    "action_key": 1357
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Irregular vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reasure client that irregular bleeding is common with progestogen-only injectables , is not harmful and usually improves over the first few months. NSAIDs can provide short-term relief. If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, evaluate for unrelated underlying conditions.",
    "action_key": 1358
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Test for rule out pregnancy  if no monthly bleeding soon after implant insertion. Remove the implant if client is confirmed pregnant.                                                                                                                                   \u2013  Reassure her that no monthly bleeding is normal with implants and not harmful.Similar to not having periods during pregnancy due to effect of hormones. \u2013 Amenorrhea does not need medical treatment. If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 1359
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Amenorrhea does not need medical treatment.                                                                                                \u2013  Reassure her that no monthly bleeding is normal with injectable contraceptives and not harmful.Similar to not having periods during pregnancy due to effect of hormones.                                                                                                      \u2013  If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 1360
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, DMPA-SC -SI",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Amenorrhea does not need medical treatment.                                                                                                \u2013  Reassure her that no monthly bleeding is normal with injectable contraceptives and not harmful.Similar to not having periods during pregnancy due to effect of hormones.                                                                                                      \u2013  If amenorrhea is unacceptable for client, assist in selecting an alternative method.",
    "action_key": 1361
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method provided that she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance for this method, provided that she is not pregnant",
    "action_key": 1362
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1363
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1364
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1365
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 42.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1366
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 1367
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 1368
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance. \n\nImplant can be started immediately for this condition.",
    "action_key": 1369
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, BMI",
        "value": 29,
        "operator": ">"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1370
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1371
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1372
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Lifestyle Behaviors",
        "value": "DAK, Smokes cigarettes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1373
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Lifestyle Behaviors",
        "value": "DAK, Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1374
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, BMI",
        "value": 29,
        "operator": ">"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1375
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nWhen multiple major risk factors exist, the risk of cardiovascular disease may increase substantially. Some progestogen-only contraceptives (POCs) may increase the risk of thrombosis, although this increase is substantially less than with combined oral contraceptives (COCs).",
    "action_key": 1376
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nIt is desirable to have blood pressure measurements taken before initiation of progestogen-only contraceptive (POC) use. However, women should not be denied the use of POCs simply because their blood pressure cannot be measured.",
    "action_key": 1377
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nWomen adequately treated for hypertension are at reduced risk of acute myocardial infarction (MI) and stroke as compared with untreated women. Although there are no data, progestogen-only contraceptive (POC) users with adequately controlled and monitored hypertension should be at reduced risk of acute MI and stroke compared with untreated hypertensive POC users.",
    "action_key": 1378
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <"
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1379
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100.0,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1380
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1381
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1382
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1383
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1384
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1385
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Acute pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1386
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1387
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1388
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1389
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery without prolonged immobilization OR Minor surgery without immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1390
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the conditions and the high cost of screening.",
    "action_key": 1391
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1392
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1393
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Current ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1394
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Current ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1395
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Current ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1396
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1397
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1398
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1399
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1400
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1401
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1402
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1403
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 1404
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Uncomplicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1405
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1406
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1407
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1408
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1409
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1410
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1411
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1412
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1413
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1414
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1415
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1416
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1417
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 9for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1418
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 9for initiat542ion) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1419
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 9for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1420
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1421
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1422
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1423
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1424
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1425
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1426
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1427
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1428
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 for continuation \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated. Classification is for women without any other risk factors for stroke. Risk of stroke increases with age, hypertension and smoking.",
    "action_key": 1429
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": "<"
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "orValues": [
          "DAK, Exclusive breastfeeding",
          "DAK, Fully breastfeeding,",
          "DAK, Nearly fully breastfeeding"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "All breastfeeding women who fulfil the criteia can safely use LAM, but a woman in the following circumstances may want to consider other contraceptive methods:\n\u2013 Has HIV infection\n\u2013 Is using certain medications during breastfeeding\n\u2013 The newborn has a condition that makes it difficult to breastfeed.",
    "action_key": 1430
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 180,
        "operator": "<"
      },
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": "DAK, Nearly fully breastfeeding",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "All breastfeeding women who fulfil the criteia can safely use LAM, but a woman in the following circumstances may want to consider other contraceptive methods:\n\u2013 Has HIV infection\n\u2013 Is using certain medications during breastfeeding\n\u2013 The newborn has a condition that makes it difficult to breastfeed.",
    "action_key": 1431
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Lactational amenorrhea method (LAM)",
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 6.0,
        "operator": "<"
      },
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Amenorrhoea",
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Breastfeeding",
        "value": "DAK, Partially breastfeeding",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "All breastfeeding women who fulfil the criteia can safely use LAM, but a woman in the following circumstances may want to consider other contraceptive methods:\n\u2013 Has HIV infection\n\u2013 Is using certain medications during breastfeeding\n\u2013 The newborn has a condition that makes it difficult to breastfeed.",
    "action_key": 1432
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Irregular vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client  that irregular bleeding is common with IUD use and usually improves over time. NSAIDs can provide short-term relief. If irregular bleeding persists or occurs after several months of normal bleeding, evaluate for other unrelated underlying conditions unrelated to method use..",
    "action_key": 1433
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Irregular blleding at unexpected times that bothers the client",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client  that irregular bleeding is common with POPs, whether breastfeeding or not, and is y not harmful. It may improve or stop after the first few months, but some women may experience ongoing irregular bleeding.To reduce irregular bleeding:1.Emphasize proper pill intake, especially after vomiting or diarrhea. 2. Suggest NSAIDs for short-term relief when irregular bleeding occurs. 3. If NSAIDs are ineffective after a few months, consider trying a different POP formulation for at least 3 months.If irregular bleeding persists or occurs after several months of normal or no monthly bleeding, consider evaluating for unrelated underlying conditions.",
    "action_key": 1434
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Irregular blleding at unexpected times that bothers the client",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that irregular bleeding is common with COCs and is generally not harmful. It often improves or stops after the first few months of use. To reduce irregular bleeding:1. Emphasize consistent daily pill intake at the same time each day. 2. Educate her on proper missed pill management, including after vomiting or diarrhea. 3. Suggest NSAIDs for short-term relief when irregular bleeding occurs. If NSAIDs do not help , try a different COC formulation for at least 3 months. If irregular bleeding persists or occurs after several months, evaluate for underlying conditions.",
    "action_key": 1435
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Reassure client that irregular bleeding is common with COCs and is generally not harmful. It often improves or stops after the first few months of use. To reduce irregular bleeding:1. Emphasize consistent daily pill intake at the same time each day. 2. Educate her on proper missed pill management, including after vomiting or diarrhea. 3. Suggest NSAIDs for short-term relief when irregular bleeding occurs. If NSAIDs do not help , try a different COC formulation for at least 3 months. If irregular bleeding persists or occurs after several months, evaluate for underlying conditions.",
    "action_key": 1436
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Copper-bearing intrauterine device (Cu-IUD)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "For unexplained vaginal bleeding (not related to the method):\n\u2013 Refer or evaluate by history/pelvic exam.Diagnose and treat as appropriate.\n\u2013 Client can continue using the IUD during evaluation.\n\u2013 If bleeding is due to STI or PID, client can continue using the IUD during treatment",
    "action_key": 1437
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": "DAK, Etonogestrel (ETG) one-rod",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Unexplained vaginal bleeding: Refer or evaluate for diagnosis and treatment. Consider stopping implants for easier diagnosis. Offer alternative method (excluding certain options) until evaluation and treatment complete. Continued use of implants allowed for STI or PID treatment.",
    "action_key": 1438
  },
  {
    "conditions": [
      {
        "key": "DAK, Issue with injectable contraceptives - Bleeding problems",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, DMPA-IM",
          "DAK, DMPA-SC",
          "DAK, DMPA-SC -SI"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Consider switching methods for abnormal bleeding unrelated to the method.\n\u2013 Refer for evaluation and treatment based on history and pelvic examination.\n\u2013 Discontinue progestogen-only injectables if the cause of bleeding is unknown, providing an alternative method.(NOT implants or a copper-bearing or LNG-IUD)\n\u2013 Progestogen-only injectables can be continued during treatment for bleeding caused by STI or PID.",
    "action_key": 1439
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Progestogen-only pills (POPs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Unexplained vaginal bleeding (that suggests a medical condition not related to the method).\n\u2013 Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.\n\u2013 She can continue using POPs while her condition is being evaluated.\n\u2013 If bleeding is caused by STI or PID, she can continue using POPs during treatment.",
    "action_key": 1440
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Unexplained vaginal bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "\u2013 Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.\n\u2013 She can continue using COCs while her condition is being evaluated.\n\u2013 If bleeding is caused by STI or PID, she can continue using COCs during treatment.",
    "action_key": 1441
  },
  {
    "conditions": [
      {
        "key": "DAK, Headache and migraine",
        "value": "DAK, Ordinary headaches",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Nonmigrainous headaches\u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131000 mg) or other pain reliever.\n\u2013 Any headaches that get worse or occur more often during use of implants should be evaluated.",
    "action_key": 1442
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reasonably certain a woman is not pregnant",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method provided that she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance, after rulling out that she is not pregnant",
    "action_key": 1443
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },

      {
        "key": "DAK, Pregnancy test result",
        "value": "DAK, Not pregnant",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method provided that she is not pregnant",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance, after rulling out that she is not pregnant",
    "action_key": 1443
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 18,
        "operator": "<"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (assuming menarche has already occurred)",
    "action_key": 1444
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "age",
        "value": 18,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1445
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 0,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1446
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Parity",
        "value": 1,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1447
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 2,
        "operator": "<"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1448
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "value": 2,
        "operator": "<"
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": true,
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1449
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time since delivery",
        "minValue": 2.0,
        "maxValue": 28.0,
        "operator": "between, <=, <"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods  options to find alternative  for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1450
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Time Postpartum",
        "value": 28,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1451
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Puerperal sepsis postpartum",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1452
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, First trimester less than 13 weeks GA",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1453
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Second trimester between 13 and 24 Weeks",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1454
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Miscarriage or abortion within past 4 weeks",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Gestational age during Miscarriage or abortion of the last pregnancy",
        "value": "DAK, Immediate post septic abortion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1455
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, Past ectopic pregnancy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1456
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Medical conditions during past pregnancy and after childbirth",
        "value": "DAK, History of pelvic surgery",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1457
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Client smokes < 15 cigarettes per day",
          "DAK, Client smokes >= 15 cigarettes per day"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1458
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      },
      {
        "key": "DAK, BMI",
        "value": 30,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1459
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      },
      {
        "key": "age",
        "value": 18,
        "operator": "<"
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Client is Obese",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance (assuming menarche has already occurred)",
    "action_key": 1460
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Multiple risk factors for arterial cardiovascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (multiple risk factors for arterial cardiovascular disease [e.g. older age, smoking, diabetes, hypertension, known dyslipidaemias])",
    "action_key": 1461
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension, but blood pressure cannot be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1462
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Adequately controlled hypertension, and blood pressure can be evaluated",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1463
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "minValue": 140.0,
        "maxValue": 159.0,
        "operator": "between, <=, <="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "minValue": 90.0,
        "maxValue": 99.0,
        "operator": "between, <=, <="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1464
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 160.0,
        "operator": ">="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 100,
        "operator": ">="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1465
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, Vascular disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1466
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Hypertension",
        "value": "DAK, History of hypertension during pregnancy, and blood pressure can be evaluated",
        "operator": "="
      },
      {
        "key": "DAK, Systolic blood pressure",
        "value": 120.0,
        "operator": "<="
      },
      {
        "key": "DAK, Diastolic blood pressure",
        "value": 80.0,
        "operator": "<="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1467
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of deep vein thrombosis (DVT)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method",
    "action_key": 1468
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, History of pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u00e2\u20ac\u201c Generally use method",
    "action_key": 1469
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Acute deep vein thrombosis (DVT)",
          "DAK, Acute pulmonary embolism (PE)"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1470
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Deep vein thrombosis (DVT) / pulmonary embolism (PE) and established on anticoagulant therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1471
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Family history of deep vein thrombosis (DVT) / pulmonary embolism (PE)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1472
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "value": "DAK, Major surgery with prolonged immobilization",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1473
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Risk factors for venous thromboembolism (VTE)",
        "orValues": [
          "DAK, Major surgery without prolonged immobilization",
          "DAK, Minor surgery without immobilization"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1474
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Known thrombogenic mutations",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (known thrombogenic mutations [e.g. factor V Leiden, prothrombin mutation, protein S, protein C, antithrombin deficiencies])",
    "action_key": 1475
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Varicose veins",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance (superficial venous disorders)",
    "action_key": 1476
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Superficial venous disorders",
        "value": "DAK, Superficial venous thrombosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1477
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 1478
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1479
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.Discuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u00e2\u20ac\u201c Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1480
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Stroke",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1481
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Dyslipidaemias",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (known dyslipidaemias without other known cardiovascular risk factors)\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 1482
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Uncomplicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1483
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Complicated valvular heart disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (complicated pulmonary hypertension, risk of atrial fibrillation, history of subacute bacterial endocarditis).\n\nRoutine screening is not appropriate because of the rarity of the condition and the high cost of screening.",
    "action_key": 1484
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with positive (or unknown) antiphospholipid antibodies",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1485
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with severe thrombocytopenia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method.\n\nSevere thrombocytopenia increases the risk of bleeding. The category should be assessed according to the severity of the thrombocytopenia and its clinical manifestations. In women with very severe thrombocytopenia who are at risk for spontaneous bleeding, consultation with a specialist and certain pretreatments may be warranted.",
    "action_key": 1486
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE on immunosuppressive treatment",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1487
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, SLE with no complications",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1488
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance.",
    "action_key": 1489
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1490
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1491
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Non-migrainous headache",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1492
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache without aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1493
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Headaches",
        "value": "DAK, Migraine headache with aura",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nClassification depends on accurate diagnosis of those severe headaches that are migrainous and those that are not. Any new headaches or marked changes in headaches should be evaluated.",
    "action_key": 1494
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Epilepsy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1495
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Depressive disorders",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nThe classification is based on data for women with selected depressive disorders. No data on bipolar disorder or postpartum depression were available. There is a potential for drug interactions between certain antidepressant medications and hormonal contraceptives.",
    "action_key": 1496
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Irregular vaginal bleeding patterns",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 1497
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance.\n\nUnusually heavy bleeding should raise the suspicion of a serious underlying condition.",
    "action_key": 1498
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Heavy or prolonged vaginal bleeding patterns",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method.\n\nUnusually heavy bleeding should raise the suspicion of a serious underlying condition.",
    "action_key": 1499
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used.\n\nIf pregnancy or an underlying pathological condition (e.g. pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation. There is no need to remove the IUD before evaluation.",
    "action_key": 1500
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Unexplained vaginal bleeding before evaluation",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method.\n\nIf pregnancy or an underlying pathological condition (e.g. pelvic malignancy) is suspected, it must be evaluated and the category adjusted after evaluation. There is no need to remove the IUD before evaluation.",
    "action_key": 1501
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometriosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1502
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Benign ovarian tumours",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1503
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Vaginal bleeding patterns",
        "value": "DAK, Severe dysmenorrhea",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1504
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with decreasing or undetectable \u03b2-hCG level",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1505
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Gestational trophoblastic disease with persistently elevated \u03b2-hCG levels or malignant disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1506
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical ectropion",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1507
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical intraepithelial neoplasia (CIN)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1508
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 1509
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Cervical cancer (awaiting treatment)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 1510
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Undiagnosed mass",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1511
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Benign breast disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1512
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Family history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1513
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Currently has breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1514
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Breast disease",
        "value": "DAK, Past history of breast cancer",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1515
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 1516
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Endometrial cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 1517
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1518
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Reproductive tract infections and disorders",
        "value": "DAK, Ovarian cancer",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 1519
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Uterine fibroids without distortion of the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1520
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Uterine fibroids with distortion of the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1521
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Anatomical abnormalities that distort the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 \u2013 Method NOT to be used",
    "action_key": 1522
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Uterine fibroids",
        "value": "DAK, Anatomical abnormalities that do not distort the uterine cavity",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1523
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance (for initiation)",
    "action_key": 1524
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) with subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 1525
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method.",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 1526
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Past pelvic inflammatory disease (PID) without subsequent pregnancy",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method.",
    "annotation": "Client is medically eligible to continue with this method with a medical eligibility category 2 \u2013 Generally use method for continuation",
    "action_key": 1527
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used.\n\nTreat the PID using appropriate antibiotics.",
    "action_key": 1528
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Pelvic inflammatory disease (PID) FP",
        "value": "DAK, Current pelvic inflammatory disease (PID)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method.",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method. \n\nTreat the PID using appropriate antibiotics. There is usually no need for removal of the IUD if the client wishes to continue its use. Continued use of an IUD depends on the woman\u2019s informed choice and her current risk factors for sexually transmitted infection (STI) and PID.",
    "action_key": 1529
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 1530
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "orValues": [
          "DAK, Current purulent cervicitis",
          "DAK, Current chlamydia",
          "DAK, Current gonorrhea"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method if client.\n\nTreat the sexually transmitted infection (STI) using appropriate antibiotics. There is usually no need for removal of the IUD if the client wishes to continue its use. Continued use of an IUD depends on  woman\u2019s informed choice and her current risk factors for STIs and pelvic inflammatory disease (PID).",
    "action_key": 1531
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 1532
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, STIs",
        "value": "DAK, Other",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible to continue with this method with a medical eligibility category 2 \u2013 Generally use method for continuation",
    "action_key": 1533
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 1534
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Conditions relevant to sterilization and FAB",
        "value": "DAK, Vaginitis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible to continue this method with a medical eligibility category 2 \u2013 Generally use method for continuation",
    "action_key": 1535
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she may or may not be medical eligible for this method depending on the provider's judgement and national policies",
    "annotation": "Exercise clinical judgment for IUD insertion in women at increased STI risk. While the overall risk of PID is low, some individuals may have a higher risk. Risk of STIs varies by individual behaviour and local STI prevalence. Consider appropriate testing and treatment for those with a very high likelihood of STIs before IUD insertion.",
    "action_key": 1536
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Health condition(s)",
        "value": "DAK, Increased risk of sexually transmitted infections (STIs)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 1537
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 1538
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "value": "DAK, High risk of HIV disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible to continue with this method with a medical eligibility category 1 \u2013 Use method in any circumstance",
    "action_key": 1539
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method",
    "action_key": 1540
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Client is medically eligible to continue with this method with a medical eligibility category 2 \u2013 Generally use method",
    "action_key": 1541
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection.",
    "action_key": 1542
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method.\n\nIUD users with severe or advanced HIV clinical disease should be closely monitored for pelvic infection.",
    "action_key": 1543
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Schistosomiasis (uncomplicated)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Schistosomiasis with liver fibrosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1544
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Non-pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for initiation) \u2013 Use method in any circumstance",
    "action_key": 1545
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Non-pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 (for continuation) \u2013 Use method in any circumstance",
    "action_key": 1546
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Known pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 4 (for initiation) \u2013 Method NOT to be used",
    "action_key": 1547
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Known pelvic tuberculosis",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for continuation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1548
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Other infections (schistosomiasis, tuberculosis, malaria)",
        "value": "DAK, Malaria",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1549
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, History of gestational diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1550
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Non-insulin dependent diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1551
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Insulin-dependent diabetes",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1552
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "orValues": [
          "DAK, Diabetes with nephropathy",
          "DAK, Diabetes with retinopathy",
          "DAK, Diabetes with neuropathy"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1553
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Diabetes > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1554
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Diabetes",
        "value": "DAK, Other vascular disease > 20 years duration",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1555
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Simple goitre",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1556
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hyperthyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1557
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Thyroid disorders",
        "value": "DAK, Hypothyroidism",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1558
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (treated by cholecystectomy)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1559
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Symptomatic gall bladder disease (medically treated)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1560
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Current symptoms of gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1561
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Asymptomatic gall bladder disease",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1562
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, History of pregnancy-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1563
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Gall bladder disorders",
        "value": "DAK, Past combined oral contraceptives-related cholestasis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1564
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Acute or flare viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1565
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Carrier viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1566
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Chronic viral hepatitis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1567
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Mild (compensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1568
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Severe (decompensated) cirrhosis",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1569
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign focal nodular hyperplasia of the liver",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method",
    "action_key": 1570
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Benign hepatocellular adenoma",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1571
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Liver disorders",
        "value": "DAK, Malignant liver tumour (hepatoma/hepatocellular carcinoma)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable",
    "action_key": 1572
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Thalassemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1573
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Sickle cell anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1574
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Anemias",
        "value": "DAK, Iron-deficiency anaemia",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1575
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method (NRTIs).\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as category 2 for both initiation and continuation.",
    "action_key": 1576
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable (NRTIs).\n\nThere is no known interaction between ART and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as category 3 for initiation.",
    "action_key": 1577
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, NRTIs (e.g. ABC, TDF, AZT, 3TC, DDI, FTC, C265, D4T)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method for continuation",
    "action_key": 1578
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for initiation) \u2013 Generally use method.\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as Category 2 for both initiation and continuation.",
    "action_key": 1579
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "orValues": [
          "DAK, EFV",
          "DAK, ETR",
          "DAK, NVP",
          "DAK, RPV"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable.\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as category 3 for initiation.",
    "action_key": 1580
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors  (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method (protease inhibitors).\n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as category 2 for both initiation and continuation.",
    "action_key": 1581
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors  (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable (protease inhibitors).\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as category 3 for initiation.",
    "action_key": 1582
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Protease inhibitors (e.g. ATV/r, LPV/r, DRV/r, RTV)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method (protease inhibitors)",
    "action_key": 1583
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 1",
          "DAK, HIV disease stage 2"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method \n\nAsymptomatic or mild HIV clinical disease (WHO stage 1 or 2) is classified as category 2 for both initiation and continuation.",
    "action_key": 1584
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      },
      {
        "key": "DAK, HIV/AIDS",
        "orValues": [
          "DAK, HIV disease stage 3",
          "DAK, HIV disease 4"
        ],
        "operator": "OR"
      }
    ],
    "action": "Counsel client that she is NOT medically eligible for this method.\nDiscuss methods and options to find alternative contraception for the client.",
    "annotation": "Medical eligibility criteria (MEC) category 3 (for initiation) \u2013 Use of method not usually recommended unless other more appropriate methods are not available or acceptable (integrase inhibitors).\n\nThere is no known interaction between antiretroviral therapy (ART) and IUD use. However, severe or advanced HIV clinical disease (WHO stage 3 or 4) as a condition is classified as category 3 for initiation.",
    "action_key": 1585
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Integrase inhibitors (e.g. RAL)",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 (for continuation) \u2013 Generally use method",
    "action_key": 1586
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy (e.g. phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1587
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Anticonvulsant therapy with lamotrigine",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance.\n\nNo drug interactions have been reported among women with epilepsy taking lamotrigine and using the LNG-IUD.",
    "action_key": 1588
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1589
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "value": "DAK, Levonorgestrel intrauterine device (LNG-IUD)",
        "operator": "="
      },
      {
        "key": "DAK, Current medications FP",
        "value": "DAK, Antimicrobial therapy with rifampicin or rifabutin",
        "operator": "="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 1 \u2013 Use method in any circumstance",
    "action_key": 1590
  },
  {
    "conditions": [
      {
        "key": "DAK, Chosen method",
        "orValues": [
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Etonogestrel (ETG) one-rod"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, postpartum",
        "value": true,
        "operator": "="
      },
      {
        "key": "DAK, Date of last birth",
        "value": 180,
        "operator": "<="
      },
      {
        "key": "DAK, Amenorrhoea",
        "value": false,
        "operator": "="
      },
      {
        "key": "DAK, Is client currently breastfeeding?",
        "value": false,
        "operator": "="
      }
    ],
    "action": "Insert implant at the time of consultation if pregnancy is ruled out",
    "annotation": "\u2013An implant can be inserted at the time of consultation if pregnancy is ruled out by check list and also pregancy test.",
    "action_key": 1591
  },
  {
    "conditions": [
      {
        "key": "DAK, Bleeding - Oral contraceptive",
        "value": "DAK, Heavy or prolonged  bleeding",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Combined oral contraceptives (COCs)",
        "operator": "="
      }
    ],
    "action": "Discuss issues and concerns.",
    "annotation": "Refer or evaluate with history and pelvic examination. Diagnose and treat as needed. Client can continue using COCs during condition evaluation. If bleeding is due to STI or PID, she can continue COCs during treatment.",
    "action_key": 1592
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1593
  },
  {
    "conditions": [
      {
        "key": "DAK, Method in mind",
        "orValues": [
          "DAK, Etonogestrel (ETG) one-rod",
          "DAK, Levonorgestrel (LNG) two-rod(Jadelle)",
          "DAK, Levonorgestrel (LNG) two-rod(Levoplant)"
        ],
        "operator": "OR"
      },
      {
        "key": "DAK, Cardiovascular disease",
        "value": "DAK, Ischaemic heart disease",
        "operator": "="
      },
      {
        "key": "DAK, Method in use",
        "value": "DAK, Levonorgestrel (LNG) two-rod(Levoplant)",
        "operator": "!="
      }
    ],
    "action": "Counsel client that she is medically eligible for this method",
    "annotation": "Medical eligibility criteria (MEC) category 2 \u2013 Generally use method for initiation",
    "action_key": 1594
  }
]